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Summary and conclusions
Cardiovascular diseases (CVDs) represents the leading cause of mortality
worldwide. These pathological conditions are mainly characterized by a
structurally abnormal heart, that is, a vulnerable substrate, prone to the
abnormal generation and/or propagation of the electrical impulse, determi-
ning the onset of ventricular arrhythmias. In this context, the assessment
of ventricular repolarization from the electrocardiogram (ECG) signal has
been shown to provide with valuable information for risk stratification and
several electrocardiographic indices have been proposed in the literature.
The main objective of this thesis is to propose methodological advances
for the assessment of ventricular repolarization instability in pathological
and abnormal conditions. These contributions are aimed at improving the
prediction of ventricular arrhythmias and, consequently, better identifying
sudden cardiac death (SCD) risk. In particular, we have addressed this
objective by developing robust methodologies for the assessment of T-wave
alternans (TWA) and ventricular repolarization instability, in invasive and
non-invasive cardiac signals, that have been evaluated in both experimental
and clinical conditions.
In the first part of the thesis, TWA was simultaneously characterized
(prevalence, magnitude, time-course, and alternans waveform) in body-
surface ECG and intracardiac electrograms (EGM) signals during coronary
artery occlusion. Signals from both body surface ECG and intracardiac
EGM recorded from 4 different anatomical heart locations (coronary sinus,
epicardial space and left and right ventricles) were analyzed following a mul-
tilead strategy. Leads were linearly combined using the periodic component
analysis (πCA), which maximizes the 2-beat periodicity (TWA periodicity)
content present on the available leads. Then the Laplacian Likelihood Ratio
method (LLRM) was applied for TWA detection and estimation. A sensi-
tivity study for TWA detection from the 5 different locations of leads was
i
ii SUMMARY AND CONCLUSIONS
performed, revealing that it is the combination of the ECG leads that bet-
ter performs. In addition, this multilead approach allowed us to find the
optimal combination of intracardiac leads usable for in-vivo monitorization
of TWA directly from an implantable device, with a sensitivity comparable
to the ECG analysis. These results encourage further research to determine
the feasibility of predicting imminent VT/VF episodes by TWA analysis
implemented in implantable cardioverter defibrillator’s (ICD) technology.
Then, we have studied the potential changes induced by a prolonged
exposure to simulated microgravity on ventricular repolarization in struc-
turally normal hearts. It is well known that this environmental condition
affects the control of autonomic and cardiovascular systems, with a poten-
tial increase on cardiac electrical instability. The effects of short- (5 days),
mid- (21 days) and long- (60 days) exposure to simulated microgravity on
TWA using the head-down bed-rest (HDBR) model were assessed. TWA
was evaluated before (PRE), during and after (POST) the immobilization
period, by the long-term averaging technique in ambulatory ECG Holter
recordings. Additionally, we proposed an adapted short-term averaging ap-
proach for shorter, non-stationary ECG signals obtained during two stress
manoeuvres (head-up tilt-table and bicycle exercise tests). Both approa-
ches are based on the multilead analysis used in the previous study. The
absence of significant changes between PRE and POST-HDBR on TWA
indices suggests that a long-term exposure to simulated microgravity is not
enough to induce alterations in healthy myocardial substrate up to the point
of reflecting electrical instability in terms of TWA on the ECG.
Finally, methodological advances were proposed for the assessment of
ventricular repolarization instability from the ECG signal in the presence of
sporadic (ventricular premature contractions, VPCs) and sustained (atrial
fibrillation) rhythm disturbance.
On the one hand, a methodological improvement for the estimation of
TWA amplitude in ambulatory ECG recordings was proposed, which deals
with the possible phase reversal on the alternans sequence induced by the
presence of VPCs. The performance of the algorithm was first evaluated
using synthetic signals. Then, the effect of the proposed method in the
prognostic value of TWA amplitude was assessed in real ambulatory ECG
recordings from patients with chronic heart failure (CHF). Finally, circa-
dian TWA changes were evaluated as well as the prognostic value of TWA
at different times of the day. A clinical study demonstrated the enhance-
ment in the predictive value of the index of average alternans (IAA) for
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SCD stratification. In addition, results suggested that alternans activity is
modulated by the circadian pattern, preserving its prognostic information
when computed just during the morning, which is also the day interval with
the highest reported SCD incidence. Thus, suggesting that time of the day
should be considered for SCD risk prediction.
On the other hand, the high irregularity of the ventricular response in
atrial fibrillation (AF) limits the use of the most common ECG-derived
markers of repolarization heterogeneity, including TWA, under this clinical
condition. A new method for assessing ventricular repolarization changes
based on a selective averaging technique was developed and new non-invasive
indices of repolarization variation were proposed. The positive impact in
the prognostic value of the computed indices was demonstrated in a clinical
study, by analyzing ECG Holter recordings from CHF patients with AF. To
the best of our knowledge, this is the first study that attempts a non-invasive
SCD stratification of patients under AF rhythm by assessing ventricular
repolarization instability from the ECG signal.
To conclude, the research presented in this thesis sheds some light in the
identification of pro-arrhythmic factors, which plays an important role in
adopting efficient therapeutic strategies. In particular, the optimal configu-
ration for real-time monitoring of repolarization alternans from intracardiac
EGMs, together with the prognostic value of the proposed non-invasive in-
dices of alternans activity and ventricular instability variations in case of
AF rhythms demonstrated in two clinical studies, would increase the ef-
fectiveness of (ICD) therapy. Finally, the analysis of ECG signals recorded
during HDBR experiments in structurally healthy hearts, also provides in-
teresting information on cardiovascular alterations produced in immobilized
or bedridden patients.
Keywords: Electrocardiogram; Intracardiac Electrogram; Ventricular
Repolarization; Cardiac Electrical Instability; T-wave alternans; Sudden
Cardiac Death; Risk Prediction; Advance Signal Processing; Implantable
Cardioverter Defibrillator; Chronic Heart Failure; Atrial Fibrillation; Ische-
mia; Microgravity; Head-Down Bed-Rest.

Resumen y conclusiones
Las enfermedades cardiovasculares representan la principal causa de morta-
lidad en el mundo. Estas condiciones patológicas normalmente se caracte-
rizan por presentar una estructura anormal del músculo cardiaco, esto es,
un substrato vulnerable propenso a la generación y/o propagación anormal
del impulso eléctrico, que resulta ser un factor determinante en el inicio de
arritmias ventriculares. En este contexto, se ha demostrado que el estu-
dio de la repolarización ventricular en la señal electrocardiográfica (ECG),
reflejada en la onda T, puede proporcionar valiosa información para la estra-
tificación de riesgo en pacientes, y varios ı́ndices electrocardiográficos han
sido propuestos en la literatura.
El principal objetivo de esta tesis es proponer avances metodológicos
para evaluar la inestabilidad de la repolarización ventricular en diferentes
condiciones anormales y patológicas. Estas contribuciones están principal-
mente dirigidas a mejorar la predicción de arritmias ventriculares y, conse-
cuentemente, identificar mejor el riesgo de padecer muerte súbita cardiaca
(MSC). En particular, se han desarrollado métodos robustos para evaluar
las alternancias de onda T (AOT) y la inestabilidad en la repolarización
ventricular, en señales cardiacas invasivas y no invasivas. Estos métodos
han sido evaluados en condiciones cĺınicas y experimentales.
En la primera parte de la tesis, se ha caracterizado el fenómeno de las
AOT (prevalencia, magnitud, evolución temporal y forma de onda de la
alternancia) simultáneamente en la señal ECG de superficie y en electro-
gramas (EGM) intracavitarios durante una oclusión coronaria. Tanto las
señales de ECG de superficie como las señales intracavitarias, registradas
en 4 localizaciones anatómicas diferentes (seno coronario, epicardio y los
ventŕıculos izquierdo y derecho) se han analizado usando una estrategia
multiderivacional. Las derivaciones disponibles se combinan linearmente
usando el análisis de las componentes periódicas (πCA), que maximiza las
v
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componentes de periodo 2 latidos presentes en las diferentes derivaciones.
Tras ello, se aplica el método del cociente de verosimilitudes para ruido lap-
laciano (LLRM, de las siglas en inglés) para la detección y estimación de
las AOT. Con un estudio de sensibilidad para la detección de la AOT desde
las 5 regiones diferentes se ha demostrado que es el grupo de derivaciones
del ECG de superficie el que mayor sensibilidad presenta. Además, esta
estrategia multiderivacional ha permitido encontrar la combinación óptima
de derivaciones intracavitarias de cara a la monitorización in-vivo de las
AOT, directamente desde un dispositivo implantable, con una sensibilidad
comparable a la obtenida con el ECG. Estos resultados animan a continuar
el estudio de la posibilidad de predecir episodios inminenetes de taquicardia
o fibrilación ventricular a través del análisis de AOT directamente imple-
mentado en la tecnoloǵıa de un desfibrilador automático implantable (DAI).
Tras ello, hemos estudiado los potenciales cambios inducidos por un pe-
riodo prolongado de exposición a microgravedad simulada en sujetos sanos.
Se sabe que esta condición ambiental afecta al control de los sistemas au-
tonómico y cardiovascular, produciendo un potencial aumento de la inesta-
bilidad eléctrica cardiaca. En concreto, se han estudiado los efectos sobre
la AOT de la exposición a la microgravedad simulada usando el modelo
head-down bed-rest (HDBR) en campañas de corta, media y larga duración
(5, 21 y 60 d́ıas, respectivamente). Se han calculado las AOT antes (PRE),
durante y después (POST) del periodo de inmobilización usando la técnica
de promediado a largo plazo en registros ECG ambulatorios. Además, se ha
propuesto una versión adaptada al análisis de registros no estacionarios de
corta duración obtenidos durante dos maniobras de estrés (tilt-test y prueba
de esfuerzo). Ambas estrategias están basadas en el análisis multiderivaci-
onal usado en el estudio anterior. La ausencia de cambios significativos
entre PRE y POST-HDBR en los ı́ndices de AOT sugieren que 60 d́ıas de
exposición a microgravedad simulada no es tiempo suficiente para inducir
alteraciones en miocardios estructuralmente sanos, hasta el punto de reflejar
inestabilidad eléctrica en términos de AOT.
Finalmente, se han propuesto avances metodológicos para determinar
inestabilidades en la repolarización ventricular en el ECG en presencia de
perturbaciones de ritmo esporádicas (contracciones ventriculares prematu-
ras, CVP) o sostenidas (fibrilación auricular, FA).
Por un lado, se ha propuesto una mejora metodológica para la estimación
de la amplitud de la AOT en registros ambulatorios, que tiene en cuenta la
posible inversión de fase en la secuencia alternante inducida por la presencia
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de CVPs. El algort́ıtmo ha sido evaluado en primer lugar usando señales
sintéticas. Tras ello, se ha evaluado también su efecto en el valor pronóstico
de la amplitud de AOT en ECG ambulatorios de pacientes con insuficiencia
cardiaca (IC). Finalmente, se han estudiado los cambios circadianos en las
AOT, aśı como el valor pronóstico en diferentes intervalos del d́ıa. Mediante
un estudio cĺınico se ha demostrado la mejora del valor predictivo del ı́ndice
de alternancia promedio (IAA, de las siglas en inglés). Además, los resul-
tados obtenidos del análisis circadiano sugieren que la actividad alternante
está modulada por este patrón, manteniendo su valor pronóstico en las horas
matinales, que se corresponden con el intervalo del d́ıa con mayor incidencia
de MSC. Aśı pues, el periodo del d́ıa parece ser otro factor importante a la
hora de determinar el riesgo de MSC.
Por otro lado, la irregularidad de la respuesta ventricular en pacientes
con FA limita el uso de los ı́ndices electrocardiográficos más comunes, entre
ellos las AOT, en registros con esta condición. Se ha desarrollado un nuevo
método para cuantificar cambios en la repolarización ventricular basado el
la técnica de promediado selectivo y se han propuesto varios ı́ndices de
variación de la repolarización. El valor pronóstico de estos ı́ndices se ha
demostrado en un estudio cĺınico, analizando registros ECG ambulatorios
de pacientes con IC en FA. Hasta donde podemos saber, éste es el primer
estudio que ha propuesto un método para cuantificar inestabilidades en la
repolarización ventricular desde el ECG adecuado a pacientes en ritmo de
FA.
En conclusión, el trabajo de investigación presentado en esta tesis ar-
roja luz en la identificación de factores pro-arŕıtmicos, lo cual resulta crucial
en la adopción terapias eficientes. En particular, la configuración óptima
de derivaciones para monitorizar AOT en señales intracavitarias, junto con
el valor pronóstico de los ı́ndices propuestos demostrado en dos estudios
cĺınicos, pueden ayudar a mejorar la eficiencia de los DAIs. Finalmente, el
análisis de señales ECG registradas durante experimentos de micrograve-
dad simulada puede aportar información útil de alteraciones en el sistema
cardiovascular a tener en cuenta en pacientes inmobilizados o encamados
durante largos periodos.
Palabras clave: Electrocardiograma; electrograma intracavitario; re-
polarización ventricular; inestabilidad eléctrica cardiaca; alternancias de
onda T; muerte súbita cardiaca; predicción de riesgo; procesado de señal
avanzado; desfibrilador automático implantable; insuficiencia cardiaca; fi-
brilación auricular; isquemia; microgravedad; Head-Down Bed-Rest.

Riassunto e conclusioni
Le malattie cardiovascolari (MCD) sono la principale causa di morte al
mondo. Queste condizioni patologiche sono normalmente caratterizzate da
difetti cardiaci a livello strutturale, e rendono perciò il cuore una struttura
vulnerabile, incline alla generazione e/o propagazione anomala di impulsi
elettrici che determinano l’instaurarsi di aritmie ventricolari. In questo con-
testo, è stato mostrato come la misura della ripolarizzazione ventricolare
a partire dall’elettrocardiogramma (ECG), possibile tramite l’onda T, for-
nisca informazioni importanti per una stratificazione del rischio, per la quale
sono stati proposti diversi indici elettrocardiografici.
L’obiettivo principale di questa tesi è il proporre sviluppi metodologici
per la valutazione della ripolarizzazione ventricolare in condizioni patologi-
che e non fisiologiche. I contributi qui presentati sono volti al miglioramento
della predizione delle aritmie ventricolari e, di conseguenza, a migliorare la
diagnosi di rischio di arresto cardiaco improvviso. In particolare, il nos-
tro approccio ha previsto lo sviluppo di metodi robusti per la valutazione
dell’alternanza dell’onda T (TWA) e dell’instabilità della ripolarizzazione
ventricolare, usando segnali cardiaci invasivi e non, e validando i metodi in
condizioni sperimentali e cliniche.
Nella prima parte della tesi, la TWA è stata caratterizzata (prevalenza,
ampiezza, andamento e forma d’onda) usando ECG di superficie ed elet-
trogrammi (EGM) intracardiaci acquisiti in simultanea durante occlusi-
one dell’arteria coronarica. I segnali provenienti dall’ECG di superficie e
dall’EGM acquisito in 4 differenti posizioni (seno coronarico, interstizio epi-
cardiale ed entrambi i ventricoli) sono stati analizzati seguendo una strategia
multilead. Le derivazioni sono state combinate linearmente usando l’analisi
di componenti periodiche (πCA), che massimizza il contenuto periodico del
segnale compreso tra 2 battiti (periodicità della TWA) sulle derivazioni dis-
ponibili. Quindi, un metodo basato sul Rapporto di Verosimiglianza Lapla-
ix
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ciano (ad esempio LLRM) è stato applicato per la detenzione e la stima della
TWA. Uno studio di sensitività per la detezione della TWA dalle 5 registra-
zioni disponibili ha mostrato che le prestazioni migliori si sono riscontrate
combinando le derivazioni ECG. Inoltre, questo approccio multilead ha per-
messo di identificare la combinazione ottima di derivazioni intracardiache
per il monitoraggio della TWA in-vivo tramite un dispositivo impiantabile,
con una sensitività paragonabile a quella data dall’ECG. Questi risultati
incoraggiano lo studio della fattibilità di predire episodi di VT/VF tramite
l’analisi della TWA implementato all’interno di un ICD.
In seguito, ci si è dedicati alla valutazione delle potenziali variazioni
indotte da un’esposizione prolungata a microgravità simulata sulla ripola-
rizzazione ventricolare in strutture cardiache strutturalmente sane. È noto
che queste condizioni ambientali hanno ripercussioni sul controllo dei sis-
temi autonomico e cardiovascolare, con un potenziale aumento di instabi-
lità elettrica cardiaca a livello della ripolarizzazione ventricolare. Gli effetti
di un’esposizione breve (5 giorni), media (21 giorni) e prolungata (60 gi-
orni) a microgravità simulata sulla TWA sono stati misurati usando il mo-
dello chiamato head-down bed-rest (HBDR). La TWA è stata valutata prima
(PRE), durante e dopo (POST) il periodo di immobilità, usando la media
sul lungo periodo su registrazioni di ECG ambulatoriali. In aggiunta, si è
proposto un approccio di calcolo degli indici della TWA sul breve periodo
modificato, per l’applicazione su registrazioni ECG non stazionarie e più
brevi, acquisite durante due manovre sperimentali che inducono una con-
dizione di stress (head-up tilt-test e test di sforzo). Entrambi gli approcci
proposti sono basati sullanalisi multilead utilizzata nello studio precedente.
L’assenza di variazioni significative tra PRE e POST-HBDR negli indici di
TWA, seppur in presenza di trend in direzione di un aumento del rischio,
suggerisce che l’esposizione prolungata a microgravità simulata non basta
ad introdurre in un miocardio sano alterazioni tali da portare ad instabilità
elettrica rilevabile dall’ECG tramite la misura della TWA.
Infine, sono stati proposti sviluppi metodologici per la valutazione dell’ins-
tabilità della ripolarizzazione ventricolare misurata sul segnale ECG in pre-
senza di disturbi sporadici del ritmo (contrazioni ventricolari premature,
CVP) e sostenuti (fibrillazione atriale, FA).
Da una parte, si è presentato un miglioramento nel metodo per la stima
dell’ampiezza della TWA in registrazioni ECG ambulatoriali, che tiene in
conto della possibile inversione di fase nella sequenza dell’alternanza dovuta
alla presenza di CVP. Le prestazioni dell’algoritmo sono state valutate dap-
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prima tramite simulazioni. In seguito, il contributo del metodo proposto al
valore prognostico dell’ampiezza della TWA è stato valutato usando ECG
reali di pazienti con scompenso cardiaco. Infine, le variazioni circadiane di
TWA sono state valutate insieme al valore prognostico della TWA a diffe-
renti ore della giornata. Uno studio clinico ha dimostrato un miglior valore
predittivo dell’indice di alternanza medio (IAA) per la stratificazione di
rischio soffrire arresto cardiaco.
Allo stesso tempo, l’elevata irregolarità della risposta ventricolare du-
rante FA limita l’uso dei marker più comuni di eterogeneità della ripolariz-
zazione derivanti dall’ECG, inclusa la TWA, in presenza di questa patologia.
È stato quindi proposto un nuovo metodo, basato su una tecnica di media
selettiva, per la valutazione delle variazioni di ripolarizzazione ventricolare,
e sono stati introdotti nuovi indici di variazione della ripolarizzazione non
invasivi. Uno studio clinico ha misurato il contributo positivo al valore
prognostico fornito da tali indici, analizzando registrazioni ECG Holter da
pazienti con scompenso cardiaco che presentavano FA. Per quanto ci risulta,
questo è stato il primo tentativo di stratificazione non-invasiva di pazienti
con arresto cardiaco durante FA, sfruttando la misura di instabilità di ripo-
larizzazione ventricolare dal segnale ECG.
In conclusione, il lavoro qui presentato contribuisce ad una migliore
identificazione di fattori che predispongono ad aritmie, fondamentale per
l’adozione di strategie terapeutiche efficaci. In particolare, la configurazi-
one ottimale per il monitoraggio in tempo reale dell’alternanza di ripolariz-
zazione da segnali EGM intracardiaci, insieme al valore prognostico degli
indici di alternanza ed instabilità ventricolare non-invasivi durante fibril-
lazione atriale, dimostrato in due studi clinici, può contribuire all’efficacia
della terapia ICD. Infine, anche l’analisi di segnali ECG registrati durante
esperimenti HDBR in soggetti sani fornisce informazioni sul sistema cardi-
ovascolare di cui tener conto in caso di pazienti immobilizzati o costretti a
letto per lunghi periodi.
Parole chiave: Elettrocardiogramma; Elettrogramma Intracardiaco;
Ripolarizzazione Ventricolare; Instabilità Elettrica; Alternanza dell’onda T;
Arresto Cardiaco improvviso; Predizione di Rischio; Elaborazione di Seg-
nali; Defibrillatore Impiantabile; Scompenso Cardiaco; Fibrillazione Atriale;
Ischemia; Microgravità; Head-Down Bed-Rest.
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1.5.1 T-Wave Alternans
1.6 Objectives and outline
of the thesis
1.1 Motivation
Cardiovascular diseases (CVDs) remain the leading cause of death world-
wide. According to data published in 2015, they are responsible for more
than 4 million deaths in Europe (45.5% of all deaths) every year [1], accoun-
ting for 17.3 million cases worldwide, a number which is expected to rise up
to > 23.6 million by 2030 [2]. Among CVDs, ischemic (or coronary) heart
1
2 Chapter 1. Introduction
disease (IHD) and stroke are both the main single causes of cardiovascular-
related death [1]. A great part of these deaths occur suddenly, shortly after
the appearance of the first symptoms and generally as a consequence of
malignant ventricular arrhythmias. This fatal outcome, known as sudden
cardiac death (SCD), accounts for over 300,000 deaths per year in Europe,
most victims being patients with structural heart disease [3]. In this con-
text, implantable cardioverter defibrillators (ICDs) have been shown to be
highly effective at terminating these life-threatening arrhythmias, eventually
preventing SCD. However, in addition to the risk induced by the invasive
procedure, the cost-effectiveness of this therapy is still low, and identifying
patients who would benefit the most from device implantation remains a
clinical problem.
These figures justify every effort in improving diagnosis, prevention, tre-
atment and risk stratification of CVDs. Actually, this represents one of the
major challenges that the European healthcare systems are facing nowadays,
due to their social and economic costs.
Several non-invasive indices have been proposed for the assessment of
the risk of developing ventricular arrhythmias. The left ventricular ejection
fraction, obtained by echocardiographic analysis, is the most widely used in
the clinical practice. In addition, the predictive value of some electrocardi-
ographic indices, mainly based on the analysis of ventricular repolarizarion,
such as QT interval/dispersion, has been proved [4], but it is still limited
by their low specificity rates. T-wave alternans (TWA) has been postulated
as one of the most promising non-invasive markers of electrical instability
and ventricular vulnerability [5]. Its prognostic value has been widely as-
sessed under different pathologies and, in the recent years, the analysis of
TWA in ambulatory ECG recordings is yielding promising results. In this
thesis, methodological advances are proposed to improve risk stratification
based on ventricular repolarization indices, mainly TWA, which are robust
to sporadic and sustained rhythm disturbances. Their clinical value was
then assessed in both experimental and clinical databases.
1.2 The Heart
The heart is a muscular organ about the size of a fist, whose main function
is to pump blood into the circulatory system. Its anatomy is actually divi-
ded into two separate, “mirrored” pumps, left and right, which supply the
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systemic (or peripheral) and the pulmonary circulatory systems, respecti-
vely. Each of these pumps consists of two chambers: the atrium and the
ventricle. The atria act as receiving chambers and help to move the blood
into the ventricle. The ventricles supply the main pumping force to eject the
blood either to the pulmonary circulation (right ventricle, RV) or throug-
hout the systemic or peripheral circulation (left ventricle, LV) each cycle.
Both pumps are separated by a muscular wall, called the septum, and di-
rection of blood is controlled by two atrio-ventricular valves (tricuspid and
mitral valves for right and left chambers, respectively) and the pulmonary
and aortic valves, located between the ventricles and the arteries [6]. See
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Figure 1.1: Structure of the heart, and course of blood through the heart chambers
and heart valves. (Reproduced from [6]).
The wall of the cardiac muscle, called the myocardium, is composed by
specialized muscle cells (myocytes) which are responsible of the rapid pro-
pagation of the electrical impulse throughout the conduction system and
trigger the mechanical force during heart contraction, defining the cardiac
cycle (heart beat). Each cardiac cycle starts with the spontaneous gene-
ration of an action potential (AP) in the sinoatrial (SA) node, located in
the right atrium (RA), which is then propagated through to the ventricles.
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This allows atrial contraction and, as a consequence, blood is pumped into
the ventricles. Then, the stronger ventricular contraction ejects the blood
into the body. This period is called systole. It is followed by a period of
relaxation called diastole, during which the heart fills with blood until the
next atrial systole [6].
1.2.1 Cardiac Electrophysiology
The heart is characterized by a specialized excitatory and conductive sy-
stem, able to generate electrical impulses that induce cardiac contraction,
and to propagate them cell to cell in a rapid and organized way throughout
the heart (depolarization phase). Following depolarization, cardiac muscle
returns to a resting state (repolarization phase) [6]. The transmembrane
potential of each myocyte experimented changes during this cycle, which is
called the action potential. Electrical activity of the heart can be characte-
rized both from measurements at the cellular level, which are fundamental
for a deeper understanding of the mechanisms behind cardiac disorders, and
from measurements at the body surface (electrocardiography), reflecting the
total extracellular activity of cardiac currents generated by potential chan-
ges across cardiac cells [7].
Cellular Electrical Activity
The AP of each cardiac cell is the result of ion charges moving in and out
of the cell through ion channels. Under resting conditions, the inside of the
cell has a more negative voltage than the outside, creating a negative trans-
membrane potential, defined as Vm = Vin − Vout. During depolarization,
the transmembrane potential raises over this resting potential (from -90 to
20 mV) due to a rapid influx of sodium ions across the myocyte membrane.
During repolarization, the membrane potential of the cell gradually returns
to its resting value due to the opening of potassium channels [7]. The AP of
a ventricular myocyte has five different phases (numbered 0-4) as illustrated
in Figure 1.2:
Phase 4: The cell is at rest during diastole, and the transmembrane
potential remains constant between -85 to -95 mV.
Phase 0: The opening of fast sodium (Na+) channels entails an
initial rapid upstroke that corresponds to the depolarization phase.
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Fast sodium channels open and this originates a rapid influx of Na+
ions into the cell. The activation of Na+ channels triggers the AP
and it is closely related to cardiac excitability.
Phase 1: The inactivation of fast Na+ channels yields to an early
and brief repolarization. Together with a net transient outward pot-
assium (K+) current, they are the responsible of the small downward
deflection present in the AP (spike-and-dome morphology).
Phase 2: The influx of calcium (Ca2+) through the L-type calcium
channels compensates the repolarizing potassium currents, delaying
repolarization and creating a slow-decaying plateau. This plateau
prolongs the AP duration (APD).
Phase 3: The L-type calcium channels (ICaL) start closing while
potassium currents are open, leading the cell to its resting state (re-
polarization) [8].














Adjacent cardiac cells are connected by low-resistance gap junctions.
When one cell depolarizes, depolarizing currents can pass through these
junctions and depolarize adjacent cells. This process results in wavefront
propagation of APs throughout the whole myocardium.
Electrical Activity of the Normal Heart
Cardiac contractions are controlled by the excitatory and conductive system
of the heart. In the normal heart, a rhythmical impulse is generated in the
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SA node, a mass of self-excitable cells located in the superior post-lateral
wall of the RA, near the entry of the superior vena cava. The electrical im-
pulse spreads throughout the atrial pathways to the atrioventricular (AV)
node, where it suffers a delay that allows the atrial contraction to further in-
crease the blood volume in the ventricles before the ventricular systole takes
place. The impulse then passes the bundle of His, which lies in the inter-
ventricular septum and divides into right and left bundle branches, finally
reaching the Purkinje system (Figure 1.3). The Purkinje system is a net-
work of specialized conduction fibers which rapidly propagate the impulse
to the inner layer of the cardiac muscle (endocardium), which is then pro-
pagated cell-to-cell towards the outer surface of the heart (epicardium) and
back to the atrioventricular groove, in order to achieve a unified contraction
within the ventricles [7].
However, ventricular repolarization is not an homogeneous process, con-
sequence of a inhomogeneous distribution of ionic dynamics and different
repolarization times. This originates spatial dispersion of repolarization
among different regions of the myocardium (i.e., between base and apex,
anterior and posterior side of the ventricles), between the two ventricles and
even transmurally, (among endocardial, midmyocardial and epicardial cells),
which has been widely documented [9]. While normal ranges of dispersion
allow for an efficient contraction of the heart, an accentuated repolarization
dispersion is associated to the risk of life-threatening arrhythmias [10–12].
Some cardiac cells have the intrinsic property of automaticity (i.e. they
can generate an AP in the absence of external stimuli). The natural pa-
cemaker of the normal heart is the SA node, as its cells are those with
higher discharge rate. This natural rhythm, driven by the SA node, is
known as the sinus rhythm (SR) [6]. The intrinsic heart rate (HR) of the
SA node is about 100-120 beats/min in absence of the autonomic nervous
system (ANS) influence [13]. The heart, however, is supplied with both
the sympathetic and parasympathetic branches of the ANS, which regulate
cardiovascular functions, including HR. Each of the branches is dominant
under certain conditions: the sympathetic nervous system acts in an alarm
situation and during exercise (“fight-or-flight” reaction), increasing HR and
myocardial contractility; the parasympathetic nervous system, on the other
hand, is the responsible of the so called “rest and digest” state predominant
during resting conditions, decreasing HR and regulating respiration, among
others.












Figure 1.3: Specialized excitatory and conductive system of the heart. Morphology
and timing of the action potentials from different regions of the heart and the
related cardiac cycle of the electrocardiogram as measured on the body surface
(Reproduced from [7]).
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Occasionally, some parts of the myocardium can develop a more rapid
discharge rate than that of the SA node in depolarization, taking the control
of the cardiac beat generation. In this cases, the pacemaker, denominated
ectopic focus, is somewhere else than the SA node and originates an abnor-
mal sequence of muscle contraction that can cause an inefficient pumping
of the heart [6].
1.3 Recording techniques
1.3.1 The Electrocardiogram Signal
The electrocardiographic signal or electrocardiogram (ECG) signal descri-
bes the electrical activity of the heart measured on the body surface, using
electrodes that are placed on the skin. This activity is the resultant of the
electrical activity of all cardiac cells at a given time, as observed in the
body surface. The timing relationship between the different APs occur-
ring at different regions of the heart and the resulting ECG recorded from
an exploring electrode positioned on the chest is illustrated in Figure 1.3.
For ECG acquisition, electrodes need to be positioned so that the spatio-
temporal variations of electrical activity are sufficiently well-reflected.

































Figure 1.4: An ECG of two cardiac cycles with definition of main waves and most
relevant time intervals (Reproduced from [7]).
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Each cardiac cycle is reflected in the ECG as a sequence of positive and
negative deflections or waves whose timing and morphology provide useful
diagnostic information when disturbances in the electrical activity of the
heart are manifested on it. These waves, associated to cardiac depolariza-
tion and repolarization, appear as a deviation from the baseline level or the
isoelectric line of the ECG, which represents the resting state of all car-
diac cells. The polarity and morphology of each individual wave depend on
the position of the recording electrode. A depolarizing wavefront moving
towards the electrode originates a positive deflection on the ECG, while
a current moving away from the electrode originates a negative deflection.
The opposite behaviour is observed during repolarization, since repolariza-
tion have an opposite polarity: a wavefront moving towards the electrode
originates a negative deflection below the isoelectric wave whereas a positive
deflection is generated if this wavefront moves away from the electrode. De-
polarization waves in the ECG are generally steeper and peakier than those
related to repolarization, which are smoother. Also the larger muscle mass
of the ventricles originates much larger ventricular depolarization waves in
comparison to atrial ones [7].
The amplitude and duration of the waves are defined considering as a
reference level the isoelectric line of the ECG. The first positive deflection
above the baseline level, with an amplitude normally lower than 300 µV
and a duration shorter than 120 ms, is denoted as the P wave and reflects
the initial atrial depolarization. Then, depolarization of right and left ven-
tricles is reflected by the succession of a series of deflections (typically one
to three), referred together as the QRS complex. In a typical beat from a
healthy adult heart, the QRS lasts for about 70-110 ms and reaches an am-
plitude of about 1-2 mV. Atrial repolarization, which occurs simultaneously
to ventricular depolarization cannot be discerned in the ECG as it is mas-
ked by the much higher amplitude of the QRS complex. There is a period
during which ventricles remain in an active, depolarized state manifested
as a nearly horizontal line between the end of the S wave (J point) and
the onset of ventricular repolarization, denoted as the ST segment. Finally,
the positive deflection originated in the ECG during ventricular repolariza-
tion is referred as the T wave, which is considerable longer (lasts for about
300 ms) and smoother than the QRS complex, as a consequence of the re-
latively slower repolarization phase of the myocardium in comparison to
cardiac depolarization [7]. Figure 1.4 illustrates the typical waves and the
most significant time intervals in a normal ECG during sinus rhythm.
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1.3.2 The Lead System
Each ECG lead represents a different electrical axis onto which the electrical
activity of the heart is projected. Therefore, each lead can be considered
to represent a different spatial perspective of the heart’s electrical activity.
The ECG signal is typically recorded with a multiple lead configuration
which includes unipolar or bipolar leads, or both. A so-called unipolar lead
reflects the voltage variation of a single electrode and is measured in relation
to a reference (commonly called the central terminal) whose voltage remains
almost constant throughout the cardiac cycle. A bipolar lead reflects the
voltage difference between two electrodes.
In the clinical practice, a number of lead configurations are used with
standardized electrode positions, including the standard 12-lead ECG and
the 3-lead orthogonal configuration. If these leads are appropriately placed,
the ensemble of the different waveforms provides a robust understanding
of the electrical activity throughout the heart, allowing the clinician to de-
termine a number of pathologies through spatial correlation of events on
specific leads. Actually, the choice of a particular lead system is guided by
the type of clinical information desired and other practical considerations.
For example, a few electrodes are usually used when only heart rhythm
information is required, while ten electrodes (12-lead configuration) is pre-
ferred when wave’s morphology needs to be analyzed [7]. Also depending on
the purpose of the exploration, there are several specialised types of ECG.
Some of them are: the resting ECG, the exercise stress test, the Holter
ambulatory monitoring, the high-resolution ECG, the intensive care unit
(ICU) monitoring and polysomnographic recordings, among others.
The Standard 12-lead ECG
The standard 12-lead ECG is the most extensively used setup in clinical
routine, recorded using 10 electrodes positioned on the body surface. Based
on the plane in which electrical activity is recorded, the 12 leads are divided
in two groups of six: the six frontal leads (Figure 1.5, left) and the six chest
lead, also referred as precordial leads (Figure 1.5, right).
The frontal leads can be sub-divided into two further configurations: the
three bipolar limb leads and the augmented unipolar limb leads. The three
bipolar limb leads, denoted as I, II and III, are obtained by measuring the




































































Figure 1.5: The direction of the six limb leads in the frontal plane (left) and the six
precordial leads in the horizontal plane (Reproduced from [7]).
voltage difference between the left arm (VLA), right arm (VRA), and left leg
(VLL), according to the following combinations:
I = VLA − VRA (1.1)
II = VLL − VRA (1.2)
III = VLL − VLA (1.3)
The three electrode positions describe the equiangular “Einthoven’s tri-
angle” with the heart positioned at its center: Lead I looks directly to the
heart from left hand, while lead II looks at the heart +60◦ clockwise from
lead I and lead III, further +60◦ clockwise from lead II.
The augmented unipolar leads are denoted as aVF, aVL and aVR, and
describe the directions which are shifted 30◦ from those of the bipolar leads
using the same electrode configuration (Figure 1.5, left). They are defined
as the voltage differences between one corner of the triangle and the average
of the remaining two:
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The six precordial leads, labeled from V1 to V6, are unipolar leads
positioned on the front and the left side of the chest, and related to a
central terminal (“Wilson central terminal”) which is defined as the average
of the voltages measured on the right and left arms and the left leg. Leads
V1 and V2, positioned in the 4th intercostal space to the right and left of
the sternum respectively, face the surface of the right ventricle. They are
followed by the V3 to V6 leads positioned at equally spaciated intervals, the
later positioned at the 5th left intercostal space in the mid-axillary line: V3
and V4 face the anterior wall of the left ventricle, while V5 and V6 face the





Figure 1.6: A vectorcardiographic loop and its projection onto the three orthogonal
planes. The two arrows outside each loop indicate the direction in which the loop
evolves (Reproduced from [7]).
The orthogonal lead system reflects the electrical activity of the heart in
the right-left axis (leadX), the head-to-feet axis (lead Y ) and the front-back
axis (lead Z). This system, in addition to the ECG information acquired
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from each individual lead, provides with additional information through
the visualization of a three-dimensional loop together with the projection
onto the XY−, XZ− and Y Z− planes (Figure 1.6). Since a loop is traced
out by the tip of the vector that describes the dominant direction of the
electrical wavefront during the cardiac cycle, this recording is referred to as
a vectorcardiogram (VCG) [7].
The most widely used orthogonal lead system, known as the Frank lead
system after its inventor [14], is obtained as linear combinations of seven
electrodes positioned on the chest, back, neck, and left foot. The resulting
leads X, Y and Z view the heart from the left side, from below, and from
the front.
1.3.3 The Intracardiac Electrogram Signal
The intracardiac electrogram (EGM) signal represents the local electrical
activity of the heart recorded by multi-electrode catheters, directly in con-
tact with the heart tissue. This kind of signals provide with more detailed
information about wavefronts propagation, including the identification of
the local activation time (time resolution), the direction and origin of the
propagation and the localization of the discrete area of excited tissue that
generates the recorded potentials (spatial resolution) [15].
Unipolar EGMs (Figure 1.7, left) represent the potential difference be-
tween the electrode in contact with the heart (the exploring electrode) and
a reference distant electrode (the indifferent electrode, generally located on
the patient’s surface). When the wavefront moves towards the exploring
electrode, it will result in a positive deflection on the EGM signal. On the
contrary, when the wavefront moves away from the electrode, it will result
in a negative deflection. The amplitude of the unipolar EGM decreases
as the distance between the wavefront and the sensing electrode increases.
It contains not only local information, characterized by a higher frequency
content, but also far-field activity, less sharp but of higher amplitude [15].
Bipolar EGMs (Figure 1.7, right) are obtained as the difference between
two close exploring electrodes (using the same reference). The amplitude of
the bipolar EGM decreases even more rapidly with increasing distance than
the unipolar amplitude and the spatial resolution increases as the distance
between the two electrodes decreases. This kind of EGMs are less sensitive
to far-field activity, as it is removed consequence of subtraction, allowing
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for a better identification of local information with a higher signal-to-noise
ratio. In contrast to unipolar EGMs, directionality of wavefront propagation
can no be reliably inferred from signal morphology [15].
Unipolar EGMs recorded by decapolar catheters placed in the epicardial
space, right and left ventricles and the coronary sinus will be used in this
thesis.

































































Figure 1.7: Example of unipolar (left) and bipolar (right) intracardiac electrogram
signals recorded at four different anatomical locations: coronary sinus (CS), epi-
cardial space (EPI), left and right ventricles (LV and RV).
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1.4 Abnormal cardiac conditions and diseases stu-
died in this thesis
1.4.1 Ventricular Arrhythmias and Electrical Disturbances
By definition, ventricular arrhythmia is any abnormal rapid heart rhythm
that originates in the ventricles [16]. This term includes ventricular pre-
mature contractions (VPCs), ventricular tachycardia (VT) and ventricular
fibrillation (VF).
Ventricular premature contraction: It is an extra, abnormal heart beat
originated by an ectopic cardiac pacemaker located in the ventricle,
that makes contract them too soon, out of sequence with the normal
beats (Figure 1.8, (b)). The clinical significance of VPCs depends
on their frequency, complexity, and hemodynamic response. Isolated
VPCs in asymptomatic and healthy patients do not require treatment.
Frequent VPCs can be a first sign of the progression towards more se-
rious ventricular arrhythmias, like VT and VF in case of heart disease
or a previous history of VT.
Ventricular tachycardia: It is a fast (≥ 120 beats/min), regular beating
of the ventricles, no longer controlled by the SA node, that may last
for only a few seconds (by definition, at least 3 beats) or for much
longer. This rhythm may cause severe shortness of breath, dizziness,
or fainting (syncope). A few beats of VT often do not cause pro-
blems. However, episodes that last for more than a few seconds can
be dangerous, as they can turn into VF.
Ventricular fibrillation: In this rhythm, the heart’s electrical activity be-
comes disordered and ventricles contract in a rapid (sometimes reaches
≥ 300 beats/min), unsynchronized way, instead of pumpimg normally
(Figure 1.8, (c)). This is the most serious cardiac rhythm disturbance,
since the ventricles pump little or no blood, which can lead to SCD
within a few minutes if not reverted to sinus rhythm.
Three main mechanisms that determine the onset and sustainability
of these life-threatening arrhythmias have been identified. They are: a
vulnerable myocardium, a trigger and external modulators [4].































Figure 1.8: Examples of ECGs (a) in normal sinusal rhythm, (b) with a prema-
ture ventricular contraction followed by a compensatory pause (c) in ventricular
fibrillation and (d) in atrial fibrillation (Reproduced and adapted from [7]).
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A vulnerable myocardium is a substrate predisposed to arrhythmogene-
sis, which means that, when a triggering factor appears, it can easily lead
to malignant arrhythmias, potentially ending in SCD. Increased dispersion
of repolarization among cardiac cells or regions of the myocardium has been
linked to ventricular vulnerability [17, 18]. Under normal conditions, elec-
trical impulses are generated at the SA node, as described in section 1.2.
Nevertheless, some ventricular cells have the ability of generating sponta-
neous APs in absence of any external stimulus (automaticity). Enhanced
automaticity of ventricular cells can lead to an ectopic activation and, if it is
maintained by the propagation of electrical activity in a circular path retur-
ning to the origin (reentry), it can degenerate into a sustained ventricular
arrhythmia [16]. Finally, external modulators can alter the electrophysio-
logical properties of the heart, and facilitate the arrhythmogenic properties
of the myocardium and the appearance of triggering factors. Among them,
the ANS is the most relevant one [19, 20].
Ventricular arrhythmias are present in most patients with CHF. Indeed,
VPCs and episodes of asymptomatic, non-sustained VT are common, and
their frequency increases as the severity of heart failure progresses. Sustai-
ned VT and its degeneration to VF are the main causes of SCD in patients
with mild-to-moderate CHF (NYHA class II and III) [21, 22]. And only a
small percentage of SCDs cases are due to bradycardia (<60 beats/min) [23].
1.4.2 Heart Failure
The heart pumps blood to the body in order to meet its oxygen and nu-
trients’ demand. Heart failure (HF) means that the heart’s pumping power
is weaker than normal and blood moves through the heart at a slower rate.
Consequently, in HF the cardiac output, which is defined as the amount
of blood pumped by the heart every minute, is lower than in the normal
heart. According to the last ESC 2016 HF guidelines, “HF is a clinical syn-
drome caused by a structural and/or functional cardiac abnormality, which
results in a reduced cardiac output and/or elevated intracardiac pressure
at rest. The current definition of HF is restricted to symptomatic stages,
namely breathlessness, ankle swelling and fatigue, accompanied by other
signs, such us elevated jugular pressure, pulmonary crackles and peripheral
oedema” [22]. Usually, HF is a consequence of an underlying cardiac di-
sease altering the cardiac output. The most common pre-existing precur-
sors are myocardial abnormalities causing systolic and diastolic ventricular
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dysfunctions, valvular dysfunction, abnormalities in pericardium and endo-
cardium, heart rhythm and other conduction disorders. Patients who have
had HF for some time are classified as chronic heart failure (CHF) patients,
while the term acute heart failure (AHF) is used to refer to a rapid onset
or worsening of HF symptoms, requiring for urgent evaluation, treatment
and, typically, hospital admission [22]. Sometimes, the term congestive HF
is used, for describing both CHF and AHF with evidence of fluid overload.
Nonetheless, the historic terminology used to describe HF is based on the
measurement of the left ventricular ejection fraction (LVEF), including HF
patients with preserved (≥50%), mid-range (40-49%) and reduced (<40%)
LVEF [22]. Nevertheless, in this thesis patients will be consider to present
a reduced LVEF if ≤35%, in agreement with prior studies using the same
population.
The prevalence of HF, although dependent on the definition, reaches ap-
proximately the 1-2% of the adult population in developed countries, rising
up to ≥10% in elderlies (>70 years) [24]. Recent data from hospitalized
patients suggest that the incidence of this pathology may be decreasing,
especially in the case of patients with reduced LVEF [25, 26]. Despite the
last improvements in treatment and the evident increase in survival rates
and reduced hospitalizations, the outcome for this pathology often remains
unsatisfactory: most deaths have cardiovascular origin, mainly SCD and
pump failure (worsening of HF) death (PFD) [27,28]. Due to the wide aeti-
ology of this disease, it lacks a single classification system to identify causes
of HF, but a proper identification of these pathologies becomes crucial in
order to adopt specific therapies.
Diagnosis of CHF is mainly based on three kinds of tests:
Blood test: B-type natriuretic peptides (BNP) are released in response
to changes in pressure inside the heart and the degree of ventricular
stretch. BNP levels are higher in patients with HF than in people who
have normal heart function and BNP≥ 35 pg/ml indicates abnormal
cardiac function. However, there are other causes (atrial fibrillation,
age, renal failure, among others) that raise BNP levels as well, so BNP
tests are recommended to rule out HF, but further screening is needed
to stablish diagnosis [22].
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Electrocardiography: Abnomal ECG provides information on previous
aetiology that can help also in therapy decision, and it increases the
likelihood of HF diagnosis, but this test still has low specificity [29–32].
Cardiac imaging: Echocardiography is the most useful test to establish
HF diagnosis due to its high accuracy, availability, safety and low cost.
It provides direct information regarding chamber volumes, systolic and
diastolic functions, wall thickness and valvular function, thus allowing
the evaluation of LVEF [33–35]. Chest X-ray imaging, able to show
pulmonary venous congestion or oedema, is also very helpful in the
case of AHF [32,36].
Symptoms and signs of HF are often unspecific, but are crucial in the
evaluation of patient’s response to the treatment. If they persist, this sug-
gests that additional therapy is required. Severity of symptoms and exer-
cise intolerance are defined according to the New York Heart Association
(NYHA) functional classification [37]. Four functional classes are distin-
guished:
Class I: Patients have cardiac disease but without limitations of phy-
sical activity. Ordinary physical activity does not cause undue fatigue,
palpitation, dyspnoea or anginal pain.
Class II: Patients have cardiac disease resulting in slight limitation
of physical activity. They are comfortable at rest. Ordinary physical
activity results in fatigue, palpitation, dyspnoea or anginal pain.
Class III: Patients have cardiac disease resulting in marked limitation
of physical activity. They are comfortable at rest. Less than ordinary
physical activity causes fatigue, palpitation, dyspnoea or anginal pain.
Class IV: Patients have cardiac disease resulting in inability to carry
on any physical activity without discomfort. Symptoms of cardiac
insufficiency or of the anginal syndrome may be present even at rest.
If any physical activity is undertaken, discomfort is increased.
Therapy
Treatment of CHF is mainly oriented to improve the general clinical sta-
tus as well as functional capacity and quality of life of diagnosed patients,
preventing hospitalization and reducing mortality [22].
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Pharmacological options include neuro-hormonal antagonists, as angio-
tensin-converting enzyme inhibitors (ACEIs) and beta-blockers, normally
accompanied by diuretics or mineralocorticoid/aldosterone receptor antago-
nists (MRAs), if symptoms/signs of congestion are present. ACEIs, through
the inhibition of the renin-angiotensin-aldosterone system, cause the relax-
ation of blood vessels and a decrease in blood volume, leading to lower
blood pressure and oxygen demand from the heart. They have been shown
to reduce both mortality and morbidity, especially in patients with redu-
ced LVEF [38–40]. Beta-blockers, which can complement ACEIs, work by
blocking the effects of epinephrine and norepinephrine receptors of the sym-
pathetic nervous system, by slowing heart rate and thereby decreasing the
heart’s oxygen demand. The use of beta-blockers is highly recommended
in the case of symptomatic patients, and it has been shown to reduce both
hospitalization and death [41–44]. Finally, MRAs antagonize the action
of aldosterone and other steroid hormone receptors with diuretic effect,
reducing oedema and cardiac workload. They are recommended in case
of persistent symptoms, despite being already treated with ACEIs and/or
beta-blockers [45, 46].
In advanced stages of the disease or when the patient is persistently
symptomatic, the above described medications are not effective enough.
Another therapeutic alternative for CHF is the use of medical devices [22].
A great part of deaths in CHF patients are SCD, mainly consequence of
ventricular arrhythmias [22,23,47,48]. The human failing heart is characte-
rized by a significant prolongation of the APD in comparison to the normal
heart. If the prolongation of APD were homogeneous in all cardiac cells, this
would not increase arrhythmogenity. However, this is not the case and en-
hanced differences in APD are present. These variations are the responsible
of spatial inhomogeneities in repolarization and dispersion of refractoriness
in the ventricles, underlying factors that lead to an increased vulnerability
of the myocardial substrate [49]. In this case, Implantable cardioverter-
defibrillators results effective in correcting ventricular arrhythmias and pre-
venting bradycardia by restoring sinus rhythm [23,50,51]. While in patients
with mild CHF (NYHA class II) this therapy has been shown to prevent
about two deaths per year for every 100 implantations, this option is not re-
commended in end-stages of CHF, as the probability of pump failure death
is higher [52]. On the other hand, cardiac resynchronization therapy (CRT)
consists on a pacemaker implantation, which continuously monitors right
and left ventricles and, in case of asynchronism in the contraction of both
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chambers, an electrical impulse is applied to correct them. Both heart’s
efficiency and blood flow are increased. This kind of therapy is appropriate
in patients with a severe-to-moderate stage of CHF [53, 54] with reduced
LVEF and/or left bundle branch block (LBBB). A QRS duration ≥ 130 ms
is generally used as the inclusion criterion for this kind of therapy.
1.4.3 Atrial Fibrillation
Atrial fibrillation (AF) is a supraventricular arrhytmia, characterized by the
desynchronization of atrial electrical activity producing an irregular ventri-
cular response. The asynchrony may be due to the appearance of secondary
(ectopic) pacemaker activity and/or to areas of slow conduction that fa-
cilitate the persistence of reentrant activity. The atria beating at a much
faster rate (300-600 beats/minute) makes the AV node discharge at irregular
intervals, since only some of the impulses get through, causing a highly ir-
regular rate of ventricular beats, often faster than the normal rate (120-160
beats/min). This ventricular response is mainly dependent on the electrop-
hysiological properties of the AV node and other conducting tissues, the
level of vagal and sympathetic tone, the presence or absence of accessory
conduction pathways, and the effect of drugs [55].
AF is the most prevalent sustained arrhythmia encountered in clinical
practice, with a prevalence of approximately 2-3% in the adult population,
which increases with age, reaching rates up to the 10-17% in octogenarians
[56,57]. It has become one of the most important health issues in developed
countries as it is expected to double its incidence by 2030 [58,59]. AF is not
only related to frequent symptoms and reduced quality of life [60] but also
constitutes a major risk factor for stroke and mortality from cardiovascular
and all causes [57, 59, 61].
Diagnosis of AF is based on ECG rhythm documentation. On the ECG,
AF is clearly observable since consistent P waves are replaced with rapid
oscillations or fibrillatory waves (“f waves”) that vary in size, shape, and ti-
ming (consequence of the asynchronous depolarization of atrial tissue). The
ECG in AF is also associated with an irregular, frequently rapid ventricular
rate (consequence of the abnormal electrical conduction from the atria to
the ventricles through the AV node), as illustrated in Figure 1.8 (d).
An AF episode can be symptomatic or asymptomatic, depending on its
duration, ventricular rate, general health status and patient perceptions.
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Symptoms are usually related to rapid heart rate and inefficient cardiac
output due to loss of atrial contraction (up to 15-20% less than without the
arrhythmia). These symptoms include palpitations, breathing insufficiency
(dyspnea), chest pain and tiredness. It can also lead to situations of angina,
shortness of breath and edema.
Mechanisms influencing atrial fibrillation
AF has a complex pathophysiology, with several mechanisms influencing
initiation, maintenance and termination of AF episodes. Indeed, it has a
heterogeneous clinical presentation: it may occur in the presence or absence
of detectable structural heart disease or other apparent risk factors and
related symptoms [57].
Structural remodelling: Structural heart disease, hypertension, diabe-
tes, and also AF by itself induce a structural remodelling of the
atria [62, 63]. In addition, inflammatory mechanisms have been also
proposed as initiators of the arrhythmia [64]. As a consequence, elec-
trical dissociation among different regions of the atria and conduction
heterogeneities become present, which facilitate the re-entry and main-
tenance of AF.
Electrophysiological mechanisms: AF by itself causes progressive chan-
ges in atrial electrophysiology, by shortening the refractory period and
the AF cycle length. It is well accepted that pulmonary veins play an
important role in the initiation and maintenance of AF, since it is the
most frequent area of generation. Three main hypothesis regarding
the generation of atrial arrhythmias are postulated: (i) the multiple
wavelet hypothesis, which states that AF is generated by various wa-
vefronts propagated in a chaotic manner through the atria [65]; (ii) a
focal hypothesis, where a focal source in the pulmonary veins lead to
fibrillatory conduction and localized reentry [66]; (iii) the presence of a
mother rotor defined as a stable, high-frequency rotating pattern that
drives AF, have recently emerged as other potential mechanisms [67].
Genetic predisposition: Genetic factors, especially in early-onset AF,
have been also associated to the presence of AF [68,69].
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Types of atrial fibrillation
Normally, AF progresses from short and isolated episodes to longer and more
frequent attacks. According to the presentation, duration, and spontaneous
termination of AF episodes, five different types of AF can be distinguished
[57]:
First diagnosed AF: This type of AF occurs when the arrhythmia is
diagnosed for the first time, irrespective of the duration of the episode
or the presence and severity of related symptoms.
Paroxysmal AF: It is a self-terminating AF ending in most cases
within 48 hours and, by definition, it may continue for up to 7 days.
Persistent AF: This type of AF lasts longer than 7 days, including
cardioverted episodes, either with drugs or by direct electrical cardi-
oversion. Persistent AF can be the first sign or can occur after some
paroxysmal episodes.
Long-standing persistent AF: It is a continuous AF with a dura-
tion greater than one year, usually leading to permanent AF, in which
cardioversion has failed or has not been attempted.
Permanent AF: This type of AF happens when cardioversion fails
or the arrhythmia relapses within 48 hours.
Therapy
The major issues in the management of patients with AF are related to
the arrhythmia itself but compromised with its prognostic impact, mainly
oriented to stroke prevention, and these are not mutually exclusive. There
are mainly two essential ways of handling the arrhythmia: rhythm control,
i.e., to restore and maintain SR, or rate control, i.e., to accept AF to conti-
nue but ensuring that the ventricular rate is controlled. Regardless of the
antiarrhythmic strategy, attention must be paid also to anticoagulation for
prevention of ischaemic stroke in AF patients [55, 57].
The rate control is achieved with medications that increase the degree of
block at the level of the AV node (beta-blockers, digoxin, calcium channel
blockers or a combination), effectively decreasing the number of impulses
that conduct down into the ventricles [70–72]. Restoration and maintenance
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of SR, indicated to improve symptoms in AF patients who remain symp-
tomatic under rate control therapy, can be achieved by various techniques,
namely electrical and pharmacological cardioversion (amiodarone, sotalol,
flecainide and propafenone, among others), catheter ablation, surgery and
maze procedures [73–78].
Atrial Fibrillation in Chronic Heart Failure
AF and CHF frequently coexist. In particular, the prevalence of AF in
patients with mild-to-moderate CHF (NYHA classes II and III), ranges
from 10% to 15% [79].
A number of mechanisms have been reported [79], supporting both that
CHF predispose to AF and that AF exacerbates CHF, often leading to
PFD or SCD outcomes [57, 59]. In properly anticoagulated AF patients,
it has been shown that most deaths were actually not related to stroke,
thus raising the need for identifying other possible mechanisms and effective
interventions to reduce mortality in AF [61]. In fact, recent data have
pointed out the independent contribution of AF to SCD risk [80–83].
Many questions arise regarding the underlying mechanisms that associ-
ate AF, CHF and SCD risk and a better understanding is needed in order
to adopt effective prediction and prevention strategies in this target popula-
tion. Current therapeutic options are mainly oriented to an adequate cont-
rol of ventricular rate and to restore and maintain sinus rhythm [22,57,84].
However, if risk stratification in each independent subgroup (AF or CHF) is
challenging, identification of patients-at-risk in this target population that
simultaneous suffer from the two diseases, becomes even more difficult. The
major limitation is that the highly irregular ventricular response present
during AF, makes the use of most electrocardiographic indices, such as QT
interval, QT dynamics, Tpeak-to-end interval or TWA inappropriate, as
they require the patient to be under a sinus rhythm condition to be pro-
perly assessed.
It is evident that the proper identification of pro-arrhythmic factors
plays an important role in adopting specific therapeutic strategies. And
this, together with an accurate risk stratification of patients, is crucial for
improving the actual cost-effectiveness of described therapies, particularly
low in the case of ICDs.
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1.4.4 Coronary Heart Disease
Coronary heart disease (CHD), also referred as ischemic heart disease, is a
pathological condition in which a fatty plaque builds up inside the coronary
arteries, restricting blood flow to the heart. When plaque builds up in the
arteries, the condition is called atherosclerosis. If the plaque ruptures, it can
form a thrombus or blood clot. A large blood clot can mostly or completely
block blood flow through a coronary artery. The condition in which the
blood flow (and thus oxygen) is restricted or reduced in a part of the body
is called ischemia. Myocardial ischemia is the name for decreased blood flow
and oxygen to myocardial cells. A myocardial infarction (MI) occurs if the
damaged heart tissue starts to die (necrosis) due to the lack of oxygen.
Over time, CHD can weaken the heart muscle and lead to HF. In addi-
tion, myocardial ischemia, and its degeneration to MI, are both conditions
that can originate a vulnerable substrate to the development of ventricular
arrhythmias.
The prevalence of CHD in the USA is around 6% in the adult population
[85], increasing up to 25% in men and 16% in women among people between
60 and 79 years old [86]. It represents the number 1 cause of death in men
and women worldwide and, although the mortality rate for this condition
has gradually decayed over the last decades in western countries, it still
causes about 20% of total deaths in Europe [86, 87].
Chest pain (angina pectoris) is the principal symptom related to CHD.
It normally lasts minutes and can be radiated to the neck, jaw or arms.
Chest pain, sometimes, can be accompanied by other less-specific symptoms,
such as fatigue, faintness or nausea. Symptoms appear or become more
severe with increased levels of exertion or emotional stress [86, 87].
Standard 12-lead stress ECG testing, by using exercise or pharmacolo-
gical stress agents, has been established as the gold standard non-invasive
test for the diagnosis of inducible ischemia [86]. Diagnostic endpoint for an
ischemic ECG is ≥ 1 mm horizontal or down-sloping ST-T segment depres-
sion (at 0.06-0.08 ms after the J point) in one or more ECG leads [86, 88].
This test provides additional information with both diagnostic and prog-
nostic relevance (hemodynamic response and HR recovery, symptoms and
workload). It should be performed in absence of anti-ischemic drugs and
ECG abnormalities at baseline.
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When the ECG test results inconclusive (for example in the absence
of symptoms or signs at maximum HR), non-invasive imaging test with
pharmacological stress can be an alternative. Among imaging techniques,
myocardial perfusion scintiography by single photon emission computed to-
mography (SPECT) and cardiac magnetic resonance (CMR) provides in-
formation related to myocardial blood flow and myocardial wall motion
abnormalities, respectively.
Ischemia produces a series of alterations in myocardial tissue that are
responsible for notable clinical and electrocardiographic features. Late re-
polarization of the ischemic zone is reflected by T-wave abnormalities on the
ECG. At the cellular level, electrical properties of the myocardial cells af-
fected by ischemia are altered: AP rest level is reduced and APD shortened.
Those changes determine a voltage gradient between the normal and ische-
mic areas, originating an injury current flowing between these regions. It is
manifested on the ECG as a ST-segment deviation (elevation/depression).
ST segment elevation in two or more contiguous leads during the acute
phase of MI is the main sign to indicate for the need of an early reperfusion
by a percutaneous coronary intervention (PCI).
1.4.5 Microgravity
The study and better understanding of ventricular repolarization and car-
diac electrical disturbances are not only of great interest in the clinical
practice. Ideed, control of autonomic and cardiovascular systems, even in
the absence of disease, relay on a set of environmental conditions that, if
changed, could produce malfunctioning. One of these conditions is gravity.
Human space-flight represents a highly risky activity, due to both engineer-
ing and human elements that could fail during the different steps of the
mission. As regards the human factor, risk assessment and identification
of risk mitigation resources are the basis for minimizing potential medical
disorders that could prevent mission success but, more important, put in
danger the crew health [89].
It is well known that gravity plays an essential role in determining the
distribution of hydrostatic pressure gradient and plasma volume within the
cardiovascular system. In particular, a prolonged weightlessness condition
results in a redistribution of body fluids from the lower half of the body
towards upper districts, leading to cardiac deconditioning and inducing sig-
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nificant changes in both autonomic and cardiovascular systems [90]. This
results in orthostatic intolerance episodes once gravity is re-established, de-
crease in plasma volume and reduced aerobic capacity, together with bone
and muscle loss. Potentially, cardiac electrical activity could also be affected
by this process. Additional factors induced by space-flight, such as sudden
pressure changes [91] or rapid onset and offset of +Gx or +Gz accelera-
tion [92–94] could also present associated risks. The occurrence of serious
cardiac rhythm disorders [95] and related diminished cardiac and vascular
functions have been identified as primary cardiovascular risks of space-flight
in the NASA Human Research Roadmap Program in 2005, currently under
reevaluation process.
Indeed, cardiac rhythm disturbances have been observed among astro-
nauts and cosmonauts since the Apollo 15 mission [96, 97], including one
documented episode of non-sustained VT [98]. However, it is not clear
whether these potentially critical events, as anecdotal reports, were due to
pre-existing conditions or derived effects induced by weightlessness. During
space-flights missions (up to 6 months), the incidence of SCD is about 1%
per year [99]. It is very low, but still exists.
Nonetheless, some concern exists about the fact that prolonged exposure
to microgravity might lead to cardiac electrical instability: bradycardia rela-
ted to long-duration space-flights that could result in prolongation of the QT
interval [100], the use of medications, alterations in the ANS [101–105], de-
velopment of apoptosis in response to pathological, physiological, and/or ge-
netic signals [106,107] resulting in cardiac atrophy [108], radiation exposure
inducing structural changes [109], psychological stress [110]. Cardiac adap-
tation to all these factors, together with adrenalin/neurohormonal changes
and stress related to space-flight, could also alter electrical conduction, in-
creasing the inhomogeneity of electrical repolarization, and thus potentially
increasing the risk of inducing cardiac rhythm disturbances.
Since research under real conditions of space-flights is of limited possi-
bility, the head-down (-6 degrees) bed-rest (HDBR) model has been proved
to be a reliable ground-based simulation analog for the most physiological
effects of spaceflight [111]. This manoeuvre represents a model of chronic
circulatory unloading, simulating sustained exposure to microgravity and of-
fers a unique opportunity for studying the effects of prolonged space-flight
on the cardiovascular system, as well as to test potential countermeasu-
res (CM) to prevent its deconditioning. From 2001, the European Space
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Agency (ESA) has led such HDBR studies, where subjects were placed on
a bed with a 6◦ negative tilt for periods ranging from five days (short-term)
to three months (long-term), resulting in a top level and valued programme.
1.5 Ventricular repolarization information from the
ECG: indices of electrical instability
The assessment of ventricular repolarization based on this non-invasive test
have been show to provide with valuable information for risk stratifica-
tion performance [4]. Ventricular repolarization activity is reflected on the
ECG throughout the T-wave. More precisely, the T-wave reflects these in-
trinsic heterogeneities of repolarizing currents, which depends on both the
sequence of ventricular activations (conduction velocity) and the inhomo-
geneity in APD of cardiac myocytes. An accentuated APD is associated to
many cardiac pathologies, such as ischemia or long QT syndrome, and insta-
bilities in ventricular repolarization have been tightly linked to arrhythmia
vulnerability [12].
Several ECG-derived indices have been proposed in the literature for
the assessment of both spatial and temporal heterogeneities of ventricular
repolarization. A brief description of proposed electrocardiographic indices
of repolarization instability is presented below.
QT interval: As illustrated in Figure 1.4, it is measured from the
onset of the QRS complex (Q-wave) to the end of the T-wave, and
represents the total duration of ventricular depolarization and repola-
rization. Prolongued values of the QT interval can reflect conduction
abnormalities during depolarization, like LBBB, and repolarization,
and it has been consolidated as one of the most traditional ECG-
derived indices for arrhythmic risk prediction [112–115].
QT dispersion: The QT interval varies from lead to lead, reflecting
regional differences in repolarization. QT dispersion (QTd) is defined
as the difference between the maximum and minimum QT intervals
across leads and it has been proposed to quantify ventricular repola-
rization dispersion [115, 116]. However it has been shown to mainly
reflect the different lead projections of the T-wave loop rather than
any other type of dispersion [117]. Therefore, it is used marginally
nowadays.
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QT variability (QTV): QT interval presents spontaneous beat-to-
beat fluctuations, reflecting temporal variations in ventricular depola-
rization and repolarization, originated by the direct action of ANS on
the myocardium [118]. Increased repolarization variability has been
associated to the risk of developing ventricular arrhythmias [118–120].
QT dynamics: The QT interval is greatly influenced by changes
in heart rhythm [121], and it takes some time until reaching a ste-
ady state after HR changes. This adaptation time provides useful
information for arrhythmic risk [122–125]. The slope of the relati-
onship between the QT interval and the RR interval, a surrogate
of the velocity in adaptation to HR, has been suggested also to in-
dicate pro-arrhythmic risk, with higher slopes associated to higher
risk [123,126–128].
Tpeak-to-Tend (Tpe) interval and dynamics: The Tpe interval,
measured from the peak to the end of the T-wave, reflects the time
differences in completing ventricular repolarization at different regi-
ons [129]. This measurement has been linked to the development of
ventricular arrhythmias in several pathological conditions [130–132].
Ventricular dispersion properties at different HRs are usually quanti-
fied by the so called APD restitution (APDR) curves, which represents
the APD as a function of the RR interval for different sites of the myo-
cardium. An increased dispersion of this APDR curve is associated to
arrhythmia propensity [133, 134]. The relationship between the Tpe
and the RR interval has been proposed as an indirect ECG surro-
gate of this APDR dispersion [135], and its clinical value has been
evaluated in different clinical settings [136–139]
QRS-T angle: It is defined as a spatial angle between the spatial
QRS vector and spatial T vector of the vectorcardiogram, measuring
the difference in mean vectors of depolarization and repolarization
[140]. An abnormally wide QRS-T angle has emerged as a prominent
variable in stratifying cardiac death risk [141,142].
T-wave alternans (TWA): Also known as repolarization alternans
(RPA), it appears in the ECG as a consistent beat-to-beat alternation
in the amplitude, duration or morphology of the ST segment and/or
the T-wave [5]. It is presently regarded as a non-invasive risk marker of
ventricular vulnerability and provides valuable information regarding
SCD risk stratification [5, 143]. As it is one of the main topics of this
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thesis, a more detailed review on TWA methodology is included in
section 1.5.1.
1.5.1 T-Wave Alternans
While visible or macroscopic TWA had been first reported at the beginning
of the 20th century and was considered as a rare finding [144], it was with the
introduction of computerized electrocardiology when non-visible microvolt-
level alternans could be detected. Since then, TWA has been considered
a much more common phenomenon. It has been reported under several
pathological conditions, including myocardial ischemia and infarction in-
duced by coronary occlusion, HF, non-ischemic cardiomiopathy and other
congenital diseases (Brugada syndrome and long QT syndrome) [5]. TWA
emerges as a consequence of a beat-to-beat alternation in the APD at the
myocyte level. It is known to reflect temporal and spatial heterogeneity of
ventricular repolarization, associated to electrical instability. Therefore, it
has been proposed as a non-invasive risk marker of ventricular vulnerability,
providing valuable information regarding SCD risk stratification [5, 143].












Figure 1.9: Two examples of ECG signals with TWA.
TWA tests are usually performed under a controlled HR increase, nor-
mally by pacing or exercise or pharmacological stress tests (a target heart
rate range of 105-110 beats/min was determined for pathologic alternans
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in adults). As microvolt-TWA can be even lower than the noise level, spe-
cially if it is assessed under exercise, TWA measurement is a challenging
task. From the signal processing point of view, TWA analysis is based on
two types of procedures: determining the presence or the absence of TWA
in the ECG signal (i.e, a detection problem) and the quantification of TWA
magnitude (i.e, a estimation problem), and a number of advanced signal
processing methods have been proposed to do it [145].
The general scheme for TWA analysis consists of two main stages: ECG
pre-processing, TWA detection and/or TWA magnitude estimation. The
two most common methods used in the clinical practice or research are
the spectral method (SM) [146] and the modified moving average method
(MMAM) [147], as they are available in commercial equipment.
The SM is based on the classical Fourier analysis in which, after beat
alignment to the QRS, the amplitude beat-to-beat series of consecutive ST-
T complexes is generated and the short-term Fourier transform applied.
Since the beat-to-beat series is generated by taking one measurement per
beat, the frequency at 0.5 cycles per beat (cpb) represents the oscillation
occurring every other beat, that is, the TWA frequency. Finally, the alter-
nans power (in µV 2) is defined as the difference between the power at 0.5
cpb and the noise level, estimated as the power at an adjacent band (0.44-
0.49 cpb). For detection, the alternans ratio (K-score) is calculated as the
ratio of the alternans power divided by the standard deviation of the noise.
TWA is considered significant if the K-score is ≥3 [146]. The TWA test
using the spectral method is usually conducted during bicycle or treadmill
exercise in order to reach an optimum heart rate [148].
The MMAM estimates the median ST-T complex patterns of odd and
even beats using a recursive moving average. The moving average allows
control of the influence of new incoming beats on the median templates
with a non-linear limiting function (i.e., the fraction of morphology change
that an incoming beat can contribute). TWA is estimated as the maximum
difference between the odd and the even median complexes at any point.
Abrupt changes due to noisy beats and extrasystoles are excluded and the
effect of noise, movement and respiration is attenuated by filtering. Howe-
ver, the MMAM does not include detection stage and it rests sensitive to
noise level changes, requiring visual validation [147]. The MMAM is mainly
utilized in the analysis of TWA in ambulatory ECG recordings [149–152].
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In this thesis, however, TWA analysis is based on the Laplacian likeli-
hood ratio method (LLRM) [153], which has been reported to outperform the
accuracy of the SM and MMAM in the presence of impulsive artifacts [154].
The LLRM is based on the signal processing theory for estimation and de-
tection and uses a statistical model including alternans and physiological
noise terms. Noise is modelled as a zero-mean Laplacian random varia-
ble, allowing for a more robust realistic description of noise present on real
ECGs. The maximum likelihood estimator (MLE) and the generalized li-
kelihood ratio test (GLRT) are used for TWA estimation and detection,
respectively [153].
All these methods are usually applied in a single-lead basis, that is,
considering each ECG lead independently. Multi-lead strategies have been
proposed for taking advantage of the inter-lead redundancy of TWA and
noise components, such as the methods based on principal component ana-
lysis (PCA) [155] or periodic component analysis (πCA) [156], thus leading
to a more robust and sensitive analysis than lead-by-lead analysis. This two
approaches include a signal transformation step before TWA detection and
estimation, where a linear transformation is applied to the multi-lead ECG
signal in order to emphasize the TWA content by exploiting the information
available in all leads. The difference between PCA and πCA is on how the
signal transformation is defined. PCA uses a maximum variance criterion to
separate signal (alternans) and noise (non-alternans) into orthogonal sub-
spaces. πCA, instead, uses a periodical criterion to separate alternans a
non-alternans components by enhancing the 2-beat periodicity of the ECG
signal, that corresponds with the TWA frequency. This last technique has
been shown to be a more robust and sensitive tool, in comparison to both
single-lead and PCA based techniques [156].
As the analysis of TWA based of πCA and together with the LLRM
is the basis for chapters 2, 3, 4, a more detailed description of the two
approaches will be included in next chapter.
1.6 Objectives and outline of the thesis
The main objective of this thesis is to propose methodological advances for
the assessment of ventricular repolarization instability in invasive and non-
invasive cardiac signals, to attain a better understanding of several patho-
logical or abnormal conditions that may lead to an improvement in clinical
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decisions, as those related to the prediction of malignant arrhythmias. In
particular, methodological advances for the analysis of TWA under experi-
mental conditions (chapters 2 and 3), and robust to sporadic (VPCs) and
sustained (AF) rhythm disturbances (chapters 4 and 5, respectively) in CHF
patients, are presented. The content of the rest of the thesis is organized as
follows:
Chapter 2: This chapter includes a comprehensive characteriza-
tion of TWA (prevalence, magnitude, time-course, and alternans wa-
veform) induced by a porcine model of myocardial ischemia. Signals
from both body surface ECG and intracardiac EGMs recorded from 4
different anatomical heart locations are analyzed following a multilead
scheme based on πCA together with the LLRM, also presented in this
chapter. Finally, under the hypothesis that a proper monitorization
of in-vivo TWA from EGM signals could alert and prevent the onset
of VT/VF episodes, an optimal intracardiac lead configuration that
maximizes TWA rate detection is proposed. One manuscript with the
research described in this chapter is under preparation.
Chapter 3: It is well known that microgravity exposure leads to car-
diovascular deconditioning with potential impact in cardiac electrical
activity. This raises the question of whether microgravity increases
arrhythmia propensity and, consequently, SCD risk if cardiac repola-
rization is adversely influenced. In this chapter the effects of short-
(5 days), mid- (21 days) and long- (60 days) exposure to simulated
microgravity on TWA using the HDBR model are assessed. TWA
is evaluated before, during and after the immobilization period, by
the long-term averaging technique of ambulatory ECG Holter recor-
dings [157]. In addition, an adapted short-term averaging approach
for shorter, non-stationary ECG tracings obtained during two stress
manoeuvres (head-up tilt-table and bicycle exercise tests) is propo-
sed. Both approaches are based on the multilead analysis presented
in chapter 2 but avoiding the detection stage, and the need for a thres-
hold definition. Finally, changes in TWA indices induced by HDBR
were quantified and discussed.
The research described in this chapter generated the following publi-
cations:
– A Mart́ın-Yebra, V Monasterio, A Pellegrini, P Laguna, E Caiani, JP
Mart́ınez. Effect of Simulated Microgravity by Head-Down Bed-Rest
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on T wave Alternans. XXXIX International Conference on Computing
in Cardiology, pp. 377-380, Krakow (Poland), September 2012.
– A Mart́ın-Yebra, E Caiani, V Monasterio, A Pellegrini, P Laguna,
JP Mart́ınez. T-Wave Alternans and Autonomic Nervous System Acti-
vity During Orthostatic Stress after 5 Days of Head-Down Bed-Rest.
Cardiovascular Oscillations (ESGCO), 2014 8th Conference of the Eu-
ropean Study Group on;, pp. 115-116, Fai della Paganella, (Italy), May
2014.
– A Mart́ın-Yebra, EG Caiani, V Monasterio, A Pellegrini, P Laguna,
JP Mart́ınez. Evaluation of T-wave alternans activity under stress
conditions after 5 days and 21 days of sedentary head-down bed-rest.
Physiological measurement, 2015;(36):pp. 2041-2055.
– EG Caiani, A Mart́ın-Yebra, F Landreani, J Bolea, P Laguna, P
Väıda. Weightlessness and cardiac rhythm disorders: current know-
ledge from space flight and bed-rest studies. Frontiers in Astronomy
and Space Sciences, 2016;(3):27
– A Mart́ın-Yebra, V Monasterio, P Laguna, JP Mart́ınez, EG Caiani.
Evaluation of changes in T-wave alternans induced by 60-days of im-
mobilization by head-down bed-rest. XLIV International Conference
on Computing in Cardiology, 2017. Accepted.
Chapter 4: The presence of one or more VPCs may alter repola-
rization dynamics, and they may introduce a phase reversal in the
sequence of alternant T-wave morphologies [158]. This could ham-
per the estimation of TWA amplitude [159,160] and, consequently, its
potential for risk stratification. In this chapter, a methodological im-
provement for the estimation of TWA amplitude in ambulatory ECGs,
which deals with the possible phase reversal induced by the presence
of VPCs in the alternans sequence is proposed. First, a simulation
scenario was generated in order to evaluate the performance of the
algorithm using synthetic signals. Then, the effect of the proposed
method in the prognostic value of TWA amplitude was assessed in
real ambulatory ECG recordings from patients with CHF. Finally,
circadian TWA changes were evaluated as well as whether the prog-
nostic value of TWA is sensitive to this circadian pattern. As a conclu-
sion, the performance of the proposed methodology on the simulation
study is discussed. Then, the improvement on the prognostic value of
TWA for SCD and the circadian modulation on alternans activity are
presented.
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The research described in this chapter generated the following publi-
cations:
– A Mart́ın-Yebra, EG Caiani, P Laguna, VMonasterio and JPMart́ınez.
Circadian Modulation on T-wave Alternans Activity in Chronic Heart
Failure Patients. XLII International Conference on Computing in Car-
diology, 2015, pp. 845-848, Nice (France). September, 2015.
– A Mart́ın-Yebra, V Monasterio, I Cygankiewicz, A Bayés-de-Luna,
EG Caiani, P Laguna and JP Mart́ınez. Post-Ventricular Premature
Contraction Phase Correction Improves the Predictive Value of Average
T-wave Alternans in Ambulatory ECG Recordings. IEEE Transactions
on Biomedical Engineering, 2017; DOI: 10.1109/TBME.2017.2711645.
Chapter 5: The highly irregular ventricular response during AF ma-
kes innapropiate the use of the most common ECG-derived markers of
ventricular repolarization heterogeneity, including TWA, in this par-
ticular condition as they require the patient to be in sinus rhythm to
be properly assessed [161]. In this chapter, we investigated whether
a non-invasive stratification of AF patients at risk of SCD is possible
by assessing the ventricular repolarization in the electrocardiogram
signal. Ventricular repolarization changes are assessed based on a
selective heart rate bin averaging technique and new indices of repo-
larization variation are proposed. A clinical study demonstrates their
prognostic values for SCD in a CHF population with AF.
The research described in this chapter generated the following publi-
cations:
– A Mart́ın-Yebra, I Cygankiewicz, A Bayés-de-Luna, P Laguna, EG
Caiani, JP Mart́ınez. Index of T-wave Variation as a Predictor of Sud-
den Cardiac Death in Chronic Heart Failure Patients with Atrial Fibril-
lation. XLIII International Conference on Computing in Cardiology,
2016, pp. 5-8, Vancouver (Canada). September, 2016.
– A Mart́ın-Yebra, P Laguna, I Cygankiewicz, A Bayés-de-Luna, EG
Caiani, JP Mart́ınez. Indices of Ventricular Repolarization Variation
for Sudden Cardiac Death Prediction in Atrial Fibrillation Patients.
Submitted to IEEE Transactions on Biomedical Engineering. Under
review.
Also, this work was awarded with the following prizes:
– Finalist of the Rosanna Degani Young Investigator Award. Index of
T-wave Variation as a Predictor of Sudden Cardiac Death in Chronic
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Heart Failure Patients with Atrial Fibrillation. XLIII International
Conference on Computing in Cardiology. Vancouver (Canada). Sep-
tember, 2016.
– Mortara mobility fellowship. Index of T-wave Variation as a Predic-
tor of Sudden Cardiac Death in Chronic Heart Failure Patients with
Atrial Fibrillation. XLIII International Conference on Computing in
Cardiology. Vancouver (Canada). September, 2016.
Chapter 6: This chapter presents the main conclusions of the thesis
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2.1 Motivation
Although the mechanisms underlying TWA are not yet completely under-
stood, this phenomenon has been linked to electrical instability and an in-
creased vulnerability of the myocardium, predisposing to the development
of ventricular arrhythmias (VT/VF) and, consequently, SCD. The presence
of TWA has been documented under several clinical conditions, including
HF, myocardial ischemia and post-MI patients [5].
Coronary occlusion by percutaneous coronary intervention (PCI) pro-
vides an excellent model to investigate the electrophysiological changes in-
duced by acute ischemia, allowing the study of the initial minutes of the
ischemic process and its progression towards tissue infarction. TWA from
body surface ECG has been previously investigated during the first minutes
of occlusion (<5 min) in patients undergoing PCI [153] and during long-
lasting (40 min) occlusion using a porcine model of MI [162]. However, few
works have characterized TWA or RPA on intracardiac EGMs, and normally
limited to pacing-induced protocols [163–168].
As TWA provides information about ventricular vulnerability, we hypot-
hesized that a proper detection and monitorization of in-vivo TWA. In EGM
signals recorded by an implantable device, an ICD for example, could alert
and prevent the onset of VT/VF episodes. Indeed, the presence of TWA on
EGMs has been proposed as a short-term predictor of VT/VF [168–171],
but this first requires a reliable detection and characterization of TWA in
EGM signals.
The goal of the work presented in this first chapter, therefore, is twofold:
(i) to characterize TWA (prevalence, magnitude, time-course with occlusion,
and alternant waveform) from both body surface ECG and intracardiac
EGM signals recorded from 4 different anatomical heart locations using a
porcine model of myocardial ischemia induced by PCI (same model used in
[167]); (ii) to search for the optimal intracardiac lead configuration clinically
accessible by an implantable device in order to maximize the sensitivity for
TWA detection. A multilead approach for TWA analysis, introduced in
section 1.5.1, that combines the periodic component analysis (πCA) with
the Laplacian Likelihood Ratio method (LLRM) was used.
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2.2 Materials
ECG and EGM signals from a porcine model of acute ischemia are analyzed
in this chapter. After being anesthetized and acutely instrumented, seven-
teen male Yorkshire swine (weight range 40-45 kg) underwent a PCI by the
occlusion of the proximal left circumflex artery (LCX). The experiments
were performed in the Animal Electrophysiology Laboratory of the Mas-
sachusetts General Hospital. The protocol was approved by the Hospital’s
Animal Care and Use Committee. The study was developed in collabora-
tion with Prof. Armoundas and his group (Massachusetts General Hospital,
Boston, USA).
Signal monitoring was initiated before starting the occlusion and lasted
throughout the whole occlusion period, thus one baseline (BASE) and one
occlussion (OCCL) recordig was available for each intervention. Standard
ECG electrodes (leads II and V4) were placed on the animal’s limbs and
chest. Intracardiac EGMs were obtained from decapolar catheters, placed
under fluoroscopic guidance in the (i) right ventricle (RV), the distal lead
being at the RV apex, (ii) the coronary sinus (CS), the distal lead being
at the distal CS, (iii) the left ventricle (LV), the proximal lead being at
the LV apex and, finally, (iv) the epicardial space (EPI) in only 5 swines.
A total of 12 intracardiac unipolar leads (3 in each of the RV, LV, EPI,
and CS catheters), 4 far-field bipolar leads (1 per catheter, derived by sub-
tracting nonadjacent pairs of unipolar leads with 2.7 to 3.6 cm spacing),
4 near-field bipolar leads (1 per catheter, derived by subtracting adjacent
pairs of unipolar leads with <0.3 cm spacing) were available for each recor-
ding. An inferior vena cava catheter was inserted as a reference electrode
for unipolar signals. Finally, an arterial line was used to monitor arte-
rial blood pressure. All signals were recorded through a Prucka Cardiolab
(General Electric) electrophysiology system that provided 16 high-fidelity
analog output signals, then sampled at 1000 Hz by a multichannel 16-bit
data acquisition card (National Instruments M-Series PCI6255). See [167]
for more information about the experimental data.
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2.3 Methods
As it was introduced in section 1.5.1, the general scheme for multilead TWA
analysis consists of three main stages: ECG pre-processing, signal transfor-
mation and TWA detection/estimation.
2.3.1 Preprocessing
Signal preprocessing included QRS detection in surface ECG lead V4 using a
wavelet-based ECG delineator [172]. Then, baseline wander was removed in
each lead using a cubic spline interpolation technique [7]. The ECG was low-
pass filtered (with cut-off frequency of 15 Hz) to remove noise out of TWA
frequency range and down-sampled to 125 Hz to reduce the computational
cost of TWA analysis. Finally, for each beat, an interval of 350 ms, 60 ms
from QRS fidutial point was selected for TWA analysis, corresponding to
the ventricular repolarization phase.
2.3.2 TWA analysis
In this chapter, TWA analysis is performed following a multilead scheme
that processes all available leads based on periodic component analysis
(πCA) [156]. πCA finds the optimal linear combination of all leads where
the 2-beat periodicity of the ST-T complex (TWA periodicity) is maximized
and projected into the first transformed lead. Then, the LLRM [153] was
applied in that new combined lead to detect and estimate the TWA wa-
veform in each segment. Combination of both approaches has been shown
to outperform the classical single-lead SM [154,156].
A detailed description of both methods is included in the following pa-
ragraphs.
Periodic Component analysis
Multilead analyisis takes the advantage of the redundancy of spatial and
temporal information present in all available leads. Combining the infor-
mation of all ECG leads by a linear transformation before TWA detection
and estimation enhances the TWA content over noise, leading to an impro-
ved alternans-to-noise ratio (ANR) in the transformed signal. The periodic
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component analysis technique searches for the optimal linear combination
of the available leads which maximizes the desired periodicity in the combi-
ned lead [173,174]. πCA-based scheme has been shown to provide a better
ability to detect TWA than previously reported schemes (single-lead-based
scheme and SM), with the potential to improve the prognostic value of
TWA [156].
Being K the number of beats of the analysis window, N the number
of samples within the ST-T complex and L the number of available ECG
leads, the ST-T complex of the kth beat in the lth lead is denoted as xk,l(n).
Each ST-T complex can be modelled as:
xk,l(n) = sl(n) +
1
2
al(n)(−1)k + v(n)k,l, (2.1)
where sl(n) is the background ST-T component present every beat, al(n)
is the alternant waveform, defined as the difference between even and odd
beats, and vl(n) the additive random noise.
For each lead l, a vector xl is built by concatenating the K consecutive
ST-T complexes, and a data matrix X is then constructed whose rows are
the vectors xTl (dimension L×NK). For TWA analysis, we are interested in
combining the ECG leads in such a way that the 2-beat periodicity (TWA
periodicity) is maximized in the resulting signal, yT = wTX.
In a first step, the repetitive sl component is cancelled by a detrending
filter that computes the difference between each complex and the previous
one:
x′k,l(n) = xk,l(n)−xk−1,l(n), k = 1, . . . ,K−1;n = 0, . . . , N −1. (2.2)
Those detrended beats are arranged to form the data matrix X′, concate-
nating the K − 1 consecutive ST-T complexes x′(n), with leads disposed as
rows (L × N(K − 1)). In this way, background ECG is removed and only
beat-to-beat T-wave variations and noise components are contained in X′.
This step avoids that πCA identifies the repetitive ECG component rather
than the TWA component due to the higher power of the first one.
To maximize the m-beat periodicity of the signal, the desired transfor-
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where y′T = wTX′ and y′T(m) = w
TX′(m). X′(m) is the equivalent of X′
after sliding the analysis window m = 2 beats forward.
By the Rayleigh-Ritz theorem of linear algebra, it can be shown that
the weight w that minimizes 2.3 is given by the generalized eigenvector
corresponding to the smallest generalized eigenvalue of the matrix pair
(AX′(m),RX′) [174], that is, the w associated to the smallest λ that ac-
complishes the following equation:
RX′w = λAX′(m)w, (2.4)








with K the number of beats in the analysis window and N the number of
samples of each learning segment. In the same way, we defined AX′(m),








Finally, the πCA transformed lead, yT = wTX, is computed applying the
transformation to the original data X. In the same way, y′T = wTX′
is the πCA transformed lead with background ECG cancellation. That
constructed ECG lead, contains the linear projection of the 2-beat periodic
components of the ECG signal and it is the lead that will be used for TWA
analysis. The nth sample of the kth beat of this πCA transformed lead is
denoted as y′k(n). πCA transformation of a real ECG signal is illustrated
in Figure 2.1.
Note that the optimal linear combination was computed for each analysis
window of K beats, as it depends on how the alternant components and
noise are distributed within the ECG leads.
Multilead TWA analysis was performed by combining ECG or EGM
leads recorded at the same anatomical location (body surface ECG, CS,
EPI, RV and LV), using a sliding signal window of K=32 beats.
Laplacian Likelihood Ratio Method
The LLRM uses a model-based approach where noise is modelled as a
zero-mean Laplacian random variable. The maximum likelihood estima-
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Figure 2.1: Eight independent leads of a real 12-lead ECG with TWA, non visible to
the naked eye, and the resulted signal after πCA transformation. TWA is clearly
enhanced in lead y, the lead associated to the smallest generalized eigenvalue.
tor (MLE) and the generalized likelihood ratio test (GLRT) are used for
TWA estimation and detection respectively [153]. Both detection and esti-
mation are applied to the πCA transformed lead y, after background ECG
cancellation, i.e, using y′.
Assuming noise as a zero-mean Laplacian distribution with unknown








n = 0...N − 1. (2.7)
This al waveform describes how the TWA amplitude is distributed within
the whole ST-T complex. Finally, the TWA amplitude is estimated as the
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The GLRT in 2.9 can be interpreted as an estimate of the ANR. In
order to decide whether TWA is present or not, the GLRT statistic Z is
compared to a decision threshold γ and TWA is considered to be present
in the analyzed window if Z ≥ γ. For a more detailed description of the
model, the reader is referred to [145].
The probability of false alarm (PFA) is defined as the probability of
having a GLRT greater than γ when no TWA is present. In this case,
we have set the detection threshold, γ, so that PFA was 0.05, under the
assumption that no TWA is likely to be found in BASE recordings. In
other words, only the 5% of the Z statistic obtained in BASE recordings
were above the threshold. This threshold was defined for each multilead
analysis. Additionally, a minimum number of 32 beats was required to
consider a significant TWA episode, in order to avoid spurious detections.
Finally if TWA was detected, the TWA waveform was estimated in the first
πCA transformed lead (the one maximizing the periodicity) using equation
2.7. When TWA was not detected, the TWA amplitude was considered to
be zero.
2.3.3 Statistical analysis
Data are presented as median (25th;75th percentiles), unless otherwise spe-
cified. In Figure 2.2 and Figure 2.5 data are represented as mean± standard
deviation. Differences in the number of BASE and OCCL recordings with
TWA were evaluated with the McNemar test. Non-parametric Wilcoxon
signed rank paired test was applied to evaluate differences between BASE
and OCCL due to the non-normality of the data. For all tests, the null
hypothesis was rejected when p≤ α, with α = 0.05.
2.4 Results
Baseline recordings had a variable duration between 6.5 to 29.2 minutes
(9.1 (7.8;12.3) minutes). In 11 interventions, balloon inflation lasted less
than 22 minutes (from 4.5 to 21.5 min). In the remaining 6, occlusion was
prolonged for more than 100 min (range 104.5 to 151 minutes), conforming
the long-occlusion group. In this study, however, the TWA phenomenon
was only characterized during the acute phase of ischemia (up to minute
30).
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There was a significant increase in heart rate during the first minu-
tes of occlusion compared to baseline records (RR=0.57±0.05 s in base-
line vs RR=0.52±0.07 s during the first minute of occlusion, p=0.008,
RR=0.53±0.07 s at minute 5 of occlusion, p=0.041, and RR=0.56±0.09
s at minute 10 of occlusion, NS). Figure 2.2 shows the time evolution of
average RR interval along the occlusion period.




















Figure 2.2: Time-course of the RR interval along the occlusion period (mean ±
standard deviation). The red dashed line represents the average RR during BASE
2.4.1 Multilead TWA analysis by groups of leads
Body surface ECG
Leads V4 and II were the leads available for the body surface ECG group.
After multilead TWA analysis in BASE and OCCL recordings, TWA epi-
sodes were detected in 14 out of 17 OCCL recordings (82.3%), but only
in 3 BASE recordings (17.6%). In occlusion, maximum TWA amplitude
ranged from 3.7 µV to 163.1 µV (32.0 (20.4;67.4) µV) and lasted for 6.2
(2.9;8.5) minutes on average. TWA episodes appeared 3.0 (1.7;6.9) minutes
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*: p<0.05 BASE vs OCCL.
Table 2.2: Results of multilead TWA analysis by locations in occlusion recordings.
TWA onset TWA duration Maximum amplitude
(min) (min) (µV)
ECG 3.0 6.2 32.0
(1.7;6.9) (2.9;8.5) (20.4;67.4)
CS 5.1 4.5 188.9
(2.1;7.0) (1.4;5.3) (134.5;290.4)
EPI 3.9 0.9 91.42
(3.0;4.7) (0.6;2.67) (72.8;98.8)
RV 3.9 4.8 285.5
(2.9;14.9) (2.6;8.6) (125.7;419.4)
LV 3.4 5.5 409.6
(2.5;5.7) (2.4;13.1) (95.1;610.0)
after balloon inflation (range: second 7 and minute 24 of occlusion). In the
BASE recordings, detected episodes had median maximum amplitudes of
17.7 (14.5;155.5) µV and a median episode durations of 60 (52;74) s.
Coronary Sinus
The three unipolar leads (two distal and one proximal) located on the coro-
nary sinus conformed the CS group. After multilead analysis, TWA episodes
were detected in 13 out of 17 OCCL recordings (76.5%), but only in 3 pigs
during the baseline conditions (duration of 36, 37 and 170 s). In OCCL,
the maximum amplitude of TWA ranged from 44.5 µV to 348.3 µV (188.9
(134.6;290.4) µV). The onset of TWA episodes ranged between 8 seconds
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and 11.6 minutes after inflation (5.1 (2.1;7.0) minutes) and lasted for 4.5
(1.4;5.3) minutes.
Epicardial space
Unipolar EGM signals for this location of electrodes were recorded in only 5
out of 17 animals. In this case, 1 BASE recording had TWA detected during
31 seconds, with a maximal amplitude of 155.9 µV. Regarding to OCCL
recordings, TWA was detected only in 3 out of 5 pigs (60%). The maximum
detected TWA amplitude in each recording was 54.4, 106.3 and 91.2 µV.
The onset of the episodes was at 2, 3.9 and 5.5 minutes after inflation, with
a duration of 56 seconds, 4.40 minutes and 14 seconds, respectively.
Right Ventricle
Analyzing TWA in unipolar EGMs recorded on the right ventricle (two
distal and one proximal leads), we found that 11 OCCL recordings presented
TWA (64.7%). At BASE recordings, short TWA episodes (duration less
than 1.5 minutes) were detected in 4 of them, with an amplitude of 474.13()
µV. Maximum TWA detected amplitude in OCCL ranged from 98.2 to 1960
µV (285.5 (125.7;419.4) µV). The onset of TWA episodes was, on average,
3.9 (2.9;14.9) minutes after balloon inflation, with a duration ranging from
53 sec to 14.9 minutes (4.8 (2.6;8.6) minutes).
Left Ventricle
Finally, the multilead analysis of all left-ventricle intracardiac leads (two
distal and one proximal) was performed to detect alternans. TWA was
found in 13 out of 17 occlusion recordings (76.5%). In this group, TWA
episodes lasted, on average, 5.5 (2.4;13.1) minutes, ranging from 1 to 21.5
minutes, with a median amplitude of 409.6 (95.1;610.0) µV. As for the
onset of TWA episodes, they appeared between 10 sec and 23.7 minutes
(3.4 (2.5;5.7) minutes) after balloon inflation. During baseline, only in 2
(11.8%) BASE recordings had TWA, during 43 and 144 s respectively.
TWA prevalence and characterization of TWA episodes by locations are
summarized on Table 2.1 and Table 2.2, respectively.
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2.4.2 Time-course analysis













































(a) LV multilead analysis













































(b) RV multilead analysis












































(c) EPI multilead analysis














































(d) CS multilead analysis













































(e) Body surface ECG multilead analysis
Figure 2.3: Time-course of normalized TWA amplitude along the occlusion period
for each multilead study. The red line represents the total number of available
recordings at any time.
Figure 2.3 shows the average time-course of normalized TWA ampli-
tude during occlusion in all multilead studies. After averaging Valt every
30 s, each individual time course was normalized respect to its maximum
amplitude attained along the occlusion, so as the maximum is one in all
the normalized time-courses. Then, all individual profiles were averaged to
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(a) LV multilead analysis
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(c) EPI multilead analysis
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Figure 2.4: Number of recordings with TWA at a given time after balloon infla-
tion in each multilead study. The blue-dashed line represents the total number of
recordings with occlusion at any time.
characterize the average TWA progression along the occlusion period. A
two-peaked pattern can be observed in all locations: a first maximum is re-
ached around 5 minutes after balloon inflation. Then, the mean amplitude
decreases and grows again to attain a second peak around 15-17 minutes
after the onset of occlusion (note that EPI records are all of them shorter
than 9 minutes and, therefore, the second peak is not visible in this group).
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The number of recordings with detected TWA at a given time instant
along the occlusion is shown in Figure 2.4. The time-course presents a pat-
tern similar to the one for amplitude: a first absolute maximum is achieved
around minute 5 after the onset of occlusion. Afterwards, this number de-
creases and it usually remains stable with 1-4 recordings until 30 min of
occlusion.
2.4.3 TWA waveform
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Figure 2.5: Evolution of the normalized TWA waveform along the occlusion period
by groups of leads (from top to bottom, ECG, CS, RV, LV and EPI analyses, re-
spectively), represented as mean ± standard deviation. Average TWA waveforms
are represented from QRS fiducial point (milliseconds). The red dashed line indi-
cates the position of peak amplitudes.
Figure 2.5 illustrates the evolution of the normalized TWA waveform
(represented as mean ± standard deviation for each sample) measured at
different time instants along the occlusion, and for each multilead analysis.
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Average TWA waveform, represented from the QRS fiducial point up to the
end of the T-wave, was computed at minute 0, 5, 10, and 15 of occlusion and
at the time of maximum TWA detected amplitude. Before averaging, all
TWA waveforms were normalized with respect to the maximum amplitude.
To do that, the TWA waveform corresponding to the maximum detected
Valt within the occlusion recording was first identified. Then, all waveforms
(i.e, at minute 0, 5, 10, 15 and maximum Valt) were normalized with respect
to the peak amplitude of the maximum one.
We observed that the TWA phenomenon at the maximum amplitude is
distributed earlier within the repolarization phase in the epicardial space
(Figure 2.5, last column). It is remarkable that the maximum amplitude in
this case, 96 ms after QRS fiducial point, appears before than in the other
locations. On the contrary, this peak appears later in EGMs from the left
ventricle than in the rest of locations (168 ms after QRS point).
2.4.4 Sensitivity for TWA detection by groups of leads
The sensitivity of TWA detection in each group of leads was also evaluated.
To do that, we need to define a gold standard. As there is no annotation
available, we considered TWA present at certain instant (k beat) if it was
detected by any of the 5 multilead analysis. That is, if the statistic Zg(k) ≥
γg where g = {ECG,CS,EPI,LV,RV}, for at least one group, and this will
be our gold standard (a logic OR of the 5 multilead detection analyses, 4 in
the cases where EPI recordings were not available). The threshold γg was
set to have a specificity rate of 95% in each group of leads, as explained in
section 2.3. This way to select the gold standard relies on the hypothesis
that intracardiac EGMs reliably detect TWA appearing locally, while TWA
appearing in other zones may not be captured, in contrast to what happens
in surface ECG.
The TWA rate (TWAR) was defined as the ratio between the total
number of beats positive for TWA in our gold-standard and the total number
of beats of the occlusion period. Additionally, the sensitivity (Ŝe) of each
multilead group was estimated, using the previously defined threshold γg,
as the ratio between the total number of beats positive for TWA and the
total number of beats positive for TWA in our gold-standard.
Table 2.3 reports the TWAR and the Ŝe of each multilead analysis obtai-
ned for each occlusion recording. Each occlusion recording had an average
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Table 2.3: TWA rate (TWAR) and estimated sensitivity (Ŝe) obtained in each
multilead analysis.
OCCL ECG CS EPI RV LV
ID beats TWAR(%) Ŝe(%) Ŝe(%) Ŝe(%) Ŝe(%) Ŝe(%)
1 892 9.2 100 0 0 0 0
2 844 50.7 77.3 31.5 7.9 0 63.1
3 697 24.2 0 30.8 0 0 69.2
4 619 16.3 0 0 100 0 0
5 1029 53.7 100 0 96.9 97.8 52.1
6 1118 94.4 98.3 12.7 NR 89.1 34.4
7 1594 67.4 83.3 39.4 NR 86.4 98.4
8 2385 83.5 93.5 49.0 NR 83.4 82.8
9 1954 52.9 92.5 49.7 NR 51.2 58.3
10 2448 30.1 95.4 22.3 NR 43.3 66.3
11 3808 50.2 42.4 20.3 NR 4.9 97.1
12 2413 52.6 45.9 17.9 NR 8.7 84.8
13 2760 26.1 43.3 27.1 NR 16.1 74.8
14 2844 8.7 13.4 99.2 NR 18.6 22.3
15 825 0 - - NR - -
16 1360 19.0 27.9 72.1 NR 0 0
17 4181 44.4 58.9 77.0 NR 49.2 50.8
Record average 40.2 60.7 34.3 41.0 34.32 53.4
Gross Average 42.4 69.1 37.6 50.3 46.0 69.0
NR: No recording available
of 1869±1100 beats (total of 31771 beats). TWA was present in the 42.4%
of the total beats during occlusion, with an average TWAR per recording of
40.2%. The multilead analysis of the ECG leads and the LV leads presented
the best sensitivity (69.1% and 69.0%, respectively). On the contrary, the
worst performance is obtained in the analysis of CS leads (37.6%). To note,
the multilead ECG analysis had a Ŝe= 100% in two analyzed recordings,
being higher than 90% in 6 of them. However, there were two recordings in
which TWA was not detected using the ECG leads, while it was detected
by the CS and LV analyses.
Finally, multilead analysis was compared to the analysis of individual
leads in terms of Ŝe. In each anatomical location, single-lead TWA analy-
sis was performed by individually processing the most distal and proximal
unipolar EGM leads, as well as two bipolar EGM leads: one with a far-
field configuration (subtracting two distant electrodes), and the other with
a near-field configuration (from two adjacent electrodes).
Figure 2.6 shows Ŝe rate of the multilead and single-lead TWA analysis.
For each group of leads, the first bar corresponds to the multilead analysis,
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followed by the single-lead analysis of the unipolar distal and unipolar prox-
imal leads (denoted as ’ud’ and ’up’ respectively) and the two bipolar, near
and far field configurations (denoted as ’bn’ and ’bf’, respectively). In the
case of the ECG group, single-lead analysis of leads V4 and II are included.
In all groups of leads except for the RV, multilead analysis clearly provided
the best Ŝe. With respect to the RV leads, the highest Ŝe is obtained when
the proximal lead was analyzed (Ŝe =49.0%), followed by the multilead
analysis (Ŝe =46.0%). The proximal lead is in all cases more sensitive than
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Figure 2.6: Sensitivity of multilead (first bar) and single-lead analysis (unipolar
distal and proximal leads, followed by bipolar near-field and far-field leads) for
each group of leads: ECG, CS, EPI, RV and LV.
2.4.5 Optimal intracardiac detection of TWA
Another objective of this study was to find an optimal intracardiac-lead
configuration that maximizes the sensitivity of TWA detection, while using
a minimum number of electrodes.
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In order to do that, 3 electrodes from each clinical accessible locations,
CS and RV, were processed using the multilead πCA method: the 2 most
distal leads (denoted with subscripts: d, and d’) and the most proximal
one (denoted with subscript p) for each region. LV and EPI anatomical
locations were considered not to be suitable for locating electrodes from
implantable devices, as they would present derived risks, including blood
clot formation. Sensitivity compared to the gold standard was evaluated
for all possible lead combinations (from 1 to 6 electrodes) with the aim
of minimizing the number of electrodes required to monitor TWA from an
implantable device.




















Figure 2.7: Optimal sensitivity (Ŝe) obtained for each combination of electrodes.
Table 2.4: Optimal combination of leads, Ŝe and the median detected TWA am-
plitude, expressed as median (interquartile range), for the optimal combination of
intracardiac leads using from 1 to 6 electrodes. Subscripts mean p=proximal lead,
d=distal lead, d’=second most distal lead.
Number of Leads Best Ŝe TWA amplitude
leads (%) (µV)
1 RVp 49.1 51.0 (162.8)
2 RVd, CSp 61.2 117.0 (291.5)
3 RVd, RVp, CSp 60.6 132.2 (316.8)
4 RVd, RVd, CSp, CSd 63.6 210.3 (336.2)
5 RVp, RVd, RVd’, CSp, CSd 61.6 221.6 (329.4)
6 RVp, RVd, RVd’, CSp, CSd, CSd’ 59.3 246.9 (317.9)
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Figure 2.7 shows the best Ŝe rate obtained for each optimal combination
of electrodes, from 1 to 6. Ŝe ranged from 49.1% using the optimal single
electrode (lead RV proximal) to 63.6% when the optimal quadruplet were
used. More detailed information including the optimal combination of leads,
Ŝe and the median detected TWA amplitude for each optimal combination
of electrodes is reported on Table 2.4. Maximum Ŝe is achieved using a
4-electrode configuration (63.6%). However, the difference with using 2 or
3 electrodes could be considered negligible (-2.4% and -3%, respectively),
with the advantage that only 2 electrodes would be enough in to efficiently
detect and monitor TWA. Therefore, combination of the distal RV lead
together with the proximal CS lead (a far field configuration analysis) would
be chosen as the optimal lead configuration.
2.5 Discussion
In the present chapter, we have performed a comprehensive study and cha-
racterization of TWA phenomenon from both body-surface ECG and in-
tracardiac EGM signals using a porcine model of myocardial ischemia. A
reliable characterization of TWA from EGM signals was required in order
to investigate our second aim: finding an optimal intracardiac lead configu-
ration for a continuous TWA in-vivo monitorization using an implantable
device.
TWA during coronary occlusion has been previously characterized both
in human and experimental hearts [153, 162, 175, 176] from surface ECG.
However, the analysis of TWA from intracardiac signals has been limited to
the study of pacing-induced alternans [163–168] and to the best of our kno-
wledge, TWA dynamics on intracardiac signals during prolonged coronary
artery occlusion has not been previously described in such detail.
Multilead TWA analysis has been performed by groups of leads recorded
at different sites, including two body surface ECG leads (II and V4) and
three unipolar EGM leads from 4 different anatomical locations (coronary
sinus, epicardial space, right and left ventricles). TWA was detected in all
but one occlusion recordings in at least one location. It was present in 14
out of 17 OCCL recordings when analyzing the ECG leads, in 13 recordings
when CS and LV leads were processed while only 11 recordings presented
TWA on the RV group of leads. Out of the 5 recordings for which epicardial
leads were available, 3 of them had TWA.
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In the ECG leads, TWA episodes were earlier detected, on average 3
minutes after the onset of occlusion, and lasted for a longer time than in
the intracardiac leads. On the other hand, the TWA onset was most delayed
in average in the CS group. Maximum TWA amplitudes were detected in
LV leads, while TWA amplitude was minimal on the ECG group. This is
in agreement with the larger signal amplitude of unipolar EGMs compared
to body surface ECG. This results are concordant with what was reported
in [167]. In that study, TWA phenomenon was investigated by using the
commercial spectral method in a subset of 10 swine from our short-occlusion
group (occlusion duration <22 min).
However, the evolution of TWA on the four intracardiac locations along
the occlusion has been first characterized here. The two-peaked pattern
observed on the average time course in all multilead analyses is concor-
dant with what was previously observed from body-surface ECGs [162].
Interestingly, this biphasic behaviour also coincides with the two phases
of increased arrhythmia incidence in a canine myocardial infarction model,
previously reported in [177]. These two phases (named Ia and Ib) occur
from 2 to 10 minutes after the onset of ischemia and after an arrhythmia-
free interval, between minute 12 and 30. A similar time-course was also
visible when evolution of alternans waveform along occlusion was studied:
normalized amplitudes increased from the first minute to minute 5, being
almost close to 0 at minute 10 with a slight increase after 15 min in all
locations. When comparing the distribution of alternans at the instant of
maximum amplitude within the repolarization phase, i.e, along the whole
ST-T complex, it is interesting that TWA is distributed clearly earlier within
the ST-T complex in the EPI leads, while it was most delayed at the left
ventricle leads.
The results of this study confirmed the improved performance of multi-
lead TWA analysis compared to single-lead analysis. We have also shown
that TWA was better detected from the ECG group (highest Ŝe) than from
the invasive EGMs. Among those, unipolar or far-field bipolar EGM leads,
capturing far-field activity, are preferable rather than near-field configura-
tion where exclusively local activity is recorded. This was also observed
in [167].
Several studies have proposed the utility of TWA detection in EGM sig-
nals for VT/VF prediction [164,165,169–171]. Based on these observations,
we aimed at finding an optimal lead configuration for TWA detection from
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the two clinically suitable locations for ICD lead implantation: the right
ventricle and the coronary sinus. Two distal and one proximal lead from
each location were selected, and TWA detection of all possible combinations
of 1 (single-lead analysis) to 6 leads was assessed. The best sensitivity was
obtained using 4 electrodes (Ŝe=63.6%) but even 2 electrodes were enough
for an efficient detection (Ŝe=61.2%) of TWA, significantly improving the
optimal performance obtained when only one CS or RV lead was processed
(Ŝe = 49.1). Although these rates did not reach the Ŝe=69.1% obtained by
the multilead analysis of the ECG leads, they are still comparable, with the
potential clinical impact of TWA monitorization from an ICD device. Using
the multilead strategy for TWA analysis, allowed us to optimize the number
of leads required for a this porpouse, and only two electrodes will be requi-
red to obtain a Ŝe >60%. In [167], however, a triangular lead configuration
was instead required.
Despite further investigation will be needed for a deeper understanding
of the association of TWA and imminent ventricular arrhythmias, detection
of TWA from an ICD could potentially help to properly identify a vulnerable
substrate prone to VT/VF, efficiently delivering therapy in those patients.
2.5.1 Limitations
Some limitations of the study need to be acknowledged. One limitation of
this study is the lack of annotations for TWA presence. Therefore, in order
to estimate and compare the sensitivity of each group of leads, we had to
define a ”gold standard” based on the detection made by our method, which
may suppose an underestimation of the Ŝe rate. On the other hand, the
threshold, defined using baseline recordings where TWA is assumed not to
be present, was set to obtain a specificity of 95%.
Another limitation relies on the absence of VF episodes during the occlu-
sion period, which impeded the study of the association between the pre-
sence TWA and the occurrence of ventricular arrhythmias. Second, this
study has characterized ischemia-induced TWA in intracardiac leads. Ho-
wever, TWA in non-ischemic conditions may have different characteristics,
and should be studied specifically. Finally, myocardial ischemia was locally
induced by the occlusion of the proximal LCX artery. Some of the results
and conclusions of our study (in particular, the optimal sites for intracar-
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diac TWA detection) may be different for other occlusion sites and ischemic
areas.
2.6 Conclusions
In this chapter, temporal and spatial TWA dynamics during acute LCX
coronary occlusion have been investigated from both, ECG and intracar-
diac EGM signals recorded at different anatomical locations. Although
ECG leads presented the best sensitivity for TWA detection, an optimal
combination of two unipolar leads located at the right ventricle and the
coronary sinus can be an efficient solution for real-time TWA detection
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3.1 Motivation
Prolonged weightlessness condition leads to cardiovascular deconditioning,
inducing changes in autonomic control of cardiovascular system [90]. This
arises several alterations in the organism, as detailed in section 1.4.5, with
potential impact also in cardiac electrical activity, and cardiac rhythm dis-
turbances may be originated if cardiac repolarization is adversely influenced.
In particular, anecdotal data of cardiac arrhythmias and conduction dis-
orders during spaceflight and higher incidence of VPCs [178], together with
reports that long-duration spaceflight, but not short-duration ones, led to
the prolongation of the QTc interval in crewmembers [100, 179], suggested
that weightlessness can potentially increase arrhythmia susceptibility, and
related SCD risk, in astronauts. More recently, spatial and temporal hete-
rogeneity of ventricular repolarization induced by short (5-days) [180] and
long duration (90-days) [181] head-down bed-rest (HDBR) were investiga-
ted. Both studies confirmed that HDBR induced a reversible increase in
ECG repolarization heterogeneity by an increase in QRS-T angle accompa-
nied by a decrease in the spatial ventricular gradient (SVG), thus supporting
the hypothesis of increased ventricular arrhythmic risk. In addition, the T
wave amplitude was found markedly reduced with HDBR.
Only one study [182] reported results relevant to TWA induced by 9 to
16 days of HDBR in 24 healthy males, concluding that this sustained immo-
bilization head-down condition could lead to the development of sustained
alternans. However, the heterogeneity of the observed subjects’ response,
and of the HDBR duration, did not allow drawing final conclusions about
the potential negative effects of HDBR on cardiac electrical stability.
The general multilead scheme for TWA analysis presented in the pre-
vious chapter (section 2.3) included a TWA detection stage. This stage
implies the definition of a threshold, which is not easily extrapolated among
different studies, as it depends on multiple factors (number of leads, the
analysis window or even the test condition). As an alternative, a new ap-
proach omitting the detection stage, suitable for the analysis of long-term
ambulatory ECG recordings has been proposed in [157]. This study used
the long-term averaging approach to longer periods for TWA quantification,
under the hypothesis that it will produce a reliable measurement of average
TWA activity, less sensitive to noise, in a fully automatic way. This appro-
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ach presents the advantage of not requiring the posterior visual verification
needed when other methodologies, such as the MMAM, are used.
Based on all previous observations, we hypothesized that HDBR indu-
ces reversible increase in ventricular repolarization heterogeneity that could
be manifested by an increase on TWA, indicating an increased ventricular
arrhythmic risk. The objective of this chapter is, therefore, to assess the ef-
fects of short- (5 days), mid- (21 days) and long- (60 days) duration HDBR
on TWA. TWA will be evaluated before, during and after the immobiliza-
tion period, by the long-term averaging technique of ECG Holter recordings
(night period) and the short-term averaging of ECG tracings obtained du-
ring two stress manoeuvres (head-up tilt-table and bicycle exercise tests).
3.2 Materials
3.2.1 Head-down bed-rest experiments
ECG recordings acquired during short-duration (SHORT, five days), mid-
duration (MID, twenty-one days) and long-duration (LONG, sixty days)
HDBR studies conducted in the context of the ESA HDBR strategy were
available for the present study. These campaigns have been hosted by two
specialized centers: the German Aerospace Center (Deutsches Zentrum für
Luft- und Raumfahrt e.V, DLR) in Cologne (Germany) and the Institut de
Médecine et de Physiologie Spatiales (MEDES) in Toulouse (France).
An only-male population was recruited, after multiple screening and
psychological tests, for two sedentary short-duration, two mid-duration and
two long-duration HDBR campaigns. The choice of including only males
was driven by ESA standardization plan. Subjects had no history of cardio-
vascular disease and were not taking medications of any kind. All volunteers
provided written informed consent to participate in the study approved by
the respective Ethical Committee for Human Research at both hosting in-
stitutions.
For SHORT and MID campaigns, the protocol was designed as a cross-
over study: every subject repeated the HDBR two or three times, one
with no intervention (control) and one or two with specific countermea-
sures (CMs) applied during HDBR, with a washout period (1.5 months for
SHORT and 4 months for MID duration campaigns) between the end of
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one repetition to the onset of the next one. The order of inclusion in the
intervention group was randomly assigned to each subject. Due to the long
washout period (> 2 years) required in the case of long-duration recruit-
ments, a multi-group design (one control and one intervention group) was
used in LONG campaigns.
The protocol for each campaign included some days of acclimation to
the bed rest facility (referred as the PRE period). Those days of baseline
data collection (BDC) are denoted as BDC-X, where X stands for the day
before the beginning of the provoking manoeuvre (i.e, the uninterrupted
HDBR period). During the HDBR, all subjects adhered to a monitored,
strict 6◦ negative head-down tilt bed-rest, 24h a day for 5, 21 or 60 days in
SHORT, MID and LONG campaigns, respectively. In this period, subjects
were under a strictly controlled diet to prevent body weight changes and
were awakened at 6:30 AM and prompted to start sleeping at 11:00 PM each
day, with no napping allowed during the day. After completing the HDBR
portion of the study, subjects remained in the facility for some additional
days (referred as POST). Those days are denoted as R+0 to R+X, where
R+0 is the day starting with termination of the immobilization period by the
orthostatic tolerance (OT) test. During the PRE and POST periods, lying
on bed during the day was not allowed. Figure 3.1 schematically shows the
protocols of SHORT, MID and LONG campaigns. Decisions regarding the
specific experimental protocol implemented for each campaign were driven
by the ESA standardization plan, also based on the need to accommodate
multiple experiments from different researchers.
Short-duration HDBR campaigns
One SHORT campaign (3 repetitions) was performed in MEDES facility
(ESA acronym: BR-AG1), in which 12 subjects (age range 21-41 years) were
enrolled. An additional SHORT campaign (3 repetitions) was organized in
DLR (ESA acronym: SAG), including 10 subjects (age range 25-44 years).
Applied interventions to be tested as CMs consisted in: (i) continuous 30
min or (ii) intermittent 6x5 min short-arm daily centrifugation periods in
BR-AG1; and (i) 25-min of daily upright quiet standing and (ii) 25-min of
locomotion replacement training in SAG.
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Figure 3.1: Schematic and timing of the OT and V O2max tests and Holter recor-
ding acquisitions, for the (a) SHORT (b) MID and (c) LONG duration HDBR
campaigns.
Mid-duration HDBR campaigns
One MID campaign (3 repetitions) was performed in MEDES facility (ESA
acronym: MNX), in which 12 subjects (age range 20-44 years) were enrolled.
An additional MID campaign (2 repetitions) was organized in DLR (ESA
acronym: MEP), including 10 subjects (age range 23-42 years). Applied
interventions to be tested as CMs consisted in: (i) resistive vibration exercise
(RVE) and (ii) RVE + high protein intake (1.8 g/kg body weight/day+0.6
g/kg body weight/day of whey protein) and alkaline salt in MNX; (i) high
protein intake (1.2 g/kg body weight/day+0.6 g/kg body weight/day of
whey protein) and alkaline salt in MEP.
Long-duration HDBR campaigns
One LONG campaign was performed in DLR (ESA acronym: RSL), inclu-
ding 24 subjects (12 in control, 12 in the intervention group, age range 20-45
years). Applied intervention to be tested in this case consisted in reactive
jumps in a sledge jump system, as a countermeasure for muscle and bone
loss.
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Table 3.1: Summary of ESA head-down bed-rest experiments included in this study.
HDBR ESA acronym Location Participants CM
SHORT BR-AG1 MEDES 12(x3) 30’ Continuous centrifugation
6x5’ Intermittent centrifugation
SHORT SAG DLR 10(x3) 25’ Passive exercise (Standing)
25’ Active exercise
MID MNX MEDES 12(x3) RVE
RVE + protein intake
MID MEP DLR 10(x2) Protein intake
LONG RLS DLR 24(x1) Active exercise (jumps)
For the SHORT campaign, all 22 subjects in sedentary HDBR comple-
ted the experiments. For the MID, only 20 out of 22 subjects in sedentary
HDBR completed the experiments (1 withdrawal in MNX and 1 in MEP).
In LONG, one subject dropped out on BCD-4 for medical reasons not re-
lated to the study. In the study presented in this chapter, only the data
obtained when the subjects were included in the sedentary control group
will be analyzed for each campaign, to allow for comparison despite the dif-
ferent campaigns and adopted countermeasures. Therefore, the final study
population is composed by 22 subjects in SHORT, 20 subjects in MID and
11 subjects in LONG. Anthropometric data of the final study population
for each campaign is presented in Table 3.2.
Table 3.2: Anthropometric data of subjects participating in SHORT, MID and
LONG duration HDBR campaigns.
SHORT MID LONG
(n=22) (n=20) (n=11)
Age (years) 31.6 32 27
(25.4;35.8) (28.25;40) (24;31.5)
Weight (Kg) 76.2 68.2 76.5
(73.6;80.4) (63.9;76.8) (68.6;83.3)
Height (m) 1.79 1.77 1.80
(1.75;1.82) (1.74;1.83) (1.78;1.83)
3.2.2 ECG acquisition
Twenty-four-hour Holter ECG recordings (H12+, Mortara Instrument Inc.,
Milwaukee, WI, 12 leads, 1000 Hz sampling frequency) were acquired at
PRE, the last day of the HDBR period and at POST. In LONG, additional
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Holter acquisitions recorded along the HDBR were also available. Additio-
nally, ECG signal tracings acquired during orthostatic tolerance (OT) test
by head-up tilt-table and during bicycle exercise test for maximum oxygen
uptake (V O2max) assessment, at both PRE and at POST periods (R+0
and/or R+1, as specified above) were also analyzed. The timing of the Hol-
ter recording acquisition, as well as of the OT and V O2max tests for each
subject and at each campaign is indicated in Figure 3.1.
Orthostatic tolerance test
At R+0, once the cardiovascular monitoring equipment was connected, the
subjects first spent a period of at least 5 min in a supine position on a
tilt board with their lower body enclosed in a lower body negative pressure
(LBNP) chamber, which was not pressurized initially. Thereafter, the tilt
angle was changed to +80◦ head-up tilt and maintained so far for 30 min in
SHORT, and for 15 min in MID campaigns. After this time, if the orthosta-
tic test was not yet ended, the pressure in the LBNP chamber was changed
by -10 mmHg decrements at 3-min intervals until the test was terminated.
Termination criteria included signs of pre-syncope (tunnel vision, pallor,
sweating or malaise, sudden bradycardia, hypotension or undue lack of sub-
ject response to questions) and/or at the request of the subject (see [183] for
more details). Orthostatic tolerance time (OTT) was defined as the time
from head-up tilt until stop criteria was reached. At the end of the test,
supine position was restored. The same protocol was performed during the
ambulatory period (PRE) to assess OTT at baseline.
Exercise stress test
Maximum oxygen uptake (V O2max) was determined during incremental dy-
namic leg exercise on a cycle ergometer (Ergometrics 800S, Ergoline, Bitz,
Germany), before (PRE) and after HDBR (at R+1, after at least 26h from
discontinuation of HDBR, except for the SHORT BR-AG1 campaign, in
which it was performed at R+0, six hours after the OT test). Breathe-by-
breathe V O2 was recorded with an Oxycon Pro metabolic cart (E. Jaeger,
Hochberg, Germany). V O2max was determined during the subject selection.
For each V O2 recording, V O2max was calculated to be the highest value in
a 60 s moving average window. The subject exercised for steps of 5 min at
power outputs estimated to require 25, 50 and 75% of V O2max. Thereafter,
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the power output was increased by +25 W every minute until exhaustion,




As in the previous study, preprocessing of ECG recordings included QRS
detection and baseline wander removal in each lead using a cubic spline in-
terpolation technique. Then, ECG was low-pass filtered and down-sampled
to 125 Hz to reduce noise and the computational cost of TWA analysis.
Finally, a segmentation of ventricular repolarization phase (ST-T complex)
was done at each beat, by defining a fixed interval of 350 ms (reduced to 44
samples after decimation) after the end of the QRS complex.
Short-term averaging
Both OT and V O2max tests are characterized by a transient stress-induced
cardiac response, consequence of the passive head-up tilt or exercise, with
the subsequent recovery phase (<40 min the whole test).
First, for the TWA analysis in the ECG recordings acquired during
the OT and V O2max tests, three specific intervals were selected for further
processing:
for OT test: 1) baseline (BAS): the 4 minutes preceding the head-
up tilt; 2) TILT: the first 4 minutes from head-up tilt; 3) recovery
(REC): the first 4 minutes once supine position was restored at test
termination.
for V O2max test: 1) baseline (BAS): the 5 minutes preceding the start
of the test, while the subject was already instrumented and sit on the
cycloergometer but not pedaling; 2) EX1: the 5 minutes of exercise
at 25% of workload; 3) EX2: from minute 5 to minute 10 of the test
at 50% of workload. The analysis was limited up to a heart rate
limit of 130 beats/min, to avoid the possible mechanical interference
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at twice of the pedaling cadence (variable, but ≥ 70 rpm) in the ECG
signal, which could induce mechanical alternant components at the
TWA frequency [184].
Automatic TWA analysis was performed in 3 steps: (1) selection of
signal segments suitable for automatic analysis, (2) estimation of the TWA
amplitude in each segment and (3) computation of the index of average
alternans activity that characterizes each analyzed interval.
The resulting preprocessed ECG signal was processed for automated
TWA analysis in segments of 32 consecutive beats with a 50% overlap. To
exclude from the analysis possible transients present in the signal, a stability
criterion based on HR and baseline wander was defined. To be considered
suitable for the automatic analysis, a segment must accomplish that (i)
the difference between the maximum and minimum instantaneous HR in
the segment is less than 20 beats/min and (ii) at least 80% of the beats
fulfilled two conditions: the difference between the ith and the (i − 1)th
RR intervals is less than 150 ms and with a difference between the baseline
voltage measured at the PQ segment in that beat and the one measured in
the preceding beat lower than 300 µV.
The method to estimate the TWA waveform is based on [157]. The 8
independent standard leads (V1 to V6, I and II) were linearly combined
using πCA, in order to maximize the TWA content in the combined lead
[156]. Then, the LLRM [153] was applied in the new combined lead to
estimate the TWA waveform of each segment. For each kth suitable signal
segment, it gives a TWA waveform yk, denoted as
yk = [yk(1), . . . , yk(N)]
T , (3.1)
with N the total number of samples within the ST-T complex. The TWA
amplitude associated to the kth segment, VTWA(k) was defined as the abso-
lute value of the mean of the TWA estimated waveform, yk.
Stress induced during both OT and V O2max tests is known to reflect
transients and noise on ECG signal tracings. This non-stationarity toget-
her with the limited duration of the tests could compromise the averaging
performance. Consequently, we proposed an adapted short-term averaging
approach for the analysis of TWA under this particular conditions.
To eliminate from the TWA amplitude the potential amount of noise
and other non-alternant ECG components which could appear and interfere
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in VTWA(k) we defined a new measurement:
V ′TWA(k) = VTWA(k)− VPWA(k), (3.2)
where VPWA(k) is the alternant component present in the P-wave of the
ECG, and was computed similarly to VTWA(k). Assuming noise as uniformly
distributed within the whole beat, VPWA(k) represents an estimate of the
noise level in the TWA measurement. Therefore, V ′TWA(k) measures TWA
amplitude over the noise level. See Figure 3.2 for illustration.
Figure 3.2: Illustration of an estimated TWA waveform and the measurement of
V ′TWA.
Based on previous observations that HDBR induces modifications in
the T-wave morphology, in particular by reducing the maximum T-wave
amplitude and T-wave area [180,181], we introduced also a normalized me-
asurement of TWA to take into account possible effects of these changes
on TWA obtained at PRE and at POST bed-rest. The normalized TWA





where VT(k) represents the mean value of the first principal component in
the ST-T complex computed by applying the PCA over the same 8 standard
leads. Finally, the index of short-term average anternans (IAAST) and the
index of short-term average normalized alternans (IAAnST) were computed
by averaging all suitable segments (all V ′TWA(k) and VTWAn(k), respectively)
at each defined interval.
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Long-term averaging of Holter recordings
In order to avoid potential confounding effects (subjects were asked to com-
plete several activities during the day), only the night period (23.00-06.00 h)
was selected from the 24-hour Holter recording for the subsequent analysis.
These ECG signals were processed in segments of L =128 consecutive beats
(with 50% overlap). The stability criteria for segment’s selection defined
in the previous section was maintained. The TWA waveform associated
to the kth ECG segment, yk, was estimated following the same multilead
approach.
The non-visible microvolt range of TWA, sometimes comparable to the
noise level, makes the TWA estimation a challenging task. In those cases,
the locally estimated alternans waveform yk may have an important noise
component that should be attenuated in order to properly measure TWA.
At this point, a novel methodological step for the computation of the long-
term averaging of TWA activity was included in the analysis, consisting
on the phase alignment of all TWA estimated waveforms, associated to the
K suitable ECG segments, before averaging. This step is needed since the
estimated TWA waveform yk may not have the same polarity, and therefore
might cancel out if they are directly averaged.
First, a detrended version of each yk, denoted as yd,k was computed,
whose samples are:
yd,k (n) = yk (n)− (ak + bkn) (3.4)
where the coefficients ak and bk were chosen as the ones with the best
least-squares fit to the samples of yk (n). This step aims to eliminate any
possible residual baseline component at the alternans frequency. Then, the







being K the total number of suitable segments for the analysis and Yd the
data matrix built by concatenating all of them Yd =
[
yd,1, . . . ,yd,K
]
.
The dominant alternans waveform was obtained as the first principal
component of the spatial correlation matrix [185], by solving the eigenvalue
equation:
RYdw1 = λ1w1 (3.6)
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where λ1 is the largest eigenvalue of RYd and w1 its corresponding eigen-











Consequently, yak = yk if y
T
d,kw1 ≥ 0 and yak = −yk if yTd,kw1 < 0. In
other words, if the waveform yk has the same polarity as the dominant w1,
it will remain unchanged, while if it has the opposite polarity, its sign will
be changed. In this way, the method aligns the polarities of the estimated
TWA waveforms, related to the phase of each alternans sequence, before
averaging them.
Finally, the index of average alternans IAA was defined as the mean
























As in the short-term analysis, the IAA normalized by the average T-
wave amplitude of the recording was also computed (IAAn).
3.3.2 Power spectral analysis of heart rate variability in OT
tests
For the ECG tracings recorded during the OT test, the instantaneous HR
variability (HRV) series, dHRV(n), was derived from the QRS detection marks
obtained in the preprocessing stage as described in [186].
For HRV spectral analysis, three intervals of 3 min and 30 sec of dura-
tion were extracted according to the previously defined intervals for TWA
analysis during OT test, but excluding HR abrupt transient changes due to
head-up tilt: 1) baseline (BAS), from minute 4 up to 30 sec before the tilt;
2) TILT, from 30 sec after head-up tilt to min 4; 3) recovery (REC), from 30
sec after supine position was restored to minute 4 of recovery. For each inter-
val, the power spectral density (PSD) of dHRV(n) was computed by using the
periodogram estimator. The power in the low frequency (0.04-0.15 Hz) and
high frequency bands (0.15-0.4 Hz), PLF and PHF respectively, were obtained
by integrating the power spectrum in the corresponding frequency bands.
Then, the normalized PLFn and the ratio PLF/PHF were computed [187].
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3.3.3 Statistical analysis
Data are presented as median and 25th and 75th percentiles (unless otherwise
specified). Non-parametric Friedman test and Wilcoxon signed rank paired
test with Bonferroni correction were applied for repeated measurements to
evaluate differences among the different stages of the HDBR (among PRE,
during HDBR and POST) in the analysis of Holter recordings.
To evaluate significance of changes induced by HDBR in the stress-
induced manoeuvres (OT and V O2max tests), non-parametric Wilcoxon
signed rank paired test was applied between PRE and POST values. In
addition, to evaluate significance of changes induced by the OT or by the
V O2max test, the same test was also applied with respect to the relevant
BAS condition, for PRE and POST separately. To evaluate potential diffe-
rences in the observed phenomena related to orthostatic deconditioning and
on the effective application of the LBNP during the OT test, we subdivided
the subjects into two subgroups, based on the OTT at POST:
LOW-OTT, including subjects for SHORT with OTT≤30 min, and
for MID and LONG with OTT≤15 min (i.e, no LBNP was needed to
induce OT test termination);
HIGH-OTT, including subjects for SHORT with OTT>30 min, and
for MID and LONG >15 min (i.e, OT test termination after LBNP
activation).
Comparisons between LOW-OTT and HIGH-OTT subgroups were perfor-
med using Mann-Whitney test.
For all tests, the null hypothesis was rejected when p≤ α, with α = 0.05.
In the case of multiple comparison, the corrected significance level, αc, is
defined as αc = α/N , with N , the total number of comparisons.
3.4 Results
3.4.1 Orthostatic tolerance test
In the SHORT group, where LBNP was applied after the first 30 min of
head-up tilt, OTT was significantly reduced between PRE and POST (38.7
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Table 3.3: HRV parameters expressed as median (25th;75th percentiles) computed
at PRE and after five (SHORT), twenty-one (MID) and sixty days (LONG) of





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(36.18;43) vs 8.3 (5.37;32.5) minutes, p<0.001). In the MID group, where
LBNP was applied after 15 min of head-up test, OTT after sedentary HDBR
was dramatically reduced (24.1 (21;28.7) vs 13 (5.9;20.1) minutes, p<0.001).
This decrease was even more accentuated in LONG, from 22.3 (18.9;24.8)
minutes at PRE to 4.6 (3.2;12.4) minutes at POST, with OTTs lower than







































































































Figure 3.3: Cumulative results for HR and TWA indices, reported as absolute
and normalized values, obtained in SHORT (top), in MID (middle) and LONG
(bottom) campaigns during orthostatic tilt test before (blue) and after (red) HDBR
(*: p<.05, PRE vs POST, #: p<.05 vs BAS).
Short-duration HDBR
In SHORT campaign, when comparing PRE vs POST, an increase in HR
was found at BAS and at TILT at the end of the bed-rest. Despite this incre-
ment, a significant decrease in IAAST at BAS was present, while IAAnST
did not change (Figure 3.3, top panels). From spectral analysis of HRV,
PLF and PLF/PHF increased at POST during BAS and REC but not during
TILT, evidencing a shift in the ANS balance towards sympathetic activation
induced by HDBR in these two phases (Table 3.3).
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When grouping subjects according to their OTT in LOW-OTT and
HIGH-OTT subgroups, we observed that already at PRE three subjects
terminated the OT test before LBNP was activated (OTT: 7.9, 22 and
24.3 min, respectively), thus showing earlier pre-syncopal symptoms even
before HDBR. To avoid confusing effects, these subjects were excluded
from the following comparison between subgroups. Accordingly, the LOW-
OTTSHORT subgroup (OTT<30 min) was composed by 12 subjects, whereas
the HIGH-OTTSHORT subgroup (OTT≥30 min) included the remaining 7
subjects.
When comparing these two subgroups at POST (Figure 3.4, columns 1
and 2) during TILT, higher values of IAAST and IAAnST, though not signifi-
cant (p=0.056 and p=0.1, respectively), were observed in LOW-OTTSHORT.
This suggests that a lower orthostatic tolerance to head-up tilt manoeuvre
could be related to an increased electrical instability measured in terms of
higher TWA. Interestingly, in both PRE and POST during the recovery
stage (REC), IAAnST was significantly higher in those subjects with lower
tolerance, i.e., the LOW-OTTSHORT subgroup compared to HIGH-OTTSHORT
subgroup.
Regarding to HRV spectral analysis, before HDBR (Figure 3.4, columns
3 and 4), in LOW-OTTSHORT, both PLFn (0.68 (0.62;0.79) vs 0.91 (0.85;0.94)
n.u., p=0.002) and PLF/PHF (2.13 (1.68;4.11) vs 10.97 (5.58;15.92) n.u.,
p=0.002) significantly increased at TILT compared to BAS. This pheno-
menon was not observed in HIGH-OTTSHORT, thus suggesting that sym-
pathetic drive during orthostatic stimulation increased particularly in the
LOW-OTTSHORT subgroup. Conversely, after HDBR, the increase in sym-
pathetic response was visible in both subgroups (Figure 4 A, bottom).
Mid-duration HDBR
As in SHORT, a significant increase in HR was found at BAS and at TILT
when comparing PRE vs POST, accompanied by a reduction in IAAST in
BAS, TILT and REC (Figure 3.3, middle panels). However, when con-
sidering IAAnST, this reduction maintained its significance only at REC.
Regarding HRV spectral analysis, PLF and PLF/PHF increased after HDBR
at REC, evidencing higher sympathetic drive at POST during this phase
(see Table 3.3).
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Figure 3.4: TWA and HRV indices computed for LOW-OTTSHORT (red) and HIGH-
OTTSHORT (blue) groups, before and after the SHORT-HDBR (up and bottom
panels, respectively).#: p<0.05, vs BAS. †: p<0.05, LOW-OTTSHORT vs HIGH-
OTTSHORT.
Only one subject at PRE terminated the OT test before LBNP was
activated (OTT: 12.1 min) and, as in the previous analysis, it was excluded
for the following subgroups comparison. When considering LOW-OTTMID
(OTT<15 min) and HIGH-OTTMID (OTTgeq15 min) subgroups, they inclu-
ded 10 and 8 subjects, respectively. From this comparison, neither IAAST
nor IAAnST differ between subgroups in this case. In both subgroups, PLF
and PLF/PHF increased during TILT when compared to BAS, suggesting
that sympathetic ANS response with head-up tilt was present before and
after HDBR.
Long-duration HDBR
After LONG HDBR, average HR was increased in all three analyzed inter-
vals. While IAAST was decreased in BAS, no significant changes were found
in the other two intervals. However, when normalized by T-wave amplitude,
the head-up tilt manoeuvre elicited a significant increase in IAAnST after
the immobilization period (Figure 3.3, bottom panels). Regarding HRV
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spectral analysis, a significant decrease in PHF after HDBR together with a
slight increase in PLFn and the ratio PLF/PHF during BAS, evidencing higher
sympathetic drive at POST during this phase (see Table 3.3).
In this study group, two subjects did not end the OT test already at PRE
(OTT: 12.75 and 9.9 minutes) and were excluded for comparison purposes.
At POST, the LBNP was only applied in 3 out of the remaining 9 subjects,
conforming the HIGH-OTTLONG subgroup, while the other 6 subjects were
in the LOW-OTTLONG subgroup. However, no significant differences bet-
ween both subgroups were found in terms of the studied repolarization and
ANS variables.







































































Figure 3.5: HR, IAAST and IAAnST distributions at each interval (BAS, EX1, EX2)
of the V O2max test, computed before (blue) and after (red) five days (top panels)
and after twenty-one days (bottom panels) of HDBR. *: p<0.05, PRE vs POST.
#: p<0.05, vs previous interval.
Due to technical problems, data during V O2max test from both the PRE
and POST were available for only 20 out of 22 subjects in SHORT. In MID,
paired data from PRE and POST were available in only 18 subjects. In
LONG, however, one PRE recording and four POST recordings had to be
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discarded due to technical problems during acquisition and one additional
POST recording missed. Consequently, only paired data from 6 subjects
were finally available.
HDBR induced significant changes on aerobic power. In particular, max-
imum HR was increased from 179 (171;186) beats/min to 184 (175;187)
beats/min in SHORT, from 183 (179;189) beats/min to 190 (180;195) be-
ats/min in MID, but without significant changes in LONG. In addition,
maximum V O2 was diminished from 3187 (2739;3626) ml/min to 3115
(2766;3473) ml/min in SHORT, from 3355 (2507;3787) ml/min to 2564
(2234;3250) ml/min in MID and from 4078 (3664;4300) ml/min to 2700
(2647;2844) ml/min in LONG (Table 3.4).
Table 3.4: Results of aerobic capacity during V O2max in SHORT, MID and LONG
duration HDBR campaigns.
HRmax V O2max TUE
(beats/min) (ml/min) (min)
SHORT PRE 179 3187 18.5
(171;186) (2739;3626) (17.8;19.9)
POST 184* 3115* 19.2
(175;187) (2766;3473) (17.9;19.9)
MID PRE 183 3355 18.5
(179;189) (2507;3787) (17.7;19.4)
POST 190* 2564* 16.2*
(180;195) (2234;3250) (15.2;17.1)
LONG PRE 187 4078 13.6
(182;192) (3664;4300) (12.7;14.2)
POST 186 2700* 10.6*
(178;196) (2647;2844) (8.8;10.8)
*: p<0.05 PRE vs POST
TUE: time up to exhaustion
Short-duration HDBR
Distribution of average HR and TWA indices are presented in Figure 3.5,
upper panels. In both at PRE and at POST, HR increased progressively
during the V O2max test (EX1 vs BAS, EX2 vs EX1, p<.001), as expected.
When compared to PRE values, HDBR induced an increase in HR, which
was significant in BAS and EX2, though not in EX1. As regards TWA in-
dices, both IAAST and IAAnST showed a similar trend during the V O2max
test, with a reduction in EX1 compared to BAS and subsequent slight in-
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crease in EX2. No significant differences between PRE and POST were
evidenced.
Mid-duration HDBR
Results of average HR and TWA indices are presented in Figure 3.5, bottom
panels. As in SHORT, HR progressively increased along the V O2max test
(EX1 vs BAS, EX2 vs EX1, p<.001). Compared to PRE, HR was signifi-
cantly higher at POST in each stage of the test. Regarding TWA analysis,





































Figure 3.6: Distribution of HR, IAAST and IAAnST at each interval (BAS and
EX1) of the V O2max test, computed before () and after (△) sixty days of HDBR.
As observed in the previous campaigns, HDBR induced a significant in-
crease in HR during BAS in all 6 subjects. Both at PRE and at POST,
only 3 out of 6 subjects presented processable ECG segments with HR <130
beats/min in EX1, while no suitable segments in any subject were available
during EX2, as all of them reached the maximum HR before, even at PRE.
To note, this group of subjects presented a higher baseline HR already at
PRE in comparison to SHORT and MID groups (87.9 (83.4;94.7) beats/min
vs 72.8 (64;82.6) beats/min in SHORT and 67.7 (64.7;79.8) beats/min in
MID). The reduced number of subjects and the final PRE-POST paired
data, did not allow to make a reliable statistical analysis in this group. In-
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dividual changes in BAS and EX1 from the final available tests are reported
in Figure 3.6.
3.4.3 Long-term averaging of TWA activity
Data from all subjects (22 in SHORT, 20 in MID and 11 in LONG) were
available for the long-term averaging of TWA. Distributions of average HR,
IAA and IAAn (in absolute values and normalized by T-wave amplitude)





















































































Figure 3.7: Distribution of average HR, IAA and IAAn (normalized by T-wave
amplitude) computed before (PRE), the last day of HDBR, and after (POST), in
SHORT (top panels), MID (middle panels) and LONG (bottom panels) of HDBR.
*: p<0.05.
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Short-duration HDBR
A significant increase in average HR at POST was found both compared
to PRE (59.5 (50.5;66.5) beats/min at PRE vs 70 (53.7;67.1) beats/min at
POST, p=0.009, αc = 0.0166) and to HDT5 (54.9 (51.0;63.2), p=0.001,
αc = 0.0166) although no significant differences along HDBR in IAA,
neither in absolute nor in normalized amplitudes, were found (Figure 3.7,
top panels).
Mid-duration HDBR
The same effect has been observed after 21 days of HDBR (Figure 3.7,
middle panels). Average HR increased at POST compared to PRE (57.3
(52.6;62.9) beats/min at PRE vs 66.2 (58.2;73.5) beats/min at POST, p=
0.002, αc = 0.0166) and compared to HDT21 (54.6 (46.1;59.6) beats/min,
p<0.001, αc = 0.0166) but no significant differences along HDBR in terms
of TWA were found (IAA=0.323 (0.188;0.451) µV at PRE, IAA=0.275
(0.201;0.373) µV at POST, p=0.167, αc = 0.0166).
Long-duration HDBR
A significant increase in HR was found at POST compared to PRE (57.1
(50.8;60.6) beats/min vs 73.6 (70.8;81.6) beats/min, p=0.003, αc = 0.0083),
HDT21 (55.7 (53.7;58.3)beats/min, p=0.003) and HDT57 (57.7 (54.7;63.3)
beats/min, p=0.003, αc = 0.0083). A similar pattern was observed with
TWA indices. The IAA showed an increasing trend at POST (0.467 (0.381;
0.574) µV) compared to PRE (0.337(0.204;0.437 µV) (p=0.2, αc = 0.0083)
and the end of the HDBR (HDT57: 0.247 (0.188;0.454) µV, p=0.091,
αc = 0.0083), tough not significant (Figure 3.7, bottom panels). These
differences become even more accentuated when normalized by T-wave am-
plitude (IAAn: 0.15 (0.085;0.21)% at POST vs 0.08 (0.038;0.14)% at PRE,
p=0.021, and 0.06 (0.040;0.012)% at HDT57, p=0.013, αc = 0.0083). Cor-




SHORT, MID and LONG duration sedentary HDBR induced a reduction in
orthostatic tolerance, as well as a decrease in maximal oxygen uptake and
reserve capacity to perform physical work, thus suggesting cardiovascular
deconditioning after the immobilization period.
In this study, we were focused on the analysis of ventricular repola-
rization alterations induced by HDBR in terms of TWA activity. TWA
was evaluated under two different conditions: (i) two non-stationary stress-
inducing manoeuvres, as the OT by head-up tilt and the V O2max by bicycle
exercise, and (ii) at rest, during the night period. The methodological ap-
proach for TWA estimation based on averaging of the TWA estimated in
short signal segments and avoiding a “hard detection” stage, has been adap-
ted to the particular condition of non-stationary and noisy conditions. We
have additionally introduced a normalization in TWA aplitude (IAAn), to
evaluate whether changes in T-wave amplitude, known to be elicited by
HDBR [180,181], could also impact on TWA estimation. Those changes on
T-wave have been related to the loss of fluids and hypovolemia, resulting in
diminished plasma volume and shrinking of heart cavities [188].
Both OT and V O2max tests lead to an increase in HR, sometimes re-
quired to elicit TWA. Despite previous observations that sedentary HDBR
reversibly increases ECG repolarization heterogeneity and, consequently,
pontentially ventricular arrhythmic risk [180, 181], we found an absence of
a clear significant increase in terms of TWA indices, in both absolute values
and normalized by T-wave amplitude, between PRE and POST 5, 21 and
60 days of HDBR under those particular conditions. Only after 60 days
of HDBR the head-up tilt induced an increasing trend in IAAnST. These
results suggest that long-duration (up to 60 days) exposure to simulated mi-
crogravity was not able to alter the ventricular repolarization heterogeneity
under stress conditions enough to the point of increasing TWA amplitude.
3.5.1 Orthostatic tolerance test
First, we evaluated TWA during OT test. We also performed spectral ana-
lysis of HRV to elucidate potential autonomic nervous system unbalance in
relation to TWA. An apparent decrease between PRE and POST-HDBR in
IAAST was visible in all campaigns (SHORT, MID and LONG) during BAS
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interval. However, when considering IAAnST, this effect disappeared, thus
probably being related to a decrease of the amplitude of the whole T-wave
at the surface ECG, in agreement to the results showing no effect of HDBR
in terms of TWA during OT test.
We observed a decreasing trend in TWA when TILT was compared to
BAS, significant only for SHORT and LONG at PRE and for MID at POST,
together with a statistically significant increase in sympathetic tone (PLFn
and PLF/PHF) with respect to baseline values (BAS) during OT. In pre-
vious studies on Long QT syndrome patients, TWA has been shown to
be provoked by emotional stress, suggesting that sympathetic stimulation
may play an important role [189]. However, this sympathetic activation
did not influence TWA amplitude in patients with structural heart disease
or ventricular arrhythmias [190]. When considering normalized amplitudes
(IAAnST) this decrease at TILT became less evident and even nonsignifi-
cant. This different behaviour in TWA indices could be explained by the
fact that sympathetic stimulation induces T-wave flattening with increasing
tilt angles, as reported in [191], thus being compensated with the normaliza-
tion step. Nevertheless, the relationship between these phenomena remains
still controversial and further research would be needed to better elucidate
the potential stabilization of repolarization with increased sympathetic tone
in healthy subjects.
As regards spectral HRV analysis, the main effect of HDBR evaluated
during the initial baseline condition was a decrease in absolute powers PLF
and PHF, together with an increase in PLFn and PLF/PHF ratio, visible but not
significant after 21 days of HDBR (MID). In previous studies, a decrease
in absolute PLF and PHF power, but no changes in PLFn and PLF/PHF had
been observed after 30 days of bed-rest during controlled breathing (0.25
Hz) [181]. Also in [192], a decrease in PHF power with an increase in PLF/PHF
after a 14-day HDBR was reported. At POST, the head-up tilt induced and
increase in PLFn and PLF/PHF with respect to baseline levels, together with
a decrease in PHF visible after 5, 21 and 60 days of HDBR, similar to what
was previously reported in [193].
Interestingly, when we subdivided subjects according to the resistance
to the head-up tilt manoeuvre at POST, in base to their OTT, higher
TWA parameters during the recovery interval were observed in subjects
with OTT<30 min (LOW-OTTSHORT) after 5 days of HDBR, suggesting
higher electrical instability associated to a more important orthostatic into-
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lerance due to cardiac deconditioning. In addition, these subjects presented
a significant increase with head-up tilt in both PLFn and PLF/PHF already
before the HDBR, while in the HIGH-OTTSHORT group this effect was not
visible. Moreover, the increase in sympathetic tone observed during TILT
was accompanied by a reduced IAAnST, in agreement with previous studies
on patients with syncopal and postural orthostatic tachycardia syndrome,
in which the reaction of sympathetic tone to orthostasis was more severe
compared to control subjects [194]. However, we could not confirm the such
differences after 21 and 60 days of HDBR. This discrepancy could also be
due to the different protocol, since LBNP was applied after only 15 min,
instead of 30 min as in SHORT.
3.5.2 Exercise stress test
In addition to evaluating TWA during OT test, we performed a similar
analysis during V O2max test. Our findings from V O2max test showed the
expected increase in HR during the considered exercise phases (i.e., BAS,
EX1, EX2) with higher values at POST compared to PRE, in agreement
with the observed decrease in maximal oxygen uptake and reserve capacity.
No HDBR-related increment in TWA was noticed, neither in absolute nor
in normalized values, for all SHORT, MID and LONG. Unfortunately, the
reduced number of tests finally available in the LONG campaign, in which
effects of bed-rest were expected to be more pronounced, limited the drawing
conclusions related to exercise induced stress on TWA. An additional LONG
campaign is currently ongoing at MEDES facility and data from 10 more
subjects is expected to be available by the end of the year to complete the
study group.
Nevertheless, our results are not concordant with the only study asses-
sing TWA PRE and POST-HDBR during incremental dynamic leg exercise
on a cycle ergometer [182]. In that study, the number of subjects with po-
sitive TWA test, requiring TWA to be present at a HR higher than 110
beats/min, was found to increase after 9-16 days of HDBR. In particular,
4 out of 24 subjects (17%) were classified as positive already at PRE, be-
coming 10 out of 24 (41.7%) at POST. However, it has to be remarked
that two positive subjects at PRE resulted negative at POST, without a
clear explanation. A possible cause of discrepancy with Grenon et al. could
be due to the fact that V O2max test in our study was performed within 26
hours after the end of HDBR (R+1 day), while in [182] it was performed
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within 6 hours after its conclusion. The fact that subjects had maintained
in the upright position for a considerable period before the test could have
mitigated some of the HDBR-induced effects.
To note, the protocols of these tests were not TWA specific but for
aerobic power assessment. TWA test required a graded increase in heart
rate, commonly during bicycle or treadmill exercise, up to an optimum HR
range of 105-110 beats/min, which was determined for pathologic alternans
in adults [5]. Usually, specific TWA tests try to keep the subject’s HR
as much time as possible within this range. However, this consideration
was disregarded in the present V O2max protocol. On the other hand, an
additional control on the pedalling candence, prompting the subject to pedal
at one third or two thirds of his heart rate, would had avoided the HR
restriction (<130 beats/min), in order to avoid the possible mechanical-
induced interference on TWA measurements [148,195].
3.5.3 Long-term averaging of TWA activity
Finally, electrical instability in ventricular repolarization was assessed by
the long-term averaging of TWA activity during the night hours. The se-
lection of the night period was motivated by the fact that subjects were
asked to perform numerous experimental tests during the day period (es-
pecially in PRE and POST periods) that could induce confounding effects.
While no statistically significant changes after 5 and 21 days of HDBR were
found, an increasing tendency in IAA at POST with respect to both PRE
and the end of the 60-day immobilization period (HDT57) was observed
in LONG, although it did not reach statistical significance. These changes
were more evident when IAA was normalized by changes on T-wave ampli-
tude. This increase in TWA could have been induced by the same pattern
observable on average HR. However, a low correlation between both para-
meters was obtained. Previous reports on which ventricular repolarization
heterogeneity was assessed using different repolarization indices (QTc, spa-
tial QRS-T angle, ventricular gradient, among others) has been shown to
be reversibly altered after short and long-duration HDBR studies [180,181].
All these observations might be an indicative of initial electrical instability
on the myocardial substrate induced by log-term HDBR.
Anyway, data available in the LONG-duration campaign was limited in
terms of study subjects, especially during V O2max test, which did not allow
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to draw final conclusions in this study group. Results need to be confirmed
in a larger population. An additional LONG campaign, currently on going
in MEDES facility, will provide data from 10 additional subjects, which are
expected to be available by the end of the year.
3.6 Conclusion
The absence of significant changes between PRE and POST-HDBR in TWA
indices suggests that a 60-day exposure to simulated microgravity is not
enough to induce significant changes in healthy myocardial substrate up to
the point of reflecting electrical instability in terms of TWA on the sur-
face ECG. Nevertheless, the increasing tendency observed after 60 days of
immobilization period might be indicative of initial alterations in the repola-
rization phase. From the clinical perspective, reduced gravitational stimulus
during HDBR experiments, could also provide interesting information which




alternans predictive value in
ambulatory recordings by


























88 Chapter 4. Improvement of TWA predictive value dealing with VPCs
4.1 Motivation
In clinical research, TWA tests are usually performed under controlled he-
art rate conditions, typically by exercise-induced stress. The most widely
used methods are the SM or the MMAM described in section 1.5.1, as
these are the two alternatives commercially available, resulting in a TWA-
positive, -negative or -indeterminate test. In the clinical practice, an im-
portant percentage of indeterminate TWA tests is reported (between 20%
and 40%) [196–198]. The main causes of an indeterminate result are ex-
cessive noise, lack of capacity to reach a target heart rate of 105 to 110
beats/min, non-sustained TWA (<1 minute) or the presence of ventricular
ectopic activity, which may directly interfere with the frequency content
of alternans [199]. Therefore, from the signal processing viewpoint, robust
algorithms able to overcome these limitations are required in order to gua-
rantee the clinical value of TWA. The LLRM [153], as an alternative to the
mentioned SM and MMAM, has been shown to outperform the accuracy of
these methods in the presence of impulsive artifacts, as the ones produced
in the beat-to-beat amplitude series by VPCs or electrode motion [154].
In the recent years, the analysis of TWA in ambulatory ECG recordings
has become a matter of increasing interest, yielding promising results [149–
152, 200, 201]. In particular, the long-term averaging of TWA activity in
24-hour Holter recordings has been shown to be an independent predictor
of SCD in CHF patients [157]. In that study, the same averaging approach
presented in the previous chapter was used, avoiding the need for visual
verification required by other methodologies, as in the case of MMAM [149–
151]. The method for TWA analysis in [157] discards unstable segments,
defined in terms of instantaneous heart rate changes, abrupt baseline wander
and the percentage of ectopic beats. Indeed, segments with a low percentage
of abnormal beats were still included in the analysis, as the LLRM for TWA
estimation is able to cope with a small number of abnormal beats. However,
the presence of one or more VPCs may alter repolarization dynamics, and
they may introduce a phase reversal in the sequence of alternant T-wave
morphologies [158], which could hamper the estimation of TWA amplitude
[159,160] and, consequently, its potential for risk stratification.
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In this chapter, we propose a method to improve the estimation of TWA
amplitude in ambulatory ECGs, by dealing with the possible phase reversal
induced by the presence of VPCs in the alternans sequence. First, a simu-
lation scenario was generated in order to evaluate the performance of the
algorithm using synthetic signals. Then, the effect of the proposed method
in the prognostic value of TWA amplitude was assessed in real ambulatory
ECG recordings from patients with CHF. Finally, circadian TWA changes
were evaluated as well as whether the prognostic value of TWA is sensitive
to this circadian pattern.
4.2 Materials
4.2.1 Simulated data
Series of 2080 beats were created by replicating one beat extracted from an
actual Holter recording (sampling frequency 200Hz), with synthetic TWA.
This TWA was generated by adding and subtracting in even and odd be-
ats respectively a given waveform (modelled as a Hamming window, with
peak amplitudes varying from 0 to 300 µV in steps of 50 µV) to the re-
polarization phase of the beat (i.e, the ST-T complex). Moreover, three
real sources of noise -electrode motion (em), muscular activity (ma) and
baseline wander (bw), obtained from the Physionet MIT-BIH Noise Stress
Test Database (NSTDB) [202]– and synthetic white Gaussian noise (gn)
were independently added to the simulated ECG in order to create a more
realistic scenario.
For each simulated TWA amplitude, baseline wander segments properly
scaled to present different standard deviations, σbw , varying from 0 to 800
µV, in 100 µV steps, were added to the synthetic ECG. These baseline
wander segments were randomly selected form one of the 2 available leads
of the NSTDB. The same procedure was replicated for the ma and em
noises, with σma and σem ranging from 0 to 200 µV, in 25 µV steps, and
for the synthetic Gaussian noise (σgn varying from 0 to 100 µV).
A total of 100 realizations were generated for each combination of noise
and TWA amplitudes in order to have a reliable characterization of the
method’s performance. For each realization, VPCs were randomly allocated
along the 2080-beat sequence. The phase of the alternans sequence in the
next beat after each one labelled as VPC was randomly selected, with a
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0.5 probability of a phase shift. Additionally, the effect of the presence of
ectopic beats in the TWA estimation was also evaluated for low, medium
and high levels of noise, varying the percentage of VPCs included in the
sequence from 0 to the 20%.
4.2.2 Ambulatory ECG recordings
A total of 992 consecutive patients with symptomatic CHF corresponding to
NYHA classes II and III were enrolled in the multicenter MUSIC (MUerte
Súbita en Insuficiencia Cardiaca) study, a prospective study designed to
assess risk predictors for cardiovascular mortality in ambulatory CHF pa-
tients [203]. Patients were enrolled from the specialized CHF clinics of eight
University Hospitals between April 2003 and December 2004. The original
MUSIC study included patients with both reduced and preserved LVEF.
Patients with preserved LVEF were included if they had CHF symptoms,
a prior hospitalization for CHF or objective CHF signs confirmed by chest
X-ray and/or echocardiography. Patients were excluded if they had recent
acute coronary syndrome or severe valvular disease amenable for surgical
repair. Patients with other concomitant diseases expected to reduce life-
expectancy were also excluded. Originally, patients in sinus rhythm, atrial
fibrillation, atrial flutter and in pacemaker rhythm were included. The cli-
nical data for the overall population were already reported in [203].
The 24-hour Holter ECG recordings of 651 patients (187 females) in
sinus rhythm, aged 18-89 years (62.9±11.9 years) were analysed in the pre-
sent study. ECG signals were acquired by using SpiderView records (ELA
Medical, Sorin Group, Paris, France) and two or three (96.8%) orthogonal
leads (X, Y , Z) sampled at 200 Hz were available for each subject. Most
patients (82.3%) were in NYHA class II. Ischemic etiology of CHF was pre-
sent in 50.2% of patients. Mean LVEF was 36.9±13.8% (range 10-70%), and
half of patients (54.7%) presented LVEF≤35%. Intraventricular conduction
delay, defined as QRS duration geq0.12s, was present in 292 patients. Some
relevant patient characteristics are summarized on Table 4.1.
Patients were followed up every 6 months during 48 months. Whithin
the study population, there were a total of 55 victims of SCD, 59 of other
cardiac causes, 26 non-cardiac deaths and 511 survivors. SCD, defined as (i)
a witnessed death occurring within 60 minutes from the onset of new symp-
toms unless a cause other than cardiac failure was obvious, (ii) an unwitnes-
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Table 4.1: Characteristics of patients. Data are presented as mean±standard devi-
ation and as absolute frequencies (percentages).
Overall population SCD group Non-SCD group
(n=651) (n=55) (n=596)
Age (years) 62.9±11.9 64.54±10.72 62.81±12
Gender (males) 464 (71.3%) 46 (83.6%) 418* (70.1%)
LVEF ≤ 35% 356 (54.7%) 40 (72.7%) 316* (53.0%)
NYHA class III 115 (17.7%) 16 (29.1%) 99* (16.6%)
Diabetes 244 (37.5%) 24 (43.6%) 220 (36.9%)
Beta-blockers 455 (69.9%) 39 (70.9%) 416 (69.7%)
Amiodarone 61 (9.4%) 6 (10.9%) 55 (9.2%)
ARB or ACE inhibitors 576 (88.5%) 45 (81.8%) 531 (89.1%)
QRS duration ≥ 120 ms 292 (44.9%) 30 (54.6%) 262 (44.0%)
LVEF: Left ventricular ejection fraction; NYHA: New York Heart Association;
ARB: angiotensin receptor blocker; ACE: angiotensin-converting enzyme.
*: p≤0.05 SCD vs Non-SCD groups
sed death (≤ 24 hours) in the absence of pre-existing progressive circulatory
failure or other causes of death, or (iii) death during attempted resuscita-
tion, was considered as an independent endpoint in this study. Endpoints
were reviewed and classified by the MUSIC Study Endpoint Committee.
The study protocol was approved by institutional investigator committees
and all patients gave written informed consent [203].
4.3 Methods
4.3.1 Preprocessing
Preprocessing of ECG recordings included heart beat detection and classifi-
cation (including identification of VPCs) using the Aristotle ECG analysis
software [204] and linear high pass filtering (0.5 Hz cut-off frequency) for
baseline wander attenuation. Then, the ECG signal was low-pass filtered
(15 Hz cut-off frequency) to remove noise out of TWA frequency range, and
down-sampled to 100 Hz. Finally, a segmentation of ventricular repolari-
zation phase (ST-T complex) was done at each beat, by defining a fixed
interval of 300 ms (30 samples after decimation) after the end of the QRS
complex (80 ms after QRS fiducial point).
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Analogously to the study presented in the previous chapter (section
3.3.1), ECG signals were processed in segments of L =128 consecutive beats
(with 50% overlap). Segments were deemed valid for automatic analysis if
at least 80% of their beats fulfilled two conditions: (i) they were labelled
as normal beats and (ii) there was a difference lower than 200 µV between
the baseline voltage measured at the PQ segment in that beat and the one
measured in the preceding beat.
Moreover, an additional criterion based on instantaneous HR changes
was applied to ensure heart rhythm stability in the segments accepted for
TWA analysis: only 128-beat segments where the difference between the
maximum and minimum RR interval, ∆RRN , was lower than 300 ms were
included (considering only RR intervals defined between normal-labelled
beats). Thus, with this criterion the RR intervals related to VPCs are not
considered to decide whether the segment is included or not.
4.3.2 TWA estimation
The method to estimate the TWA waveform is based on [157]. For each kth
signal segment, it gives a TWA signal yk, denoted as
yk = [yk(1), . . . , yk(N)]
T , (4.1)
with N the total number of samples within the ST-T complex. The three
orthogonal leads are linearly combined using πCA, in order to maximize
the TWA content in the combined lead [156]. Then, the LLRM [153] was
applied in that new combined lead to estimate the TWA waveform of each
segment (yk). The original method in [156] disregarded the possible phase
shift in the TWA produced by the presence of any VPC (a maximum of
20% of VPCs was allowed).
4.3.3 VPC processing
The possible phase shift following a VPC influences TWA estimation. Two
examples of TWA sequences without and with a phase shift after the VPC
are shown in Figure 4.1. As the LLRM has been demonstrated to be robust
enough to the presence of impulsive noise [145], in the original method [157]
segments with a low percentage of VPC were accepted for TWA analysis
and processed in the same way as segments with all normal beats. However,
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if the ectopic activity produces a phase shift in the sequence of repolariza-
tion waveforms during a TWA episode, TWA could be undetected and its
amplitude could be underestimated. To avoid this problem, we introduced
an additional processing step when VPCs are present in the segment, con-
sisting on controlling the phase of the alternans sequence after the ectopic
beat.
A B A B A B A
VPC
A B A B A B
A B A B A B VPC A B A B A B
( a )
( b)
Figure 4.1: Two TWA sequences including a VPC extracted from real ECG signals
of patients undergoing a percutaneous transluminal coronary angiography (PTCA):
in (a) the alternans sequence maintains the phase after the VPC while in (b) there
is a phase shift after the VPC.
Let us consider a VPC within a segment of L beats with TWA. If more
than one consecutive VPC appear, the whole sequence of VPCs is considered
as a single VPC for the purpose of the algorithm described in this section.
In the following, we will consider, without loss of generality, that an
alternant pattern ABAB . . . AB is present in the signal. Note that if no
TWA is present, A and B beats are expected to be similar.
If the ectopic beat lies in an odd position within the series, the se-
quence of beats before the abnormal beat can be represented as Spre =
{ABAB . . . AB}. As the abnormal beat may, or may not, reset the phase,
the alternant sequence after the ectopic (Spost) can be either Spost1 =
{ABABAB...} or Spost2 = {BABABA...}. On the contrary, if the ecto-
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pic beat is in an even position, the sequence of beats previous to the VPC
will end in an A beat (i.e. Spre = {ABAB...ABA}) and, again, there are two
possible continuations of the series after the VPC: Spost1 = {ABABAB...}
or Spost2 = {BABABA...}.
The proposed approach consists on determining what is the relative
phase of the Spost sequence of beats with respect to the Spre sequence,
discarding the abnormal beat, and properly concatenating Spost at the end
of Spre. If needed, the first beat of the post-VPC series is also eliminated
to keep the continuity of the alternans phase in the resulting series. As an
illustrative example, Figure 4.2 shows two possible scenarios where Spre and
Spost are in phase (a) and out of phase (b). In the latter situation, both the
ectopic and the following beat need to be discarded in order to preserve the
phase of the alternans in the final sequence.
To determine the relative phase between the two subsequences (Spre and
Spost), the following procedure is applied:
1. The TWA waveform of each subsequence (yk,pre and yk,post in Spre
and Spost, respectively) was estimated using the LLR method [153],
i.e. as the median of the demodulated differences (alternative sign
change) between the consecutive ST-T complexes included in each
subsequence.











respectively, are both positive or both negative (same sign), this in-
dicates that TWA has the same polarity in both subsequences and,
consequently, both of them start with the same phase. On the con-
trary, if ȳk,pre and ȳk,post have opposite signs, this indicates that both
sequences start out-of-phase. Therefore, if the Spre has an even num-
ber of beats and both sequences start in phase, only the VPC beat is
discarded before concatenation (Figure 4.2 (a)). The same procedure
is applied when the Spre has an odd number of beats and Spost starts
at the opposite phase. In the remaining two cases, both the VPC and
the next beat are discarded before concatenation, in order to keep
continuity of the TWA phase.
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A B A B A B A B A B A B A B A
Final sequence of ST-T complexes
Spre Spost
ST-T complex ST-T complex




(a) yk,pre and yk,post with the same phase
A B A B A B A B B A B A B A B
ST-T complex ST-T complex






Final sequence of ST-T complexes
A B A B A B A B A B A B A B
Spre Spost
(b) yk,pre and yk,post with opposite phase
Figure 4.2: Two examples of synthetic TWA sequences including the presence of one
VPC, and the processing applied for the estimation of the alternans waveform. (a)
Spre and Spost sub-sequences start at the same phase (ȳk,pre > 0 and ȳk,post > 0)
and the VPC is in an odd position: only the VPC is excluded in the final sequence
considered for the estimation of TWA waveform. (b) Spre and Spost sub-sequences
start with the opposite phase (ȳk,pre > 0 and ȳk,post < 0) and the VPC is in an
odd position: both the VPC and the following beat are excluded in this case.
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If there are M >1 non-consecutive abnormal beats in one ECG signal
segment,M+1 subsequences can be defined. In this case, the same described
approach is followed to concatenate the sequence of beats after each VPC
to the previous sequence until all VPCs have been processed. Subsequences
of just one or two beats are discarded.
Note that in the absence of TWA, the procedure can be applied in the
same way, even if the estimated phases are related to other beat-to-beat
variability components rather than TWA.
4.3.4 Alternans waveform estimation
Finally, the TWA waveform of the kth segment, yk, was expressed as the
median of the demodulated differences between ST-T complexes of even and
odd beats [153], after the phase correction is applied to the data.
4.3.5 Phase alignment of alternans waveforms
TWA waveforms, yk, may not have the same polarity and, therefore, might
cancel out when averaging. Thus, before final averaging, phase-alignment
step is needed. As described in the previous chapter (see section 3.3.1), this










where yd,k is a detrended version of yk and w1 is the dominant waveform,
obtained by a classical PCA analysis (see section 3.3.1 for a detailed des-
cription).
Finally, the index of average alternans including the VPC processing



























Data are presented as mean ± standard deviation for continuous variables
and as number (percentage) for categorical variables, unless otherwise speci-
fied. Comparisons between SCD and non-SCD groups were evaluated by the
two-tailed MannWhitney and Fisher exact tests for quantitative and catego-
rical data, respectively. Non-parametric Friedman test and Wilcoxon signed
rank paired test with Bonferroni correction were applied to evaluate diffe-
rences among time intervals in circadian analysis. Prognostic value of TWA
indices in predicting SCD was determined with univariate Cox proportional
hazards analysis. Survival analysis was performed by using Kaplan-Meier
estimator and comparison of cumulative events by log-rank test. For all
tests, the null hypothesis was rejected when p≤ α, with α = 0.05. In the
case of multiple comparison, the corrected significance level, αc, is defined
as αc = α/N , with N = the total number of comparisons.
4.4 Results
4.4.1 Simulation study
The effect of VPCs and the possible phase resetting of the alternans sequence
in the estimation of the IAA index were evaluated using synthetic signals.
Figure 4.3 shows examples of simulated beat sequences with artificial TWA
and four additive noises: Gaussian noise, baseline wander, muscular activity
and electrode motion.
For each TWA level, noise type, noise level and VPC probability, 100
different realizations were generated, randomizing the presence of the VPCs
along the whole beat sequence, as well as the posterior phase resetting of
the alternans sequence. Figure 4.4 shows the mean and standard deviation
of the estimated IAA index, computed including the VPC processing and
phase alignment (IAAVP, blue line) and when these steps are not included,
i.e. analyzing raw beat segments (IAAnVP, grey dashed line), under different
levels of noise (σgn, σbw, σem and σma), for a VPC probability of 2%. Each
curve is associated to a different TWA simulated amplitude. From top
to bottom, peak amplitudes of alternans waveform were set to 300, 250,
200, 150, 100, 50 and 0 microvolts, which corresponds to average alternans












































Figure 4.3: Simulated ECGs with added artificial TWA (a) and corrupted by dif-
ferent noises: Gaussian noise (b), baseline wander (c), electrode motion (d) and
muscular activity (e).
amplitudes (IAAsim) of 159.8, 133.2, 106.6, 79.9, 53.3, 26.6 and 0 microvolts,
respectively.
Additionally, the effect of the number of VPCs present in the segment
was also evaluated. For low, medium and high noise levels, the IAA was
estimated by varying the probability of having a VPC from 0 to 20% (Figure
4.5). Peak alternans amplitudes from 0 to 200 µV in steps of 50 µV are
represented (corresponding to IAAsim of 0, 26.6, 53.3, 79.9 and 106.6 µV).
4.4.2 Ambulatory ECG
Holter ECG signals from CHF patients were processed using the same met-
hodology. We computed both IAAVP and IAAnVP indices, as a measurement
of the average TWA amplitude for the 24h recording, and compared the as-
sociated prognostic values. Patients were classified as TWA(+) or TWA(-)
based on a risk threshold (TWA(+) if IAA ≥ thrisk, TWA(-) otherwise).
This thrisk threshold was defined as the third quartile of the total distribu-
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Figure 4.4: IAA estimation on synthetic signals with different noises types and
levels (σgn, σbw, σma and σem in panels (a), (b), (c) and (d), respectively) when
the probability of VPCs is limited up to the 2%. Results are represented as mean
std of 100 realizations for each combination of σ and alternans amplitude. From top
to bottom, the curves represent the measured IAA with both methods when the
simulated mean TWA amplitude (IAAsim) was, respectively of 159.8, 133.2, 106.6,
79.9, 53.3, 26.6 and 0 µV (corresponding with the alternans peak amplitudes of
300, 250, 200, 150, 100, 50 and 0 µV). Blue line corresponds to the IAA estimated
with the ectopic protection and phase alignment (IAAVP) and grey dashed line
represents the IAA estimation without any protection (IAAnVP).
tion of IAA indices. Accordingly, the TWA(+) group is composed by the
25% of patients (n=163) with the largest IAA values each time. See Table
4.2 for the distribution of SCD events in the TWA(-) and TWA(+) groups.
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Figure 4.5: Effect of the number of VPCs present in the segment on IAA estimation
for a low (left column), medium (middle column) and high (right column) levels of
noise, from top to bottom σgn, σbw, σma and σem. Results are represented as mean
std of 100 realizations, where blue line corresponds to the IAA estimated with
the VPC processing and phase alignment (IAAVP) and grey dashed line represents
the IAA estimation without any protection (IAAnVP). In each panel, from top
to bottom, the curves represent the measured IAA with both methods when the
simulated mean TWA amplitude (IAAsim) was, respectively of 106.6, 79.9, 53.3,
26.6 and 0 µV (corresponding with the alternans peak amplitudes of 200, 150, 100,
50 and 0 µV).
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Finally, we evaluated the effect of including additional VPCs in the
processing and we assessed the prognostic value of IAA indices in SCD
prediction by performing a univariate Cox proportional hazards analysis.
Results are summarized on Table 4.3. We started by including in the analy-
sis only those VPC-free segments with ∆RRN < 300 ms, i.e. stable rhythm
segments containing only normal beats. TWA(+) outcome was not associ-
ated with SCD. By sequentially adding segments containing a maximum of
1, 2 and 3 VPCs, TWA(+) outcome according to IAAVP was in all cases
successfully associated to SCD when the ectopic processing was included in
the processing. In contrast, no association was found between IAAnVP and
SCD, except when a maximum of 1 VPC was allowed, being the hazard
ratio in all cases lower than the one obtained with the ectopic processing
(IAAVP). Hazard ratios were increased by 17%, 19%, 29% when including 1,
2 and 3 VPCs, respectively. Finally, when all segments with ∆RRN < 300
ms regardless of the number of VPCs were included in the analysis, neither
IAAnVP, nor IAAVP preserved the alternans predictive value (see Table 4.3).
Table 4.2: Number of SCD events included in TWA(-) and TWA(+) groups as
a results of the analysis with the ectopic processing (IAAVP) and without any
protection (IAAnVP). Data are expressed as absolute frequencies and percentages
whithin TWA groups. Significant differences between the number of SCD events
in TWA(-) and TWA(+) groups are indicated by *(p<.05) and **(p<.005).
IAAnVP IAAVP
TWA(-) TWA(+) TWA(-) TWA(+)
(n=488) (n=163) (n=488) (n=163)
∆RRN <300 37 18 - -
with no VPCs (7.6%) (11.0%)
∆RRN <300 34 21* 32 23**
with ≤1 VPC (7.0%) (12.9%) (6.6%) (14.1%)
∆RRN <300 36 19 34 21*
with ≤2 VPCs (7.4%) (11.7%) (7.0%) (12.9%)
∆RRN <300 37 18 34 21*
with ≤3 VPCs (7.6%) (11.0%) (7.0%) (12.9%)
∆RRN <300 36 19 37 18
(7.4%) (11.7%) (7.6%) (11.0%)
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Table 4.3: Association of IAA indices with sudden cardiac death computed in pa-
tients with chronic heart failure. Results from the analysis with the ectopic proces-
sing (IAAVP) and without any protection (IAAnVP) are included. Hazard ratios
significantly greater than 1 are indicated in bold.
Average # Risk threshold Hazard ratio p-value
of segments (thrisk) (95% CI)
∆RRN <300 527±414 thnVP
risk
=1.394 µV 1.590 0.11
with 0 VPC (0.901,2.808)
∆RRN <300 669±448 thnVP
risk
=1.381 µV 2.030 0.011
with ≤1 VPC (1.174,3.509)
thVP
risk
=1.470 µV 2.386 0.002
(1.391,4.092)
∆RRN <300 749±455 thnVP
risk
=1.354 µV 1.708 0.060
with ≤2 VPCs (0.977,2.987)
thVP
risk
=1.544 µV 2.026 0.011
(1.172,3.502)
∆RRN <300 804±458 thnVP
risk
=1.339 µV 1.582 0.112
with ≤3 VPCs (0.898,2.786)
thVP
risk
=1.649 µV 2.035 0.011
(1.177,3.518)
∆RRN <300 1018±423 thnVP
risk




=2.282 µV 1.502 0.157
(0.885,2.638)
Finally, survival probability curves for the most significant predictive
indices are shown on Figure 4.6. Results associated to both IAAnVP and
IAAVP indices are included in grey and blue lines, respectively.
Circadian analysis of IAAVP
Several studies have reported differences in repolarization dynamics between
day and night, as well as in the incidence of SCD events [205–207]. In this
section, circadian TWA changes in the 24-h hour Holter recordings from
our CHF population were assessed. In addition, we evaluated whether the
prognostic value of IAAVP is sensitive to this circadian pattern. To do
that, the IAAVP was measured in consecutive 6-hour intervals (00.00-06.00
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Figure 4.6: Survival probability curves of sudden cardiac death associated to
IAAnVP (grey lines) and IAAVP (blue) in the chronic heart failure population.
Each panel includes results corresponding to different selection criteria: (a) seg-
ments with ∆RRN < 300 ms with a maximum of 1 VPC allowed; (b) segments with
∆RRN < 300 ms with a maximum of 2 VPCs and (c) segments with ∆RRN < 300
ms with a maximum of 3 VPCs.












































Figure 4.7: Distribution of HR and IAAVP indices for each day interval. Number
of records in which IAAVP could be computed at each day period is indicated on
left panel above the boxes.*: p<0.001, αc = 0.0083
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According to the results presented in the previous section, this analysis
was performed only considering the index that led to the best stratification
performance, that is, including segments with ∆RRN <300 ms and ≤1
VPCs.
The distributions of HR and IAAVP for the four defined intervals are
presented in Figure 4.7. Significant differences were found between the
night and all daytime periods. IAAVP was minimal during the night pe-
riod, reaching its maximum value for the interval defined from 12.00 to
18.00 h (IAA00-06VP =0.60 (0.41;0.97) IAA
12-18
VP = 1.19 (0.79;1.89) µV, p<0.001,
αc = 0.0083). It should be noticed here that not all recordings presented
processable data for the total 24 hours, and consequently the index could
not be computed for each interval in all subjects (number of available re-
cordings for each day period are indicated in Figure 4.7, top of right panel).
The same trend was observed when considering average HR. Howe-
ver, only a weak correlation was found between IAAVP and average HR
(R2 =0.038, p<0.001). The computation of the IAAVP index for each time
interval was also computed by restricting to ECG segments with average
HR within an specific range from X-10 to X beats/min, denoted as IAAXVP,
where X = {70, 80, 90, 100}). Results shown similar pattern of variation
along the day for each HR range (Figure 4.9). Additionally, an increasing
tendency from IAA70VP to IAA
100
VP in all day periods, was evidenced.

















Figure 4.8: Scatterplot of IAAVP versus HR.
4.4 Results 105



























426 478 481 485













282 411 436 419















144 300 336 294
Figure 4.9: Distribution of IAAVP HR-restricted indices at each day interval consi-
dering segments with average HR from 70 to 100 beats/min. Number of records in
which IAAVP could be computed at each day period is indicated above the boxes.
*: p<0.001, αc = 0.0083
In order to evaluate the effect of the circadian pattern on the prognostic
value, we replicated the Cox proportional analysis associated to the each
index computed for each day interval. Patients at risk were defined accor-
ding to a risk threshold which, as in the previous study, was set at the
third quartile of the total distribution. Results are summarized in Table
4.4. By setting a cut point IAA06-12VP =1.621 µV, the index computed during
the morning hours was still successfully associate to SCD.
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Table 4.4: Association of IAAVP indices with SCD death.
Hazard ratio
(95% CI) p-value
IAA00-06VP ≥ 0.973 1.45 (0.784, 2.690) 0.236
IAA06-12VP ≥ 1.621 1.96 (1.114, 3.429) 0.019
IAA12-18VP ≥ 1.886 1.60 (0.891, 2.856) 0.116
IAA18-24VP ≥ 1.973 1.69 (0.934, 3.048) 0.083
4.5 Discussion
In this chapter, we have proposed a method to improve the quantification
of TWA activity in long-term ambulatory recordings by overcoming the
presence of VPCs and the possible associated phase shifts in the alternans
sequence, as well as other sources of noise that could lead to the underesti-
mation of TWA amplitude.
TWA testing, usually performed in the clinical setting in stress tests,
provides a positive, negative or indeterminate test result [199]. However,
the rate of indeterminate tests remains high (up to 40%) [196–198] and the
analysis of TWA on ambulatory ECG recordings has recently emerged as
an alternative [149–152, 200, 201]. In particular, fully-automatic long-term
averaging of TWA activity in 24h-ECG recordings has been already shown
to be an independent predictor of SCD [157]. In that study, TWA esti-
mation is based on the LLRM, which has been proved to be more robust
than other methods to the presence of impulsive noise [145,154], as the one
produced in the beat-to-beat series when isolated abnormal beats (VPCs)
are present in the analyzed segment. However, both unaltered and rever-
sed phase of the alternans sequence following a premature beat have been
described in the literature [158, 208] and this potential phase resetting can
have a relevant impact on TWA estimation [147, 159, 209]. In particular, if
the phase reversal occurs in the central beat of the segment, it can lead to
measure a zero-voltage alternans when spectral analysis is used [160]. In
order to overcome this limitation, the new approach presented in this work
included an additional phase reversal control after the presence of any VPC,
ensuring the phase continuity if alternans is present in the segment. For that
purpose, the VPC and, if needed, the following beat are discarded before
4.5 Discussion 107
estimating TWA magnitude in the segment. As a note, this methodology
requires prior beat classification and VPC identification.
Additionally, all estimated alternans waveforms were aligned in sign,
using a correlation criteria, before IAA estimation.
4.5.1 Simulation study
First, the accuracy of TWA estimation was assessed using synthetic ECG
signals with added synthetic TWA and in the presence of four different
types of noise: white Gaussian noise, baseline wander, muscular activity and
electrode motion. According to the simulation results, with a fixed VPC
probability per beat of 2%, the estimation accuracy is clearly higher when
the ectopic processing and phase alignment were included (i.e, IAAVP) than
when this step is not included (IAAnVP). Note that even in the absence of
noise, TWA amplitudes are slightly underestimated as a consequence of the
pre-processing baseline removal linear filter. Results evidenced also that
TWA amplitude was markedly underestimated and had a larger variance
when the VPC processing was not applied, being this bias larger as the noise
level increased for a given TWA level. Moreover, both bias and variance were
larger as the simulated TWA amplitude increased, but still both parameters,
and especially the variance, were greatly reduced when the processing of
ectopic beats and phase control were included.
Secondly, the impact of the number of VPCs on the TWA estimation was
also evaluated. In this case, IAAVP values remained essentially unchanged
as the VPC probability increased for low and medium levels of noise. Howe-
ver, both parameters, bias and variance, significantly increased for IAAnVP
even when a very low percentage of VPCs (5̃%) was allowed with low noise
levels, regardless of the noise type.
A similar pattern of degradation for any gn, bw and ma noises was
observed. Still, both methods appeared to be sensitive to high ma and em
noise levels (>100 µV) and >5% of VPCs probability. Actually, this led to
an over-estimation of IAAVP with greater variances, in the absence of TWA,
most probably due to noise components overlapping the TWA bandwidth,
thus being interpreted as TWA. Even so, results confirm that the new
approach represents a robust alternative for TWA estimation against the
presence of moderate levels of noise and VPCs and the possible subsequent
alternans phase reversal.
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Nonetheless, in this simulation study only the effect of the possible phase
resetting in the alternans sequence after the VPC has been taken into consi-
deration, disregarding other possible induced changes in TWA morphology
and amplitude, which were assumed unaltered. It is known that in real ECG
signals the presence of a VPC, in addition to the possible phase resetting of
alternans sequence, has also a derived effect in subsequent repolarizations,
and changes in T wave morphology after VPCs have been studied [210–212].
Consequently, other possible variations in the sequence of TWA amplitu-
des, that could interfere in TWA measurement, could be also present in real
ECGs.
4.5.2 Ambulatory ECG recordings
From a clinical perspective, with this work we have also demonstrated that
the inclusion of the VPC processing in the TWA estimation led to an en-
hanced predictive value of the average TWA activity in the examined CHF
population. That is, hazard ratios associated to the classification obtained
for IAAVP, including the VPC processing step, were always increased with
respect to those based on IAAnVP.
The motivation for using the long-term average of alternans activity in
ambulatory ECGs was to provide with a reliable and robust measurement
of TWA in a fully automatic way, but this requires for some additional re-
strictions in order to consider only suitable ECG segments to be included in
the automatic analysis. In particular in this study, segments were conside-
red suitable for the automatic analysis based on instantaneous RR-interval
changes associated to “Normal” labelled beats present in the segment, and
only those segments with instantaneous changes lower than 300 ms were in-
cluded (∆RRN < 300 ms). Nevertheless, from a physiological view-point, it
becomes necessary to limit the maximum presence of VPCs as it would not
make sense to measure TWA if many VPCs were included. Segments with
more than 20% of abnormal beats were directly excluded from the analysis.
Moreover, the sequential inclusion of ECG segments with a controlled
number of VPCs evidenced how the presence of VPCs affected the prognos-
tic value of the index. Using the most restrictive criterion, that is, discarding
segments containing any number of VPCs, led to the loss of predictability of
the IAAnVP. This could be explained by the low number of segments that
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had fulfilled this requirement, consequently compromising the long-term
average TWA estimation.
However, as this restriction was relaxed and segments with one VPC
were included, TWA(+) outcome obtained for both IAAnVP and IAAVP
was successfully associated to SCD, with more than a 2-fold increased risk
in TWA(+) classified patients than in TWA(-), providing the best stratifi-
cation performance. The inclusion of segments with 2 and 3 VPCs in the
analysis decreased the hazard ratio, but still with significant association
with SCD outcome for IAAVP. However, when the ectopic protection was
not included, then IAAnVP lost its predictive value. Still in the last case,
when no limitation in the number of VPCs was imposed (∆RRN < 300
ms), the predictive value of IAAnVP and IAAVP was lost.
Actually, the presence ofm VPCs in a 128-beat segment, originatesm+1
shorter subsequences within it, which, as m increases, could compromise the
local TWA estimation (i.e. yk,pre and yk,post) used for the posterior decision
in the concatenation of subsequences. This fact can be especially critical if it
is the case that the Spost alternans sequence is also altered by the abnormal
beat, being more sensitive as the number of VPCs included in the segment
increases. This may also explain why the inclusion of all segments with
more than 3 VPCs did not add additional prognostic value with respect
to the other scenarios. Some studies have already revealed an increment
in TWA amplitude after the occurrence of one isolated VPC just in some
patients [158, 208], but the effect of more than one VPC within a short
period of time (<128 beats) needs to be investigated.
Finally, higher thrisk values associated to the IAAVP (th
VP
risk) were obtai-
ned with respect to thnVPrisk, as reported on Table 4.3. This is in agreement
with the the fact that IAAnVP underestimates TWA amplitude with respect
to IAAVP as shown in the simulation study (see Figures 4.5 and 4.6). The
use of a 75th percentile of the total distribution of TWA measurements for
the definition of the thrisk, already utilized in [157], is commonly adopted
when a technique is first tested on a population [213,214]. Nevertheless, the
applicability of the cut-points derived in this study still require additional
prospective evaluation.
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Circadian analysis
TWA activity was significantly higher during the day periods than during
the night. Moreover, average TWA activity computed during the morning
(from 06.00 to 12.00 h) period was associated with the risk of SCD in CHF
patients. Interestingly, it coincides with the period of most elevated risk for
SCD, whose distribution has been reported to present a primary peak of
incidence from 7 to 11 a.m. and a secondary peak from 5 to 7 p.m. [207]. It
should be remarked that the IAA06−12VP index would considerably reduce the
required time for ECG monitoring from 24 to 6 hours, which could imply
some practical advantages in the clinical practice.
Moreover, the increasing trend observed in IAAVP when computed in
segments with increased HR is also consistent with the fact that TWA ampli-
tudes for the same subject rise with instantaneous HR. The HR-restriction





similar when considering IAA80VP and IAA
90
VP. However, only a weak cor-
relation was found between average HR and IAAVP along the day. This
suggests the influence of other HR-independent factors in IAAVP, which
are known to be also determinant for TWA and related to higher cardiac
electrical instability. Changes in autonomic neurotransmitters, with and
increased activity of sympathetic nervous system during the day, especially
more prominent at waking time, could be other determinant factors that
significantly influence TWA [151]. Also, fluctuations in symptomatic and
silent myocardial ischemia episodes, well-known to be linked to TWA phe-
nomenon, have been reported to present this similar behavior [215]. This
supports the hypothesis that TWA modulation along the day could be ac-
tually due to a circadian effect.
4.6 Conclusion
The proposed methodology for computing the index of average alternans,
deals with the presence of ventricular premature contractions and with the
possible induction of phase resetting in the alternans sequence. The simula-
tion study showed that it represents an accurate and noise-robust solution
for quantifying TWA. Moreover, the analysis of ambulatory ECGs of mild-
to-moderate CHF patients demonstrated the enhancement in the predictive
value of IAA for SCD stratification by analyzing segments with limited
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number of VPCs. In addition, results suggest that a circadian pattern mo-
dulates the IAAVP index, and that the time of the day should be considered
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5.1 Motivation
As introduced in section 1.4.3, AF is the most common arrhythmia and it
has become one of the most important public health issues in developed
countries, together with CHF. Both pathological conditions are highly as-
sociated to poor outcomes, including SCD. Actually, recent data reported
that AF can increase the risk of ventricular arrhythmias [80–83] leading to
SCD more often than to stroke. However, the mechanisms that associate
AF, CHF and SCD risk are still unclear and a deeper understanding is re-
quired to adopt effective predictive and therapeutic strategies in this target
population. ICD implantation, which protects from SCD by terminating
ventricular tachyarrhythmias, can be an alternative, but it results difficult
to identify those patients who may benefit the most from this therapy, es-
pecially in the AF subgroup.
The most common ECG-derived markers (see section 1.5 for a detailed
description), including QT-interval duration and dynamics, the Tpe interval
or TWA to name some of them, require the patient to be in sinus rhythm
to be properly assessed [161]. It is the highly irregular ventricular response
during AF, mainly influenced by the properties of the AV node and atrial
electrophysiology, that makes the use of those indices not appropriate in
this particular condition.
In this chapter, we hypothesized that a non-invasive stratification of
AF patients at risk of SCD is possible by assessing ventricular repolariza-
tion in the electrocardiogram signal. For that purpose, a new method to
quantify ventricular repolarization changes based on a selective heart rate
bin averaging technique is presented. New indices of repolarization varia-
tion are proposed and their prognostic values for SCD evaluated in a CHF
population with AF.
5.2 Materials
The potential clinical value of the proposed indices was evaluated in a cohort
of 171 patients with permanent AF enrolled in the MUSIC study, already
introduced in section 4.2.2. Some relevant patient characteristics of the AF
subgroup are summarized on Table 5.1. Within the study population, a
total of 19 patients were victims of SCD, 24 of other cardiac causes, 20 of
non-cardiac deaths and 108 were survivors after 48 months of follow-up.
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Table 5.1: Characteristics of atrial fibrillation patients. Data are presented as
mean±standard deviation and as absolute frequencies (percentages).
Overall population SCD group Non-SCD group
(n=171) (n=19) (n=152)
Age (years) 68.9±10.4 69.2±10.5 68.9±10.4
Gender (males) 128 (74.8%) 16 (84.2%) 112 (73.7%)
LVEF ≤ 35% 87 (50.9%) 14 (73.7%) 73* (48.0%)
NYHA class III 49 (28.6%) 5 (26.3%) 44 (28.9%)
Diabetes 50 (29.2%) 6 (31.6%) 44 (28.9%)
Ischemic etiology 46 (26.9%) 10 (52.6%) 36* (23.7%)
Beta-blockers 100 (58.5%) 9 (47.3%) 91 (59.9%)
Amiodarone 25 (14.6%) 2 (10.5%) 23 (15.1%)
Digoxin 106 (62.0%) 11 (57.9%) 95 (62.5%)
QRSd ≥ 120 ms 71 (41.5%) 11 (57.9%) 60 (39.5%)
*p≤0.05 SCD vs Non-SCD groups
LVEF: Left ventricular ejection fraction
NYHA: New York Heart Association; QRSd: QRS duration.
5.3 Methods
5.3.1 Preprocessing
Preprocessing of ECG recordings included detection and labelling of ven-
tricular complexes using the Aristotle ECG analysis software [204]. The
RR interval associated to the ith beat was defined as the difference between
the R-wave positions of the ith and (i− 1)th beats, as illustrated in Figure
5.1. Then, after high-pass linear filtering of baseline wander, the ECG was
low-pass filtered (with cut-off frequency of 15 Hz) in order to remove noise
out of T-wave frequency range and down-sampled by a factor of 2. From
the 3 orthogonal leads, the vector-magnitude of the VCG signal was also
computed.
5.3.2 Selective beat averaging
We proposed the use of a concept similar to selective beat averaging techni-
que [216] to compute the average T-wave variation waveform in consecutive
beats defined by bins of stable RR. The algorithm proceeds as follows:
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Figure 5.1: Illustration of the vectormagnitude of an ECG signal with main expli-
cative intervals.
1. After automatic identification, ventricular QRS − T complexes were
grouped based on their associated RR interval. To do that, we first
define S as the set of all triplets of consecutive beats within the Holter
recording: (i, i + 1, i + 2), for any initial beat i. We then subdivide
the considered range of RRs (initially between minRR = 300 ms and
maxRR = 1600 ms) into K bins, denoted as Ik, (k = 1, · · · ,K). For
each bin, an associated subset Sk is defined as containing those triplets
in S whose first element i is included in Ik, and whose difference
between consecutive RR intervals (i.e, between RR(i+1) and RR(i),
and between RR(i + 2) and RR(i + 1)) is lower than half of the bin
width. That is:













We set the bin width as δ=40 ms. In this step, basically triplets of
consecutive beats that were preceded by a similar RR interval were
selected, thus allowing the assumption of stability.
2. For each triplet of beats included in Sk, two T-wave variation wa-
veforms, ∆T1(n) and ∆T2(n), were defined as the difference between
each pair of consecutive ST-T complexes:
∆T(i,1)(n) = T(i+1)(n)− T(i)(n) (5.4)
∆T(i,2)(n) = T(i+2)(n)− T(i+1)(n), n = 1, . . . , N (5.5)
where Ti(n) denotes the ST-T complex of the i
th beat (Figure 5.1),
defined as a fixed interval of 300 ms after the end of the QRS complex,
with n the index of the sample within the complex.








where v+i (n) quantifies the average repolarization variation in each tri-
plet, and v−i (n) measures the alternant repolarization variation along
the three consecutive stable beats. In the following, we will use vector
notation, being v+i and v
−
i the column vectors whose elements are the
samples of v+i (n) and v
−
i (n), respectively.
4. Since this variation of the ventricular repolarization activity can be
within the range of few microvolts, comparable to the noise level, we
replicate the analysis already presented in the previous chapters in
the context of TWA analysis, where all TWA waveforms were alig-
ned in phase before final averaging. In this case, the phase-aligned
waveforms, va+i and v
a−



























where w+1 corresponds to the first eigenvector associated to the gre-
atest eigenvalue λ+1 of the correlation matrix Rv+ estimated from all
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variability vectors v+i , and w
−
1 is the first eigenvector associated to
the greatest eigenvalue λ−1 of the correlation matrix Rv− estimated
from all variability vectors v−i (see section 3.3.1 for more details).
5. Finally, the average repolarization variation associated to the kth bin,
i.e. the subset Sk, denoted as v
+
k , is defined as the median waveform
of all va+i computed for the respective bin. In the same way, the
alternant variation waveform associated to the same bin, denoted as
v
−
k , is defined as the median waveform of all v
a−
i .
5.3.3 The 3-beat indices of ventricular repolarization varia-
tion
Based on these two measurements, we propose two indices to characterize
the repolarization variation in the 24-hour Holter recording: the index of
average repolarization variation and the index of alternant variation within
sequences of 3 beats, I+V3 and I
−
V3, respectively. They were defined as the
mean absolute value of the final average waveform of all bins (of all va+k and
v
a−















































with N the total number of samples in the ST-T complex.











V3Z for leads X, Y and Z, respectively.
Additionally, we defined the heart-rate restricted indices I+90V3 and I
−90
V3 by
including only bins associated to heart rates faster than 90 beats/min (i.e.
RR <660 ms).
5.3.4 The 2-beat index of ventricular repolarization varia-
tion
Instantaneous beat-to-beat repolarization variation in 2-beat sequences, de-
noted as IV2, is also computed, following a similar approach but considering
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only pairs of 2 consecutive beats (i, i + 1) with similar RR. In that case,








RR(i) ∈ Ik, |RR(i+ 1)−RR(i)| ≤ δ2
}
(5.13)
A single T-wave variation waveform was computed for each pair of beats




























k (n), analogous to the computation of the previous indices, is
the median variation waveform of all ∆Ti (n) included in the corresponding
subset S′k, after being aligned in sign.
Also in this case, the index I90V2, including bins associated to heart rates
faster than 90 beats/min, was computed.
5.3.5 Statistical analysis
Data are presented as median (25th; 75th percentiles) for continuous varia-
bles and as number (percentage) for categorical variables, unless otherwise
specified. Two-tailed Mann-Whitney and Fisher exact tests were applied
to evaluate differences between groups in quantitative and categorical data,
respectively. Survival analysis was performed by using Kaplan-Meier esti-
mator and comparison of cumulative events between groups by the log-rank
test. Prognostic value of proposed indices in predicting SCD was deter-
mined with univariate and multivariate Cox proportional hazards analysis.
For all tests, the null hypothesis was rejected for p≤0.05.
5.4 Results







V3 are presented in Figure 5.2, for both SCD and
non-SCD groups of patients. As shown in the figure, SCD outcome was
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Figure 5.2: Distribution of IV3 and IV2 indices for non-SCD and SCD groups. *:
p≤0.05 non-SCD vs SCD.
I+V3 and I
−
V3 were not computable in 8 out of 171 Holters (4.7%) as only
2 leads were available and the vector-magnitude of the VCG could not be
computed. Moreover, the additional restriction imposed when computing
I+90V3 and I
−90
V3 , by considering only bins of RRs associated to HRs ≥ 90 be-
ats/min, led to the exclusion of 7 additional recordings (8.7% of the total
population) in which there was not any suitable triplet of beats accomplis-
hing the conditions in that range.
Both indices were also computed in each lead individually. The associ-
ated distributions, are shown in Figure 5.3. Also in this case, SCD group is
associated to higher values, with significant differences between groups in
case of using lead X and bins with HRs ≥ 90 beats/min.
Regarding the 2-beat indices, the distributions of IV2 and I
90
V2 values for
both groups are also presented in Figure 5.2 (right pannels). While IV2
values did not present significant differences between SCD and non-SCD
groups, I90V2 was higher in SCD group in comparison with the non-SCD





































































































Figure 5.3: Distribution of IV3X, IV3Y and IV3Z in left, middle and right pannels, for
non-SCD and SCD groups. *: p≤0.05 non-SCD vs SCD.
(11.49;26.296) µV, NS). In this case, I90V2 was not computable in 10 out of
171 recordings, either because only 2 leads were available (8 recordings) or
because the methodology did not select any processable interval (2 recor-
dings).
Then, the individual predictive value of each index was tested. To do
that, the same strategy as in the previous study was followed, setting a risk
threshold thrisk corresponding to the 75
th percentile of the total distribution
of IV3 values (i.e. IV3(+) if IV3 ≥ thrisk and IV3(−), otherwise).









were successfully associated to SCD outcome (see Table 5.2).
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Table 5.2: Association of IV3 and I
90
V2 indices with sudden cardiac death in patients
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M1: Adjusted model includes age, gender, New York Heart
Association class, left ventricular ejection fraction≤35%, diabetes,
the use of antiarrhythmic drugs (beta-blockers, digoxin
and amiodarone), and the proposed index
In addition to the univariate Cox proportional model, one multivariate
model (M1) was also constructed by adjusting for significant clinical covari-
ates including age, gender, NYHA class, LVEF≤35%, diabetes and the use
of antiarrhythmic drugs (beta-blockers, digoxin and amiodarone). To note,
the index I−90V3X preserves its predictive value with hazard ratios of 3.76 and
3.20 for univariate and M1 models, respectively.
Regarding to the I90V2 index, patients classified as I
90
V2(+) were success-
fully associated with SCD outcome, with hazard ratios of 2.66 and 2.88 for
univariate and M1 models, respectively (see Table 5.2). However, the index
lost its predictive value if no restriction in HR was imposed (IV2).
Figure 5.4 shows the Kaplan-Meier survival curves for SCD associated to
most significative indices. Clearly, mortality rates were always significantly
higher in the positive (+) group in comparison to patients classified as
negative (−) at the end of the follow-up period.
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5.4.1 Combination of IV3 and IV2
Finally, an additional analysis was performed to assess whether the use
of combined indices would improve SCD risk stratification. First, results
derived from the analysis of I−V3 and I
+
V3 were combined, then additional
information from I90V2 analysis was also included. Results from univariate
and M1 multivariate models are shown in Table 5.3. The combination of
I−V3 and I
+





most of the cases. Nonetheless, the better prognostic values were obtained
when I90V2 was also considered: the combination of patients that were simul-




V2(+) in the individual analysis,
identified patients with more than 4-fold increased risk of SCD in the univa-
riate analysis. The best performance is obtained by considering patients at




V2(+) (i.e, the group of patients
that were classified as positive in these three cases: I−V3X(+) & I
+
V3X(+) &
I90V2(+) group) which presented more than 6-fold increased risk of SCD in the
two predictive models (univariate and M1). Kaplan-Meier survival curve is
shown in Figure 5.4 (d).
5.5 Discussion
Non-invasive assessment of ventricular repolarization heterogeneities during
atrial fibrillation is not a straightforward task, consequence of the irregular
ventricular activity present under this particular condition. In this chapter,
a new method able to quantify ventricular repolarization changes, suitable
in the particular condition of AF was presented. The prognostic value of
some derived indices was evaluated in a chronic heart failure population with
AF. We found that both the 3-beat index of ventricular repolarization vari-
ation, I−90V3 , and the 2-beat index of ventricular repolarization variation I
90
V2,
restricted to heart rates ≥ 90 beats/min, which quantify consecutive T-wave
variations based on a selective beat averaging methodology, independently
predicted SCD in this study population. Interestingly, the computation
of IV3 in a single-lead basis led to an improvement in the predictive value






V3X). Moreover, risk stratifica-
tion based on the combination of IV3 and I
90
V2 indices rather than individual
performance, provided the identification of patients at highest risk of SCD.
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Table 5.3: Association of the combination of IV3 and I
90
V2 indices with sudden cardiac












































































































































































































































































































































































































































































































































































































The underlying mechanisms that associate AF and SCD are still in-
triguing. Actually, recent data have suggested SCD as the most common
single cause of death in AF patients, rather than stroke or deaths from
other cardiovascular origin [61, 217]. Indeed, some studies suggested that
AF is intrinsically pro-arrhythmic in the ventricle, increasing susceptibility
to ventricular arrhythmias (and, consequently, SCD) [80–83], whereas ot-
hers support the hypothesis that AF is actually acting through other risk
factors, like CHF, leading to the increase in SCD incidence [218, 219]. A
more comprehensive understanding of this phenomenon is still needed to
better plan treatment strategies. In this context, non-invasively ascertai-
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ning in what patients this proarrhythmic risk is higher, is crucial for the
question of therapy decision-making. However, it is the irregularity in the
ventricular response during AF that makes the use of well-established elec-
trocardiographic markers for SCD prediction not extensible to patients in
this rhythm. Indices such as TWA, among others, require the patient to be
under a sinus rhythm condition to be properly assessed [161], while there
is not any standard method for measuring QT interval/dynamics or TWA
when irregular ventricular rhythm is present. Data on SCD stratification in
AF patients based on electrical instability in the ventricle are scarce.
The methodology, measurements based on selective beat averaging [216],
selected consecutive beats preceded by a similar RR interval (≤ ±20 ms),
from which beat-to-beat variations in ventricular repolarization were asses-
sed under stable rhythm. First, selecting triplets of stable beats, two indices
were computed: I+V3, measuring the average repolarization variation within
the triplet, and I−V3, which could be considered as a measurement of the
average alternant variation in the triplet. The later arises as a first attempt
in the assessment of instantaneous local alternans, as the irregular ventri-
cular rate contraction during AF prevent from the evaluation of sustained
TWA. However, as the irregularity in HR increases, it can become challen-
ging to find 3-beats sequences with similar RR along the Holter recording,
and this can compromise the bin characterization. The IV2, restricted to
only two consecutive stable ventricular repolarizations, adds the advantage
that more stable pairs than triplets resulted available to characterize each
bin, leading to a potentially more robust estimation of the repolarization
variations. In all cases, the positive association of higher ventricular varia-
bility with SCD outcome in our study population is in agreement with the
fact that repolarization heterogeneity predispose to this fatal outcome in
sinus rhythm patients [161].
It is known that ventricular repolarization is very influenced by the he-
art rate in previous beats, with a memory that can attain 2-3 min [123,220].
Therefore, it can be argued that beats that are averaged within a given bin
may present different repolarization morphologies due to different RR histo-
ries. However, the QT/RR slope, which expresses adaptation of ventricular
repolarization to HR, has been shown to be decreased in AF compared to
sinus rhythm [221]. Also, the most important effect is that of the HR in
the previous beat, which is similar in all averaged beats. In the proposed
method, the beats selected for averaging have stable instantaneous HR and
they are averaged with other beats with similar previous HR. Also, due to
5.6 Conclusion 127
the irregular series of RR intervals that characterizes AF, it can be expected
that the effect of the different long-term histories will be small. Finally, the
averaging will fade the possible morphological differences, compensating the
different RR histories of the different pairs/triplets.
Several independent predictors associated to SCD in AF populations
have been proposed, including male sex, diabetes, history of myocardial in-
farction, heart failure, higher heart rate and left ventricular hypertrophy,
among others [61,217]. Also in a previous study based on the irregularity of
the RR series extracted from high-resolution 20-minute ECG, which inclu-
ded a subset of 155 AF patients from our cohort, authors demonstrated that
reduced irregularity of RR intervals in terms of approximate entropy (ApEn)
during AF was also predictive of all-cause death and SCD, in contrast to
traditional HRV indices [222]. However, to the best of our knowledge, this is
the first study in the attempt to non-invasively stratify CHF patients with
AF at risk of SCD by assessing ventricular repolarization instability from
the ECG signal. These results open the door to further research in this field.
For example, the evaluation of combined non-invasive indices of ventricu-
lar dispersion together with HR-derived indices may improve stratification
performance.
5.5.1 Limitations
The study present some limitations that need to be acknowledged. Although
results obtained in this study have shown prognostic value in our study
population, this population is limited in terms of the number of SCD events
(n=19). Therefore, further prospective studies in AF populations, with and
without CHF, are needed in order to evaluate the actual clinical value of
the indices. Moreover, this is a post hoc analysis and, as the MUSIC study
was aimed at the evaluation of prognostic models in CHF not focused on
the detailed analysis of the AF group, relevant information regarding the
clinical course of AF patients, such as duration, were not available.
5.6 Conclusion
In this chapter, we have shown how increased ventricular repolarization
beat-to-beat variation was associated to SCD in CHF patients with AF. We
have introduced two new sets of indices, computed from triplets and pairs
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V2 best stratified AF patients according to their risk of SCD,
with larger variability associated to lower survival probability. In addition,
risk assessment based on the combination of the proposed indices led to an
improved prognostic value compared to the individual performance, with
a better identification of high-risk patients. Although results should be
confirmed in additional prospective studies, these results encourage furt-
her research on the evaluation of ventricular repolarization ECG-derived
markers in future studies on patients with AF.
Chapter 6
Conclusions and future work
6.1 Summary and main
conclusions
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6.1 Summary and main conclusions
The objective of this thesis was to propose methodological advances for
the assessment of ventricular repolarization instability, in pathological and
abnormal conditions, leading to an improvement in prediction of ventricular
arrhythmias and, consequently, SCD risk. In particular, we have addressed
this objective by developing robust algorithms for the assessment of T-wave
alternans, in invasive and non-invasive cardiac signals. These methods have
been applied and evaluated in both experimental and clinical conditions.
First, TWA was simultaneously characterized in body-surface ECG and
intracardiac EGM signals during coronary artery occlusion. A multilead
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strategy that linearly combines the information available in different le-
ads maximizing the 2-beat periodicity (TWA periodicity) content was used.
This approach allowed us to find the optimal combination of intracardiac
leads usable for in-vivo monitorization of TWA directly from an ICD device.
Then, possible induced effects of simulated microgravity on cardiac elec-
trical instability were also assessed in terms of TWA. Based on the same
multilead approach, a long-term averaging technique for TWA estimation
on Holter recordings was used, and adapted for shorter and non-stationary
ECG recordings.
Finally, methodological advances in the assessment of ventricular repo-
larization instability in the presence of sporadic (VPCs) and sustained (AF)
rhythm disturbances were proposed. On the one hand, a methodological im-
provement for the estimation of TWA amplitude is proposed, which deals
with the possible phase reversal on the alternans sequence induced by the
presence of VPCs. On the other hand, the high irregularity of the ventri-
cular response in AF limits the use of TWA under this clinical condition.
A new method for assessing ventricular repolarization changes based on a
selective averaging technique was developed and new non-invasive indices
of repolarization variation were proposed. The positive impact in the prog-
nostic value of the computed indices was demonstrated in clinical studies.
6.1.1 Optimal detection of TWA in intracardiac electrogram
signals
T-wave alternans, reflecting spatio-temporal repolarization heterogeneity,
has been linked with electrical instability and an increased vulnerability of
the myocardium, predisposing to the development of ventricular arrhythmias
(VT/VF) [5]. It has been demonstrated that TWA can be inducible by coro-
nary artery occlusion [147,153,162,175,176], and it has been widely characte-
rized from body-surface ECG in both experimental models and humans. Ho-
wever, the analysis of TWA from intracardiac signals is scarcer and, in most,
cases limited to the study of pacing-induced alternans [163–165,167,168].
Attention has been recently focused on the usefulness in continuous mo-
nitoring intracardiac alternans as a predictor of electrical instability and
myocardial vulnerability [167–170], but a comprehensive intracardiac cha-
racterization of this phenomenon was first required.
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In this thesis, TWA phenomenon was measured at both body-surface
ECG and intracardiac EGM signals during coronary artery occlusion has
been characterized. To do that, a multilead approach based on periodic
component analysis (πCA) was used, that optimally combines the available
leads in such a way that the 2-beat periodicity of the signal is maximi-
zed [156], together with the Laplacian Likelihood Ratio Method (LLRM).
Intracardiac TWA was characterized by analyzing different leads in four
different anatomical locations: the coronary sinus, epicardial space and the
right and left ventricles.
Results obtained when analyzing TWA from the ECG leads were concor-
dant with previous studies in both humans and experimental data [153,162].
A similar behavior with the progression of the occlusion period was observed
on the intracardiac leads. TWA episodes in intracardiac signals appeared
delayed and were shorter that in the body-surface ECG leads, with higher
amplitudes. The comparison of multilead results with those obtained with
individual unipolar and bipolar leads confirms the improved sensitivity for
a given specificity that can be achieved by the multilead approach. Alt-
hough the sensitivity for TWA detection was higher in ECG leads than in
EGM leads from a single area, a linear combination of just two intracardiac
leads from the right ventricle and the coronary sinus can detect intracar-
diac alternans with a similar performance. The potentiality of this study,
as mentioned before, is that proper TWA monitorization using an ICD de-
vice, may provide real-time information of electrical instability and help in
properly delivering ICD therapy.
6.1.2 Methodological advances for analysis of TWA and ven-
tricular repolarization variations under rhythm distur-
bances
TWA tests are usually performed in the clinical routine under controlled
heart rate, typically by exercise-induced stress. However, an important per-
centage of the test performed using the commercially available methods (SM
and MMAM) still have indeterminate results [196–198]. One of the reasons
is the presence of ventricular premature contractions (VPCs). Even if the
LLRM has been shown to outperform estimation accuracy in the presence
of impulsive noise, as a VPC appearing within the alternans sequence, it is
known that VPCs may alter repolarization dynamics and introduce a phase
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reversal on the alternans sequence [158]. In this case, TWA estimation and,
consequently, its potential clinical value can be unfavourably affected.
The long-term averaging of alternans activity in ambulatory ECGs has
been shown to provide prognostic value for SCD [157]. The advantages of
this technique are that (i) it proceeds in a fully-automatic way, without the
necessity of posterior visual inspection; and (ii) it avoids a hard detection
stage and the need for a detection threshold definition.
In this thesis, we proposed the inclusion of a VPC processing step for
the control of the alternans sequence before and after the VPC, in order
to ensure its continuity in phase before TWA estimation. We have demon-
strated how the inclusion of this step leads to an improved stratification
performance of the index of average alternans (IAA) in a CHF population.
In addition, this index showed to be sensitive to the circadian pattern, pre-
serving its prognostic information when computed from 06.00 to 12.00 in
the morning. Interestingly, this day interval is known to be the one with
the highest incidence of SCD events.
If sporadic heart rhythm disturbances, as VPCs, compromised the use-
fulness of TWA, this phenomenon can not be assessed in the absence of a
sinus rhythm condition. The irregular ventricular activity present in atrial
fibrillation patients, therefore, is not suitable for TWA analysis. And to the
best of our knowledge, there are not standard ECG-derived risk markers
adapted to this particular condition.
With the aim of overcoming this limitation, we have developed a new
method to quantify beat-to-beat variations in ventricular repolarization on
ambulatory Holter recordings, during AF rhythm. Using a selective heart
rate averaging technique, consecutive beats preceded by a similar RR in-
terval were selected, and the average variation with in the ST-T complex
for each RR range computed. We proposed two new sets of indices: (i) the
2-beat index of ventricular repolarization variation, (IV2), computed from
pairs of stable consecutive beats; (ii) the 3-beat indices of ventricular repo-
larization variation, computed in triplets of stable consecutive beats, and
from which the average variation with in the triplet (I+V3) and the alternant
variation within the triplet (I−V3) were quantified.
These indices, when restricted to beats associated to HRs faster than 90
beats/min, were found to be significantly associated to SCD risk in CHF
patients with AF, with a larger ventricular repolarization beat-to-beat va-
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riation associated to lower survival probability. In addition, risk assessment
based on the combination of the proposed indices improved stratification
performance compared to their individual potential, providing with a bet-
ter identification of high-risk AF patients. As far as we know, this is a
pioneer study that attempts a non-invasive SCD stratification AF patients
through the assessment of the ventricular repolarization instability using
the ECG signal.
Nevertheless, the actual prognostic value of both methodologies needs
to be confirmed in larger prospective studies, and extending the analysis to
different clinical conditions.
6.1.3 Evaluation of changes on TWA activity induced by
simulated microgravity
Apart from studying the prognostic value of ventricular repolarization in the
pathologic heart, we have also studied the changes in the structurally normal
heart induced by a prolonged exposure to simulated microgravity. This
environmental condition affects the control of autonomic and cardiovascular
systems, with a potential increase of cardiac risk.
Changes in ventricular repolarization in terms of TWA activity have
been evaluated during and immediately after short- (5 days) mid- (21 days)
and long-duration (60 days) head-down bed-rest campaigns. A comprehen-
sive characterization of this phenomenon was provided by the analysis at
rest conditions, selecting the night period from ambulatory Holter recor-
dings, and during two stress induced manoeuvres: an orthostatic tolerance
test by head-up tilt and a V O2max exercise test. In this case, after πCA
transformation, the long-term averaging technique was used for TWA es-
timation. An adapted methodology, suitable for the analysis of shorter,
non-stationary ECG signals obtained during the two stress manoeuvres was
proposed (short-term averaging).
We concluded that a 60-day exposure to simulated microgravity was not
enough to induce significant changes in healthy myocardial substrate up to
the point of manifesting electrical instability in terms of TWA. However,
subjects from the long-duration campaign presented an increasing trend of
TWA activity after 60 days of immobilization period. Although this results
need to be confirmed with data from an ongoing campaign, they might
be indicative, together with previous observations of a reversible increase in
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repolarization heterogeneity after HDBR observed in other indices [180,181],
of initial alterations in the repolarization phase.
6.1.4 Clinical significance
Accurate stratification of patients at risk of SCD is crucial for improving
the actual cost-effectiveness of therapeutic strategies, which remains par-
ticularly low in the case of ICDs. Any efforts aimed at developing tools
that can help in clinical decisions, especially in the proper identification of
pro-arrhythmic factors, are, therefore, more than justified. The research
presented in this thesis sheds some light in this context.
On the one hand, ICD technology could be improved by integrating al-
gorithms for real-time monitoring of repolarization alternans that, if confir-
med in further studies, may help in increasing the effectiveness rate of shock
therapy. On the other hand, the ECG signal represents a non-invasive, easy
and, most important, cheap solution for cardiac evaluation. The study of
ventricular repolarization from the ECG, reflected on the ST-T complex,
can provide valuable prognostic information when abnormalities are pre-
sent. The computation of the indices proposed in this thesis using a simple
ambulatory ECG recording, would help in the identification of patients at
higher risk of suffering from SCD. All of that would present a positive
impact in both, the patient and healthcare systems. Finally, the analysis
of ECG signals recorded during reduced gravitational stimulus, as HDBR
experiments, also provides interesting information which can be taken into
account in immobilized or bedridden patients.
6.2 Future work
Some future research lines derived from this work are presented below. Some
of them have been already proposed in the previous chapters as a possible
solution to the acknowledged limitations; others arise from the obtained
results.
An optimal intracardiac lead configuration for TWA detection has
been proposed. In that study, TWA were induced by occlusion of
the LCX artery. However, it is known that TWA prevalence and
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magnitude are dependent on what and how myocardial region is af-
fected by the occlusion. Therefore, investigation of the optimal lead
combination when TWA are induced by occlusion in the left anterior
descending and the right coronary arteries would allow to define the
best configuration, also independent of the occlusion site.
The absence of significant changes in terms of TWA induced by long-
term exposure to microgravity did not allow us to draw clear conclu-
sions. Indeed, initial alterations were visible after 60 days of bed-rest,
though not statistically significant. A deeper evaluation of ventricu-
lar instability through other markers, such as QT and Tpe interval
dynamics, or the recently proposed index of T-wave morphology res-
titution would help to better elucidate possible electrical instabilities
after long-duration exposure to simulated microgravity.
The prognostic value of the indices presented in chapters 4 and 5 has
been validated in the MUSIC database, including patients with CHF
in sinus rhythm and AF, respectively. Future prospective studies,
extending also to other groups of patients, should validate their actual
clinical value.
The indices of ventricular repolarization variation proposed in chap-
ter 5, were computed using the three orthogonal leads, both indepen-
dently and from the vector-magnitude of the VCG signal. It would
be interesting to study if the use of multilead approaches, such as
PCA, could help to better capture the repolarization instability, thus,
improving predictability.
On the other hand, the joint evaluation of the proposed indices of
ventricular repolarization, together with indices related to the auto-
nomic nervous system, as those derived from HRV analysis or heart
rate turbulence, may improve stratification performance.
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